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ABSTRACT 
The work in this thesis describes the cloning and 
initial characterisation of a large gene family whose 
members encode specific proteases involved in the 
. 
lV 
processing of biologically active peptides. This family 
has been termed the glandular kallikrein multi-gene family 
since all its members encode serine proteases closely 
related to glandular kallikrein. Glandular kallikrein 
enzyme activity has been implicated_ by in vivo and in vitro 
studies in a wide variety of essential physiological 
functions, in addition to its role as a kininogenase. The 
use of molecular techniques has shown that the glandular 
kallikrein gene family comprises 25-30 highly homologous 
but distinct genes, all of which are closely linked on 
chromosome seven in the mouse. 
The 9.5 kilobase (kb) nucleotide sequence of a mouse 
genomic clone (AMSP-1) which contains one complete 
kallikrein gene (mGK~l) and the 3 1 end of another (mGK-2) 
has been determined. The two genes on AMSP-1 are encoded 
on the same DNA strand; the first gene (mGK-1) is complete 
and consists of five exons and four intrans, together 
spanning 4.5 kb. The 3 1 end of another gene (mGK-2) is 
located 3.7 kb upstream from the 5 1 end of mGK-1. The 
mGK-1 gene has been shown to be transcriptionally active in 
the male mouse submaxillary gland. 
V 
The isolation and partial characterisation of other 
genomic kallikrein clones has demonstrated that the 
kallikrein genes are frequently tightly linked and are 
highly conserved in their DNA sequence and structural 
organisation. Differences in the coding potential of these 
genes and the amino acid sequences of other known 
kallikreins seem to be functionally related to the 
substrate specificity of the different enzymes. 
In order to study the expression of the mGK-1 gene, a 
synthetic 19-mer homologous to a portion of mGK-1 was 
designed. This oligonucleotide was found to hybridise only 
to mGK-1 sequences. This method offers a means of 
investigating the tissue-specific expression of individual 
members of the kallikrein gene family. 
AMV: 
Apr: 
Bis: 
cDNA: 
Ci: 
ddNTP: 
dNTP: 
DNAse: 
ds: 
EDTA: 
Hepes: 
IPTG: 
kb: 
NaOAc: 
pfu: 
RNAse: 
ss: 
SSC: 
Tcr: 
Tris: 
UV: 
X-gal: 
ABBREVIATIONS 
avian myeloblastosis virus 
ampicillin resistant 
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complementary DNA 
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deoxyribonuclease 
double-stranded 
Vl 
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CHAPTER ONE 
GENERAL INTRODUCTION 
Eukaryotic protein biosynthesis is an extremely 
complex process involving a multitude of steps, most of 
which can be envisaged as points at which the expression of 
a particular phenotype may be regulated (Brown, 1981). 
Some of the regulatory mechanisms which operate on gene 
expression at the transcriptional, post-transcriptional and 
translational stages of protein biosynthesis have been 
identified and are the subject of recent reviews (Darnell, 
1982; Brown, 1981). Furthermore one can speculate that 
several types of post-translational control may operate, 
which also affect the final concentration of a particular 
protein in a cell. Following translation, proteins undergo 
many significant modifications before they appear in their 
biologically active/functional form. These include the 
alteration of specific amino acids by phosphorylation, 
glycosylation and acylation mechanisms (Uy and Wold, 
1977). In addition many biologically active peptides are 
initially synthesised as precursors which require a highly 
specific peptide cleavage event to occur before their 
activity can be fully realised (Neurath and Walsh, 1976). 
These final maturation steps represent another control 
point at which the expression of a eukaryotic gene may be 
influenced. 
The work described in this thesis involves the 
characterisation of a multi-gene family, members of which 
are responsible for the post-translational maturation of 
certain growth factors. The family has been termed the 
2 
kallikrein gene family since all of its members are closely 
related to glandular kallikrein. The following literature 
survey provides a background to the work described in this 
thesis. 
1.1 Post-translational limited proteolysis 
Since the initial discovery that proteolytic digestive 
enzymes such as trypsin and chymotrypsin are activated by 
the selective cleavage of a peptide bond (Neurath and 
Dixon, 1957), it has become . apparent that similar 
mechanisms operate in many fundamental biologi~al 
processes. Limited proteolysis plays an important role in 
blood coagulation (Davie and Fujikawa, 1975), blood 
pressure regulation (Orstavik, 1980), the complement 
pathway (Hugli, 1975) and polypeptide hormone production 
(Docherty and Steiner, 1982). 
The remainder of this chapter summarises what is 
currently known about the enzymes involved in polypeptide 
hormone maturation. Two control mechanisms have evolved to 
regulate the action of enzymes responsible for limited 
proteolysis as exemplified by the activation of 
trypsinogen. Trypsinogen, which is synthesised in the 
acinar cells of the pancreas, is initially activated by the 
highly specific protease, enterokinase, which is secreted 
from the brush border of the small intestine (Maroux 
et al. , 19 71) . Thus, by compartmentalising the substrate 
and the enzyme to different cells, the activity of trypsin 
I 
I 
I 
I 
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I 
I 
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is restricted to the digestive tract where it performs its 
primary degradative functions. This example also 
demonstrates the specificity of such limited proteolysis, 
since only one peptide bond is cleaved in trypsinogen and 
no other protein has yet been reported to be a substrate 
for enterokinase (Maroux et al., 1971). These control 
mechanisms of compartmentalisation and specificity may also 
be used to control the enzymes involved in the maturation 
of polypeptide hormones as detailed in the following 
sections. 
1.2 Polypeptide hormone precursors 
Peptide hormones fall into two categories according 
their biosynthetic pathways. The prolactin (Cooke et al., 
1981), placental lactogen (Shine et al., 1977), growth 
hormone (Seeburg et al., 1977) family and the glycoprotein 
hormone family (Fiddes and Goodman, 1979, 1980) are 
examples of hormones initially synthesised with a very 
hydrophobic NH 2-terminal prepeptide. This signal sequence, 
common to most secretory proteins (Chretien and Seidah, 
1981) assists in the initial microsomal segregation of 
peptides destined for secretion. This is .achieved by the 
signal recognition particle, which mediates the specific 
attachment of polysomes involved in the synthesis of 
secretory proteins to the microsomal membrane of the 
endoplasmic reticulum (Walter and Blobel, 1981). During 
the process of protein translocation across the membrane, 
,1, 
.I 
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the prepeptide sequence is removed (Walter and Blobel, 
1980). The above-mentioned hormones, after membrane 
transport and packaging are present in their 
physiologically active form ready for export. 
However, the vast majority of hormones fall into a 
different category, since in addition to a prepeptide which 
is lost during membrane transport, they possess extra 
'pro'-peptide sequences which are not required for 
biological activity. Such hormones include 
adrenocorticotropin (ACTH) ~ S-lipotropin (S-LPH) 
(Nakanashi et al., 1979), insulin (Steiner and _Oyer, 
1967; Ullrich et al., 1977), relaxin (Hudson et al., 
---- ----
1981a), somatostatin (Hobart et al., 1980), vasopressin 
( Land et al . , 1982), oxytocin (Land et al., 1983) and the 
enkephalin precursors (Kakidani et al., 1982; Noda et al., 
1982) . 
As a result of molecular cloning studies, it has 
recently become clear that many of the smaller peptide 
hormones are initially synthesised as part of a common 
precursor containing several different hormone sequences, 
often peptides which are regulated by the same 
physiological stimuli, such as the ACTH-S-LPH precursor 
(Nakanashi et al., 1979). An examination of the primary 
structure of hormone precursors (Figure 1.1) reveals that 
cleavage at one or a number of peptide bonds is required to 
release the biologically active component of the 
precursor. It would appear therefore that limited 
I 
~ 
Figure 1.1 Diagrammatic representation of the structure of 
polypeptide precursors (diagram reproduced from 
Steiner, 1982). The final biosynthetic products are 
represented as dark lines, and additional I pro' 
sequences as wavy or broken lines. More detailed 
information on the structure of the ACTH and 
enkephalin precursor forms has been published 
elsewhere (Nakanashi et al. 1979; Kakandani et al., 
--
1982; Noda et al., 1982). 
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proteolysis plays an important role in hormone 
biosynthesis, and thus may be an important step in 
regulating hormone activity. For this reason an 
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examination of the enzymes involved is essential for a 
complete understanding of hormone biosynthesis. 
1.3 Enzymes implicated in polypeptide hormone maturation 
A comparison of the proforms of various hormones 
reveals little in common with regard to the position, 
length and structure of the 'pro'-sequences. One 
generalisation that can be made is that sites cleaved 
during processing consist of basic amino acids usually 
present in pairs, commonly lysine-arginine (see Figure 
1 . 1 ) . Studies on an abnormal proinsulin, in which one of 
the cleavage site arginine residues has been changed to a 
neutral residue, show that this mutation prevents the 
• 
11, 
I 
I II 
correct processing of the insulin precursor (Gabbay et al., I 
' 
,ill 
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1979; Robbins et al., 1981). The presence of basic amino 
acids at the cleavage points would therefore appear to be a 
necessary requirement for correct maturation. It has been 
suggested that this requirement for basic amino acids 
points to the involvement of a tryptic-like enzyme(s) 
hormone processing (Steiner, 1982). In addition a 
. in 
carboxypeptidase-like activity would be required to remove 
the exposed basic residue after the initial cleavage has 
occurred (Steiner, 1982). 
Several studies have implicated the involvement of 
6 
both acid thiol and serine proteases in prohormone 
. processing. 
Since cleavage probably occurs at the stage of 
secretory processing near the Golgi apparatus and continues 
in the secretory granules (Sun et al., 1973; Steiner 
et al., 1974), extracts from these granules have been used 
to isolate potential processing enzymes. Extracts from the 
secretory granules of anglerfish and rat pancreatic islets 
have been shown to contain an activity which converts 
proinsulin, prosomatostatin_ and proglucagon into their 
respective active configurations (Fletcher et al., 1980; 
Fletcher et al., 1981; Docherty et al., 1982). By the use 
of specific inhibitors, these studies were able to 
demonstrate that the 'converting activity' shared many 
properties with acid thiol proteases. This activity was 
similar but clearly distinct from the well characterised 
acid thiol protease cathepsin B. 
An intriguing situation is the differential processing 
of the multi-hormone precursor pro-opiomelanocortin (POMC) 
in the anterior and intermediate lobes of the pituitary. 
The predominant products synthesised in the anterior lobe 
are ACTH and S-LPH while the intermediate lobe produces 
mainly a-melanotropin (a-MSH) and S-endorphin (Chretien and 
Siedah, 1981). One possible explanation for this 
differential expression of the component peptides of POMC 
is that different processing enzymes exist in each of the 
pituitary lobes. Loh and Gainer (1982) found an enzyme 
jl 
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activity in the secretory granules of rat intermediate lobe 
which was capable of converting toad POMC into ACTH, a-MSH 
and S-LPH but incapable of further processing S-LPH to give 
S-endorphin. Inhibitor studies again indicated that this 
activity was consistent with that of an acid thiol protease 
distinct from cathepsin B or D. Conversely other workers 
have demonstrated that a highly specific kallikrein-like 
serine protease called tonin can also cleave ACTH from the 
POMC precursor. This enzyme, present in large amounts . in 
the rat submaxillary gland has also been found in the 
anterior lobe of the rat pituitary (Chretien apd Seidah, 
1981). Clearly more detailed biochemical and physiological 
studies are needed before any of the above enzyme 
activities can be proven to be responsible for hormone 
maturation. 
Although very little is known about the enzyme(s) 
responsible for the specific processing of many hormonal 
peptides, a considerable amount of data has accumulated 
concerning the processing of nerve growth factor (NGF) and 
epidermal growth factor (EGF). Unlike the instances 
discussed above, the enzymes which process NGF and EGF 
remain bound to their specific substrates after the 
cleavage event facilitating the isolation and study of 
these particular processing enzymes (Frey et al., 1979; 
Berger and Shooter, 1977). Detailed biochemical studies 
have revealed that these enzymes are highly homologous 
serine proteases closely related to glandular kallikrein 
8 
(Bothwell et al., 1979). The remainder of this chapter 
will be devoted to a description of the properties of these 
enzymes and the evidence which suggests that they are 
encoded by members of a multi-gene family. 
1.4 Structure of the EGF and NGF complexes 
The male mouse submaxillary gland, being the richest 
source knowri for EGF and NGF, has been the tissue of choice 
for detailed studies of the biosynthesis of these growth 
factors (Frey et al., 1979; Berger and Shooter, 1977). 
EGF and NGF have been isolated from this gland as high 
molecular weight (HMW) complexes. The EGF complex of 
79,000 d, known as HMW-EGF, is composed of two EGF peptide 
chains, two molecules of binding protein (EGF-BP) and two 
zinc ions (Taylor et al., 1970). The growth-promoting 
activities of EGF, which include the accelerated 
proliferation and differentiation of skin tissue (Birnbaum 
et al., 1976), corneal epithelial tissue (Ho et al., 1974) 
and lung epithelium (Catterton et al., 1979), are 
attributed solely to the EGF peptide. The EGF-BP is a 
trypsin-like arginyl esteropeptidase (Taylor et al., 1970). 
High molecular weight NGF; (7S NGF; 130,000 d) is a 
complex of three subunits (a, S, y) having the 
stoichiometry a 2y 2S (Server and Shooter, 1976). The 
stability of this complex is dependent on the presence of 
zinc ions (Pattison and Dunn, 1975)~ The S-NGF peptide 
which is entirely responsible for the biological activity 
9 
of NGF (Greene et al., 1971), is composed of two identical 
peptide chains each containing 118 amino acids (Angeletti 
and Bradshaw, 1971). NGF activity has been shown to be 
essential for the survival and differentiation of 
sympathetic and sensory neurons (Levi-Montalcini and 
Angeletti, 1968; Levi-Montalcini, 1976) as well as the 
survival of adrenal chromaffin cell precursors (Aloe and 
Levi-Montalcini, 1979). They-subunit is a trypsin-like 
arginyl esteropeptidase with very similar properties to 
EGF-BP (Greene et al., 1969_; Server and Shooter, 1976). 
Although strikingly similar, y-NGF and EGF-BP will not 
substitute for each other in complex formation (Server and 
Shooter, 1976). No activity has yet been assigned to the 
a-subunit of NGF (Stach et al., 1980). 
The finding that the growth-promoting activity and the 
arginyl esteropeptidase activity both exist within the same 
intracellular granules, discounts any suggestion that these 
complexes are artifacts of purification (Pasquini et al., 
1974). Their biological relevance is also emphasised by 
their presence predominantly as BMW-complexes in mouse 
saliva (Burton et al., 1978). Studies have shown that the 
7S NGF complex must dissociate before any biological 
activity is achieved (Stach and Shooter, 1980; Harris-
Warrick et al., 1980). The biological effects of NGF and 
EGF have been recently reviewed (Carpenter and Cohen, 
1979; Thoenen and Barde, 1980). The following sections 
will be limited to a discussion of their biosynthesis. 
10 
1.5 Biosynthesis of EGF (Frey et al., 1979) 
The biologically active form of EGF, isolated from the 
HMW-EGF complex, is a peptide of 53 amino acids having a 
molecular weight Mr of 6045 d (Savage et al., 1972). A 
precursor to EGF, of molecular weight 9000 d was 
demonstrated by pulse-chase experiments performed on 
isolated mouse submaxillary glands. This Mr9000 species 
was isolated in its native form from submaxillary gland 
extracts, and shown by chymotryptic peptide mapping to 
contain all the peptides characteristic of EGF except for a 
modified ·cooH-terminal peptide. This indicates that the 
Mr3000 propeptide is located at the COOR-terminal end of 
proEGF. 
Incubation of the Mr9000 species with purified EGF-BP, 
at a 1:1 molar ratio, resulted in its complete conversion 
to the Mr6045 EGF species and the formation of the HMW-EGF 
complex. If EGF-BP was added to the Mr9000 species at a 
molar ratio of 0.5:1, only 50% of the Mr9000 species was 
converted to EGF. The reaction is thus stoichiometric 
rather than catalytic. The absolute specificity of this 
reaction was demonstrated by the inability of a five 
hundred fold excess of Y-NGF, S-NGF endopeptidase or 
trypsin to cleave the Mr9000 species. Thus EGF-BP is 
capable of processing proEGF and participating in the 
subsequent complex formation (Figure 1.2). 
The pulse chase experiments also indicated that there 
is an even larger precursor form of EGF which is probably 
11 
not solubilised under the conditions used or is not 
precipitated with EGF antibodies. The cloning of the mRNA 
for mouse EGF has indicated that the initial precursor form 
of EGF is considerably larger than the Mr9000 species 
(Ullrich, A., pers. comm.). It remains to be seen whether 
EGF-BP is responsible for the processing of this earlier 
precursor, but it is clearly responsible for the processing 
of the Mr9000 species to EGF. 
1.6 Biosynthesis of NGF (Berger and Shooter, 1977) 
The biosynthetic events believed to be involved in the 
formation of the 7S NGF complex are outlined in Figure 
1. 3. Pulse chase experiments performed on isolated 
submaxillary glands demonstrated an immediate Mr 22,000 
precursor of S-NGF. They-subunit of NGF is capable of 
cleaving this peptide to release individual S-NGF chains of 
13,260 d. Unexpectedly EGF-BP was also capable of cleaving 
proS-NGF correctly. However this seems unlikely to occur 
in vivo since Y-NGF would still be needed for the formation 
of the 7S NGF complex; an event in which EGF-BP is 
incapable of participating (Server and Shooter, 1976). The 
probable explanation for this result as advanced by Frey 
et al., (1979), is that the proS-NGF used was not in its 
native configuration since it was isolated from a 
denaturing gel. In contrast, experiments on proEGF (see 
1.4) were performed on a protein isolated directly from a 
Figure 1. 2. Diagrammatic representation of the postulated 
biosynthetic events in the formation of the high 
molecular weight EGF complex (reproduced from Frey 
et al., 1979). More recent experimental data 
indicate that proEGF lS a considerably 
peptide than that represented in this 
(Ullrich, A., pers. comm.). 
larger 
diagram 
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Figure 1.3 Biosynthesis of NGF and its high molecular 
weight complex, 7S NGF (Reproduced from Shooter 
et al., 1982). As detailed in 1. 6, the precursor 
form of NGF contains additional NH 2-terminal 'pro 
1 
sequences than illustrated here (Scott et al., 
1983) . 
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gland homogenate (Frey et al., 1979). The a-subunit of NGF 
may also confer some specificity on the reaction. 
The recent molecular cloning of the mRNA for S-NGF 
(Scott et al., 1983) has demonstrated that the initial 
----
precursor for S-NGF is larger than the Mr 22,000 precursor 
protein described by Berger and Shooter (1976). The 
nucleotide sequence of this clone predicts a 307 amino acid 
polypeptide which contains NGF (amino acids 188-305). 
There are three potential basic cleavage sites within the 
NH 2-terminal extension of NGF, at positions 115-116, 144-
147, 186-187 respectively; and an Arg-Arg pair at position 
305-306, adjacent to the carboxy-terminus. Whether 
cleavage occurs at all of these sites is unknown, but 
cleavage at residues 115-116 would result in a precursor 
product of Mr22,000 as observed by Berger and Shooter 
(1976). The authors suggest that since Y-NGF is capable of 
binding to the carboxy-terminal arginine residue of S-NGF 
(Server and Shooter, 1976) it is also responsible for the 
removal of the two carboxy-terminal amino acids (Scott 
et al., 1983). 
1.7 Relationship of Y-NGF and EGF-BP to other proteolytic 
enzymes 
The studies described in the two previous sections, 
clearly show that for the two growth factors, NGF and EGF, 
the mechanism of their biosynthesis involves processing 
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into the biologically active form and individual packaging 
into stable complexes ready for export(Server and Shooter, 
1976; Berger and Shooter, 1977; Frey et al., 1979). The 
two arginine-specific serine proteases involved in this 
mechanism, Y-NGF and EGF-BP, share very similar physical, 
chemical and immunological properties with each other and 
with other arginine-specific proteases found in the 
submaxillary gland (Bothwell et al., 1979). One of the 
characterised proteases in this class is S-NGF 
endopeptidase (Wilson and Shooter, 1979). Y-NGF, EGF-BP 
and S-NGF endopeptidase are all potent arginyl 
esteropeptidases as determined by their ability to cleave 
synthetic esters of arginine. They have very little 
general proteolytic activity and share similar inhibition 
properties (Wilson and Shooter, 1979). They all have 
molecular weights of around 26,000 d and very similar amino 
acid compositions as outlined in Table 1.1 (Thomas et al., 
1981; Taylor et al., 1974; Wilson and Shooter, 1979). 
The strong conservation of their amino acid sequence (~80% 
between Y-NGF and EGF-BP) and the demonstration that they 
share many common antigenic determinants clearly show that 
these three enzymes are members of a closely-related group 
of serine proteases (Thomas et al., 1981; Silverman, 1977; 
Bothwell et al., 1979). These similarities are further 
emphasised by the ability of S-NGF endopeptidase to form 
complexes, albeit of low stability,· with either EGF or with 
the a and S-NGF subunits (Wilson and Shooter, 1979). 
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Y-NGF EGF-BP S-NGF endo. 
K 19 21 17 
H 6 6 5 
R 4 4 3 
D+N 29 28 30 
T 17 15 12 
s 12 14 16 
E+Q 14 21 17 
p 16 15 19 
G 20 23 20 
A 12 14 12 
C 10 10 11 
V 12 11 12 
M 7 3 4 
I 9 7 12 
L 23 24 27 
y 9 10 7 
F 8 7 5 
w 6 5 4 
Table 1.1 Amino acid compositions of y-NGF (Thomas et al., 
1981), EGF-BP (Taylor et al., 1974) and S-NGF endopeptidase 
(Wilson and Shooter, 1979). Standard abbreviations are 
used for amino acids (Dayhoff, 1978). 
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In addition, all of these proteases were found to 
possess substantial kininogenase activity compared to their 
low general proteolytic activity. The kininogenase 
activity was measured by the ability to release vasoactive 
kinins from mouse plasma LMW-kininogen (Bothwell et al., 
1979). This is a property normally attributed to the 
proteolytic enzyme glandular kallikrein which, like these 
enzymes, is a highly-specific arginyl esteropeptidase 
having little or no general proteolytic activity (Orstavik, 
1980; Tschesche, et al., 1979). The S-NGF endopeptidase 
was found to be twenty-five fold more active as a 
kininogenase than either Y-NGF or EGF-BP (Bothwell et al., 
1979). The rate of kinin release by S-NGF endopeptidase 
was comparable to that previously described for mouse 
submaxillary gland kallikrein (Porcelli et al., 1976). As 
essentially all the kininogenase activity of the 
submaxillary gland co-purifies with S-NGF endopeptidase, 
Bothwell et al., (1979) maintain that S-NGF endopeptidase 
is identical to mouse submaxillary gland kallikrein. The 
similarity of these proteases to glandular kallikreins from 
other sources further emphasises that Y-NGF, EGF-BP and 
S-NGF endopeptidase (kallikrein) belong to the same enzyme 
family as glandular kallikreins, for example, Y-NGF is 60% 
and 71% homologous with pig pancreatic kallikrein and rat 
submaxillary gland kallikrein respectively (Tschesche 
et a 1 . , 19 7 9 ; Fiedler and Fritz, 1981; Lazure et al., 
1981). 
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S-NGF endopeptidase was so named because of its 
ability to cleave an NH 2-terminal octapeptide from the 
S-NGF chain. Since S-NGF endopeptidase is the major form 
of salivary gland kallikrein, the biological relevance of 
its action on S-NGF is questionable. This is supported by 
the finding that the modified S-NGF chain retains its 
biological potency (Mobley et al., 1976) and no biological 
activity has yet been demonstrated for the released 
octapeptide (Angeletti et al., 1974). 
Several reports (Schenkein et al., 1977; Wilson and 
Shooter, 1979) suggest that there are four additional 
kallikrein-like protease activities similar to Y-NGF, 
EGF-BP and S-NGF endopeptidase in the mouse submaxillary 
gland. These may include the serine protease y-renin, 
which mimics the activity of the acid protease renin by 
cleaving angiotensin 1 from angiotensinogen in vitro. 
Amino acid sequence analysis of y-renin (see Figure 3.3) 
suggests that it is very closely related to the kallikreins 
(Poe et al., 1983). The hypothesis that kallikrein (S-NGF 
endopeptidase), y-NGF and EGF-BP are only a few members of 
a large group of enzymes functioning in the proteolytic 
processing of biologically active peptides is supported by 
the finding of other growth-promoting activities associated 
with arginyl esteropeptidases (Weimar and Haraguchi, 
1975). 
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These include:-
{i) mesenchymal growth factor (MGF), which 
stimulates the growth of mesenchymal cells and causes a 
loss of differentiation in muscle and cartilage (Attardi 
et al., 1969). 
----
(ii) thymocyte transforming factor (TTF), responsible 
for the transformation of small thymic lymphocytes into 
cells of the plasma series without cell division (Naughton 
et a 1 . , 1 9 6 9 ) . 
----
(iii) factor two (F-2) which causes a powerful growth 
stimulation of mesenchymal cells (Weimar and Haraguchi, 
1975). 
A more detailed physical characterisation of these 
growth factors is necessary to determine if, like EGF and 
NGF, they are present as high molecular weight complexes 
comprising the growth factor and a specific kallikrein-like 
esteropeptidase activity. 
1.8 Glandular kallikreins 
As noted in the previous section, Y-NGF and EGF-BP are 
closely related to glandular kallikreins. This finding, as 
suggested in a recent review (Schachter, 1980), questions 
whether the many biological effects attributed to glandular 
kallikrein are the result of one protein or rather the 
cumulative actions of quite distinct but closely-related 
enzymes. 
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Kallikrein or kallikrein-like activities have been 
found in a wide variety of tissues in addition to the 
salivary gland (Werle, 1972). Recent studies using 
techniques of immunohistochemistry and immunoflourescence 
have defined the subcellular location of glandular 
kallikreins. Kallikrein has been localised to the tubular 
duct cells of the submaxillary gland (Orstavik et al., 
1975; Simson et al., 1978), the acinar cells of the 
pancreas (Orstavik and Glenner, 1978), and the distal 
convoluted tubular cells of the kidney (Orstavik et al., 
1979). Kallikrein-like antigens have been isolated from 
bovine mammary glands (Peeters et al., 1976) rat stomach 
(Uchida et al., 1980) and rat intestine (Moriwaki et al., 
-- ---
1980) as well as lung, brain and nerve tissue (Werle, 
1972). Interestingly the prostate gland of the guinea pig, 
in addition to containing substantial kallikrein activity 
(Schachter et al., 1978), contains large amounts of NGF. 
This kallikrein activity may be due to Y-NGF. 
The many proposed physiological roles for glandular 
kallikreins have recently been reviewed (Schachter, 
1980). These include the regulation of local blood 
pressure, ion transport, cell proliferation, and prohormone 
processing. In summary, the properties of the 
characterised members of the kallikrein enzyme family, in 
particular that of strict substrate specificity, suggest 
that glandular kallikreins play a role in many biologically 
significant events involving the limited proteolysis of 
biologically active peptides . 
CHAPTER TWO 
MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Chemicals and reagents 
Adenosine triphosphate (ATP): Sigma 
Ampicillin: Sigma 
Acrylamide: Bio-Rad 
Cesium chloride: Metallgesellschaft 
Chloramphenicol: Sigma 
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Deoxynucleotide triphosphates (dGTP, dATP, 
dTTP, dCTP): Sigma 
Dideoxynucleotide triphosphates (ddGTP, ddATP, 
ddTTP, ddCTP): P-L Biochemicals 
a-
32
P-cordycepin (~3000 Ci/mmol): Amersham 
a-
32 P-dATP and a- 32 P-dCTP (~3000 Ci/mmol): 
Amersham and New England Nuclear 
y-
32
P-ATP (~7000 Ci/mmol): New England Nuclear 
Dimethyl sulphate: Eastman-Kodak 
Guanidine thiocyanate: Merck 
Hydrazine: Pierce 
Isopropyl-S-D-thiogalactopyranoside (IPTG): 
Sigma 
I 
N,N -methylene bisacrylamide (Bis): Bio-Rad 
Nitrocellulose 0.45 µm, 0.1 µm: Schleicher and 
SchUll 
Phenol: Wako Chemical Industries 
Piperidine: Sigma 
2.1.2 
19 
Sephadex G-50 (medium): Pharmacia 
Spectinomycin: Upjohn 
I I 
TEMED (N,N,N N -tetramethylethylenediamine): 
Sigma 
Tetracycline: Sigma 
Urea: Schwarz/Mann 
5-Bromo-4-chloro-3-indolyl-S-D-
galactopyranoside (X-gal): Sigma 
X-ray film (AR, or RP-5): Kodak 
All other chemicals were analytical grade. 
Enzymes 
Unless otherwise indicated all enzymes were obtained 
from commercial sources and used in accordance with the 
manufacturer's specifications. 
sources were for: 
The following enzymes 
Bal31 exonuclease: New England Biolabs 
Calf intestinal alkaline phosphatase (CIAP): 
Collaborative Research 
Deoxyribonuclease I: Sigma 
E.coli DNA polymerase I, Klenow fragment: 
Boehringer-Mannheim and N.E. Biolabs 
Mungbean nuclease: P-L Biochemicals 
Proteinase K: Boehringer-Mannheim 
Pronase: . Boehringer-Mannheim 
2.1.3 
20 
Restriction enzymes: N.E. Biolabs, BRL, and 
Boehringer-Mannheim 
AMV reverse transcriptase: Life Sciences Inc. 
Ribonuclease A: Sigma 
s 1 nuclease: Sigma 
Terminal transferase: Ratliffe Biochemicals 
T4 DNA ligase: gift from N. Deacon 
T4 polynucleotide kinase: N.E. Biolabs 
Nucleic acids 
HindIII synthetic "linkers" (5 1 -CCAAGCTTGG-3 1 ) and the 
synthetic Ml3 primer (5'-GTAAAACGACGGCCAGT-3 1 ) were a gift 
from Genetech Inc., San Francisco. 
The synthetic kallikrein primer complementary to a 
portion of mGK-1 (5'-CAGGGGTTTTGGGCCAAAG-3 1 ) was a gift 
from J.Coghlan, Howard Florey Institute, Melbourne. 
Oligo(dT) 12 _ 18 and oligo(dT)-cellulose were obtained 
from Collaborative Research. 
Carrier nucleic acids were either from Boehringer-
Mannheim (E.coli tRNA) or Sigma (Herring sperm DNA). 
Influenza RNA size markers were a gift from J. Blok. 
Balb/c and C57BL/6 mouse genomic DNA were gifts from 
K. Reed. 
Some of the Quackenbush mouse submaxillary gland total 
RNA used in this study was a gift from T. Lockett. Other 
RNA samples were purified from mouse submaxillary glands 
provided by M. Sleigh (Quackenbush is an outbreed strain of 
Swiss Webster mice). 
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2.1.4 Bacterial strains and DNA vectors 
The following derivatives of E.coli Kl2 were used for 
transformation experiments and propagation of 
bacteriophages lambda and Ml3. 
RRl: 
LE392: 
JM103: 
F-, hsd S20 (rB-, mB-), ara-14 proA2, 
lacY1 , galK2, rpsL20 (Smr), xyl-5, mtl-1, supE44, 
A- (Bolivar et al., 1977). 
F,- hsd R514 (rK-, mK-), supE44, supF58, lacYl or 
6(laclZY)6, galK2, galT22, metBl, trpRSS, A-
(Murray et al., 1977) 
6(lac pro), thi, rpsL20(Smr) supE, endA, sbcB, 
I 
hsdR-, F traD36, proAB, laciq, Z6Ml5 (Messing et 
al., 1981). 
RRl and JM103 cells were grown in Luria (L) broth 
(tryptone, lOg/1; yeast extract, Sg/1; sodium 
chloride, Sg/1). LE392 cells were grown in 
L-broth supplemented with 10 mM Mgc1 2 and 0.2% 
maltose. 
DNA fragments were cloned into the plasmid pBR322 
(Apr, Tcr) (Figure 2.1) and the Ml3 vectors mp8 
and mp9 (Figure 2.2). 
Figure 2. 1 Restriction endonuclease map of the 4362 bp 
plasmid pBR3 22. The plasmid confers the phenotype 
Apr Tetr. Inactivation of the Amp and Tet genes can 
be achieved by cloning fragments into the unique Pst 
I or BamHI, HindIII and Sall restriction sites, 
respectively. The position of these sites a ·nd the 
additional unique restriction sites for Aval, PvuII, 
ClaI and EcoRI are shown within the inner circle. 
The posj_tion and size of the fragments obtained by 
digestiion of pBR3 22 with any of the enzymes TaqI, 
Ava II, Hae II, HinfI, Alu I, Hae III and HpaII are 
shown on the outer circles; sizes are ordered 
alphabetically (Bolivar et al., 1977; Sutcliffe, 
1978). 
Hind.II. 
Pvu I 
Hind TI;. 
Psi I r' ~Sol l Ampr r 
C1 
C 
10 
D t 
pBR322 
Figure 2. 2 A genetic map of the single-stranded phage 
vectors Ml3 mp8 and Ml3 mp9. The HaeII - cleavage 
sites of the two different vectors have been mapped 
with respect to the genetic map (Messing et al., 
1977). Map uni ts are given in kb. The difference 
between the two molecules is shown in detail by the 
nucleotide sequence of the . relevant region of the 
lac (S-galactosidase) gene. The recognition sites 
for . various restriction endonucleases are 
underlined. The amino acid sequence corresponding 
to the polylinker fragment which was inserted into 
the original vector Ml3 mp2 . lS set up and numbered 
(reproduced in modified form from Messing and 
Vieira, 1982). 
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2.2 Isolation of nucleic acids 
2.2.1 Mam_malian genomic DNA 
High molecular weight DNA was prepared from liver 
essentially as described by Gross-Bellard et al., (1973). 
All manipulations were carried out at 4°C unless otherwise 
stated. 10 g of liver in NKM buffer (0.15 M NaCl; 5 mM 
KCl; 2 mM MgC1 2 ) was broken up by 10 to 12 strokes in a 
tissue homogenizer. The cells were washed twice in NKM 
buffer and lysed by the addition of 2 mM MgC1 2 . An equal 
volume of TKM buffer (10 mM Tris-HCl, pH7.4; 0.2 M KCl; 2 
mM MgC1 2 ) was added and the cell debris, containing intact 
nuclei, collected by centrifugation at 5000xg for 10 
minutes. The pellet was resuspended in NKM buffer, washed 
twice in an equal volume of NKM buffer, and added dropwise 
to a slowly stirring solution of 10 mM NaCl, 10 mM Tris-
HCl, pHB.O, 10 mM EDTA, 0.5% sodium dodecyl sulphate (SDS), 
100 µg proteinase K/ml at 37°C over a 12 hour period. A 
further 100 µg proteinase K/ml of was added and the 
solution incubated overnight at 37°C. The solution was 
gently extracted with an equal volume of phenol saturated 
with TE (10 mM Tris-HCl, pH8.0; 1 mM EDTA) and chloroform 
(1:1). After centrifugation at 5000xg for 10 minutes, the 
solvent phase was removed and the aqueous phase extracted 
with an equal volume of chloroform in a similar fashion. 
The aqueous solution was dialysed against three changes of 
TE for 16 hours. The viscous solution was treated with 
23 
ribonuclease A (20 µg/ml, 37°C, 3 hours), phenol-chloroform 
extracted and dialysed against TE for a further 16 hours. 
The high molecular weight DNA (200-500 µg/ml) was stored at 
4°C. Genomic DNA was prepared from tissue culture cells by 
the same procedure. 
2.2.2 RNA isolation from tissue (Kaplan et al., 1979) 
Mouse submaxillary glands were surgically removed from 
adult male Quackenbush mice and added to 5 volumes of 
extraction buffer (SM guanidine thiocyanate; 10 mM EDTA; 
50 mM Tris-HCl, pH7.6; 5% v/v S-mercaptoethanol) and 
homogenized using an Ultra-Turrax blender. Sodium lauryl 
sarcosine was added to 4% (w/v) and the solution mixed by 
homogenization, followed by the addition 0.5 g of . cesium 
chloride (CsCl) /ml of homogenate. 32 ml of this solution 
was carefully layered onto a 6.0 ml cushion of 5.7 M CsCl 
in a SW27 ultracentrifuge tube. After centrifugation 
(25,000 rpm, 16 hours), the supernatant was decanted and 
the pelleted RNA resuspended in TE, followed by the 
addition of 0.1 volume of 3M NaOAc, pH6.0 and 2.5 volumes 
of ethanol. The RNA was kept at -20°C under ethanol until 
required. 
2. 2. 3 
1972) 
Purification of poly{A)+ mRNA (Aviv and Leder, 
A column containing 0.5 g of preswollen oligo(dT)-
cellulose was washed in 0.1 M NaOH, and equilibrated with 
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binding buffer (0.5 M NaCl; 10 mM Tris-HCl, pH8.0; 1 mM 
EDTA). Total RNA was resuspended in binding buffer at a 
concentration of 1 mg/ml, heated to 65°C for 5 minutes, 
cooled on ice and loaded onto the oligo(dT) column. The 
flow of RNA was monitored by A260 as measured by an ISCO 
ultra-violet (UV) spectrophotometer. After all the unbound 
RNA had passed through the column, the poly(A)+ mRNA was 
eluted with TE buffer (10 mM Tris-HCl, pH8.0; 1 mM EDTA). 
The poly(A)+ peak fraction was collected and further 
purified by an additional cycle of oligo(dT)-cellulose 
chromatography. 
2.2.4 Supercoiled plasmid DNA (Clewell, 1972; Guerry 
et al. , 19 7 3) 
RRl cells containing the appropriate plasmid were 
grown overnight in L-broth containing antibiotics (either 
20 µg Tetracycline/ml or 50 µg Ampicillin/ml). 10 ml of 
stationary phase cells were added to 1 litre of prewarmed 
L-broth and incubated at 37°c with shaking until the cells 
reached mid-log phase (on600 = 0.4-0.5). At this point 
chloramphenicol (150 µg/ml) or spectinomycin (250 µg/ml) 
was added to the culture and incubation at 37°C was 
continued for 12-16 hours. 
Cells were collected by centrifugation (5000 rpm, 
5 min.), resuspended gently in 20 ml of ice-cold 25% 
sucrose in TE, and Lysozyme (5.0 ml, 5 mg/ml) and EDTA 
(10 ml, 0.25M, pH8.0) were added and the mixture was 
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. incubated on ice for 10 minutes. 30 ml of Triton lysis mix 
(0.1% v/v Triton X-100; 62.5 mM EDTA, pH8.0; 20 mM Tris-
HCl, pHB.O) was added and the mixture centrifuged at 18,000 
rpm for 45 minutes in an SS-34 rotor. The supernatant was 
carefully decanted, treated with ribonuclease A (1 µg/ml, 
30 minutes, 37°C) and subsequently with pronase (1 µg/ml, 
30 minutes, 37°C). The solution was phenol-chloroform 
(1:1) extracted and the aqueous phase dialysed against 
three changes of 0.3 M NaCl in TE for 16 hours. 2.5 
volumes of ethanol were added, the solution chilled at 
-20°C for 2 hours, and the precipitated DNA was pelleted by 
centrifugation (10,000 rpm, 15 minutes, SS-34). 
Supercoiled plasmid DNA was prepared by CsCl/ethidium 
bromide density gradient centrifugation. The precipitated 
DNA was dissolved in a solution containing 2.8 ml of TE, 
3.3 g of CsCl and 0.7 ml of EtBr (4 mg/ml) and centrifuged 
for 40 hours at l8°C (SW55 Ti, 45,000 rpm; Ti50, 45,000 
rpm). The above volumes were scaled according to the 
amount of plasmid DNA to be purified. DNA in the gradient 
was visualized by UV light (350nm) and the lower 
supercoiled plasmid DNA band was removed by side-puncture 
with a 30 (gauge) needle. Ethidium bromide was removed by 
four sequential extractions with isobutanol saturated with 
TE. After an ether extraction to remove any remaining 
isobutanol, the plasmid DNA was dialysed against three 
changes of 0.3 M NaCl in TE for 16 hours. DNA was ethanol 
precipitated (2.5 volumes EtOH, -70°C, lhour), resuspended 
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in water (concentration~ lmg/ml) and stored frozen at 
-20°C. 
2.2.5 Ml3 double-stranded(ds) replicative form (Messing 
et a 1 . , 19 7 7 ) 
One litre of L-broth was inoculated with 50 ml of 
stationary phase JM103 cells and 0.5 ml of Ml3-infected 
JM103 cells. Cells were harvested when they had reached 
stationary phase (37°C, 4-5 hours) and the Ml3 double-
stranded replicative form was purified by the same 
procedure used for plasmids (2.2.4). 
2.2.6 
1980) 
Ml3 single-stranded (ss) DNA (Heidecker et al., 
Ml3 plaques were picked with an applicator stick, 
inoculated into 2 ml of L-broth and grown for 6 hours at 
37°c. 1.5 ml of cells were centrifuged in an Eppendorf 
bench centrifuge for 60 sec. One ml of supernatant was 
aspirated and mixed with 300 µl of a 25% polyethyleneglycol 
6000/2.5 M NaCl solution and incubated overnight at 4°C. 
Phage were pelleted by centrifugation (4 mins, Eppendorf) 
and resuspended in 100 µl of TE. The ssDNA ( 2-5 µg) was 
purified by phenol-chloroform (1:1) extraction and ethanol 
precipitation. 
2.2.7 
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Bacteriophage lambda DNA (Maniatis et al., 1978) 
Bacteriophage (10 5-10 6pfu) stored in PSB (0.01 M Tris-
HCl, pH7.4; 0.1 M NaCl; 0.01 M MgC1 2 ; 0.05% gelatin) were 
adsorbed to 100 µl of a stationary phase culture of LE392 
in 1 ml of LM broth at 37°C for 30 minutes. The infected 
culture was added to 40 ml of pre-warmed LM broth and 
incubated at 37°c with vigorous shaking, until lysis had 
occurred. 
After cell debris had been removed by centrifugation 
(10,000 rpm, 15 min) the supernatant was treated with 
deoxyribonuclease I (10 µg/ml) and ribonuclease A (10 
µg/ml) for 30 minutes at 37°C. Phage particles were 
precipitated by the addition of a fifth volume of 25% 
polyethyleneglycol 6000/2.5 M NaCl and incubation at 4°C 
overnight. The precipitated phage were pelleted by 
centrifugation (8000 rpm, 20 min.) were resuspended . in 1 ml 
of ~.80 buffer (0.01 M Tris-HCl, pH7.4; 0.1 M NaCl) and 
incubated at 37°c with SDS (0.5%) and pronase (10 µg/ml) 
for 30 minutes. DNA was purified by phenol-chloroform 
(1:1) extraction and precipated by the addition of 0.1 
volume of NaOAc, pH6.0 and 2.5 volumes of ethanol. After 
incubation at -20°C for 30 minutes the phage DNA was 
pelleted in an Eppendorf microfuge, washed in 95% ethanol 
and resuspended in water at a concentration of 
approximately 0.1 mg/ml. Phage DNA stocks were routinely 
stored at 4°C. 
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2.3 Enzymatic reactions 
2.3.1 Restriction endonuclease digestion 
DNA was restricted at concentrations of 50-200 µg/ml 
in HaeIII buffer (6.6 mM MgC1 2 ; 6.6 mM S-mercaptoethanol; 
6.6 mM Tris-HCl, pH7.4). Salt was added to the reaction as 
specified by the manufacturer's conditions for each 
enzyme. Generally a two-fold excess of enzyme was used and 
the digest allowed to proceed for 2 hrs at 37°C (65°C for 
TaqI). Reactions were terminated either by heating at 65°C 
for 5 minutes or by the addition of EDTA (to 12.5 mM), 
followed by phenol-chloroform (1:1) extraction and ethanol 
precipitation (as above). The extent of the digestion was 
monitored by routine gel electrophoresis. 
2.3.2 Bal31 digestion of DNA (Legerski et_ al., 1978) 
The exonuclease Bal31 was used to generate a series of 
overlapping plasmid deletions for use in sequence 
analysis. Linearised plasmid DNA (25 µg) was incubated 
with 15 units of Bal31 at 30°C in a volume of 250 µl of 
reaction buffer (12 mM CaC1 2 ; 600 mM NaCl; 1 mM EDTA; 20 mM 
Tris-HCl, pH8.l). Aliquots were removed at 1 minute 
intervals, phenol-chloroform (1:1) extracted and ethanol 
precipitated. The extent of the reaction was monitored by 
agarose gel electrophoresis. Conditions were adjusted 
according to the extent of the deletion required. 
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2.3.3 Synthesis of high specific activity hybridisation 
probes (Taylor et al., 1976) 
Radioactively-labelled DNA hybridisation probes were 
prepared by primed synthesis using the Klenow fragment of 
E.coli DNA polymerase I and random primers. The random 
primers of 8-12 nucleotides in length, were prepared by 
treating herring sperm DNA with DNase I and fractionation 
on a DEAE-Sephadex G-50 column. Plasmid DNA or isolated 
insert DNA (~l00-200ng) was denatured in the presence of 
100 µg of primers by boiling for 2 minutes and cooling on 
ice for 1 minute. The reaction mixture was made up to 
30 µl by the addition of cold deoxynucleotide triphosphates 
(dATP, dGTP and dTTP to 0.75 mM), 30 µCi of a 32-P-dCTP 
(~3000 Ci/ mmol), reverse transcriptase buffer (final 
concentration: 50 mM Tris-HCl, pH8.3; 7 mM MgC1 2 ; 20 mM 
KCl; 20 mM S-mercaptoethanol) and 1 unit of E.coli DNA 
polymerase I (Klenow). After 30 minutes incubation at 
37°C, the reaction was terminated by the addition of EDTA 
(to 12.5 mM) and phenol-chloroform (1:1) extraction. The 
aqueous phase was passed through a Sephadex G-50 column 
(1 x 6 cm, G-50 medium grade) equilibrated with O.lM NaCl 
in TE. Approximately 400 µl fractions were collected from 
the column and their radioactivity monitored using a Geiger 
counter. The labelled DNA probe, which eluted in the void 
volume, was ethanol precipitated and its specific activity 
determined by Cerenkov counting. The specific activity 
obtained was between 10 7-10 8 cpm/µg DNA. 
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2.3.4 (a) Labelling 3'termini with a- 32 P-dNTP's 
and reverse transcriptase (Roberts et al., 1979) 
Restricted DNA (20 µg) was dissolved in a 40 µl 
reaction containing 50 mM Tris-HCl, pHB.3, 7 mM MgC1
2
, 
20 mM KCl, 10 mM S-mercaptoethanol, 30 µCi of the 
appropriate a- 32 P-dNTP and 30 units of AMV RNA-dependent 
DNA polymerase (avian myeloblastosis virus reverse 
transcriptase) and incubated at 37°c for 30 minutes. The 
labelling reaction was terminated by the addition of EDTA 
(to 12.5 mM) and two . successive phenol-chloroform (1:1) 
extractions followed by ethanol precipitation. 
(b) Labelling 3'termini with a- 32P-cordycepin 
and terminal transferase (Tu and Cohen, 1980) 
DNA samples which had been restricted with the 
enzymes PstI and SacI were labelled at their 3'termini with 
a-
32P-cordycepin. DNA (30 µg) was labelled in a 50 µl 
reaction volume containing 0.1 M potassium cacodylate, 2.5 
mM Tris base, 1 mM Coc1 2 , 2 mM dithiothreitol, pH6.9, 40 
µCi of a- 32P-cordycepin and 12 units of terminal 
transferase. After 30 minutes incubation at 37°C, the 
reaction was terminated by the addition of EDTA (to 12.5 
mM), phenol-chloroform (1:1) extraction and ethanol 
precipitation. 
DNA labelled at the 3'termini by either method 
(a orb) was further restricted so that fragments only 
labelled at one end could be prepared for chemical 
degradation sequencing reactions (2.7.1). 
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2.3.5 Labelling 5'termini with y- 32P-ATP and T4 
polynucleotide kinase (Chaconas and van de Sande, 1980) 
DNA fragments were treated with calf intestinal 
alkaline phosphatase (CIAP) in order to remove their 5 1 
phosphate groups. The 5'termini were then labelled by 
incubation at 37°C for 30 minutes in a 20 µl mix containing 
60 mM Tris-HCl, pH7.5, 8 mM MgC1 2 , 10 mM dithiothreitol, 50 
µCi of y- 32 P-ATP and 2 units of T4 polynucleotide kinase. 
The reaction was terminated by the addition of EDTA (to 
12.5 mM) and phenol-chloroform (1:1) extraction, followed 
by ethanol precipitation. 
Synthetic DNA fragments labelled in this fashion were 
purified by ion-exchange chromatography on a G-25 DEAE-
Sephadex column. 
2.3.6 Construction of double-stranded complementary DNA 
(ds cDNA) 
Synthesis of ds cDNA was performed essentially as 
described by Ullrich et al., (1977). Single stranded (ss) 
cDNA was synthesised in a 150 µl reaction volume containing 
20 µg poly{A)+ mRNA, 50 mM Tris-HCl pH8.3, 20 mM KCl, 7 mM 
MgC1 2 , 10 mM S-mercaptoethanol, 20 µg of oligo (dT) 12 _ 18 , 
1 mM dGTP, dATP, dTTP, 0.1 mM dCTP, 30 µCi of a- 32P-dCTP 
and 50 units of reverse AMV transcriptase. This reaction 
mixture was incubated at 42°C for 45 minutes and then 
terminated by the addition of EDTA (-to 12.5 mM) and two 
sequential phenol-chloroform (1:1) extractions. The RNA-
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DNA hybrid was purified from unincorporated deoxynucleotide 
triphosphates by G-50 chromatography (2.3.3). After 
ethanol precipitation, the RNA was hydrolysed at 70°C for 
30 minutes in a 100 µl reaction containing freshly prepared 
0.1 M NaOH and 1 mM EDTA. Hydrolysis was terminated by the 
addition of a tenth volume of 2M NaOAc, pH4.5 and 2.5 
volumes of ethanol. 
Second-strand synthesis was performed in a 100 µl 
reaction volume containing the ss cDNA, 50 mM Tris-HCl, 
pH8.3, 20 mM KCl, 7 mM MgC1 2 , 10 mM 8-mercaptoethanol, 1 mM 
each of dATP, dGTP, dTTP, 0.1 mM dCTP, 30 µCi of a-32p_ 
dCTP, and 25 units of AMV reverse transcriptase. After 
incubation at 42°C for 90 minutes, 2 units of E. coli DNA 
polymerase I (Klenow) were added and the reaction mixture 
incubated for a further 10 minutes at room temperature. 
The ds cDNA was purified by G-50 chromatography. The 
success of the second-strand synthesis was monitored by 
comparing its sensitivity to the single-strand-specific 
exonuclease s 1 with that of the single-stranded cDNA. 
The hairpin loop of the ds cDNA was removed by 
_incubating the DNA at 20°C for 10 minutes in a 50 µl 
reaction volume containing 0.3 M NaCl, 30 mM NaOAc, pH4.5, 
4.5 mM Znso4 and 100 units of s 1 nuclease. The reaction 
was terminated by the addition of a tenth volume of Tris 
base, pHl0-11, EDTA (to 12.5 mM) and phenol-chloroform 
(1:1) extraction. ds cDNA was purified by G-50 Sephadex 
chromatography and ethanol precipitation. 
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The termini of the ds cDNA were repaired by incubation 
at 20°C for 10 minutes in a reaction volume containing 50 
mM Tris-HCl, pH8.3, 7 mM MgC1 2 , 20 mM KCl, 10 mM S-
mercaptaethanol, and 1 µM dNTP's and 1 unit of E.coli DNA 
polymerase I (Klenow). The reaction was terminated by the 
addition of EDTA (to 12.5 mM), phenol-chloroform (1:1) 
extraction and ethanol precipitation. 
Synthetic "linker" DNA, encoding the HindIII 
recognition sequence (5'-CCAAGCTTGG-3'), was ligated to the 
cDNA (2.3.8) before insertion into the HindIII site of 
plasmid pBR322 (Shine et al., 1977). 
2.3.7 
1977) 
Dephosphorylation of vector DNA (Shine et al., 
To increase the efficiency of vector-insert ligation, 
vector DNA was treated with alkaline phosphatase to remove 
the 5' phosphate groups. Vector DNA was treated with CIAP 
(0.1-0.2 units/µg DNA) in the presence of 100 mM Tris base, 
pH 10-11, 0.2% SDS for 1 hour at 37°C. The reaction was 
terminated by three sequential phenol-chloroform (1:1) 
extractions and ethanol precipitation. The precipitated 
DNA was washed twice with 70% ethanol and once with 95% 
ethanol to remove SDS. 
2.3.8 Ligation of DNA molecules (Ullrich et al., 1977) 
Cohesive-end ligations were performed at DNA 
concentrations of 20-50 µg/ml in the presence of 
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0.5 mM ATP, 8 mM MgC1 2 , 10 mM dithiothretiol, 60 mM Tris-
HCl, pH7.5 and 2 units of phage T4 DNA ligase. Ligation 
reactions were incubated overnight at 4°C. The extent of 
ligation was monitored by agarose gel electrophoresis, 
using an unligated control. Blunt-end ligations (including 
linker ligations) were performed as above but at higher DNA 
concentrations (100-200 µg/ml) and in the presence of 
0.1 mM ATP. 
2.4 Bacterial transformation and selection of 
recombinants 
2.4.1 Transformation 
Competent RRl (for pBR322 plasmid recombinants) and 
JM103 (for Ml3 phage recombinants) cells were prepared and 
stored as 500 µl aliquots at -70°C (Morrison, 1979). An 
aliquot of the ligation mixture (2.3.7) was added to 200 µl 
of thawed competent cells, incubated on ice for 30 minutes 
and then heat shocked at 42°C for 90 seconds. 
For RRl transformations, the mix was left on ice for 
30 minutes, inocubated into 5 ml of L-broth and incubated 
at 37°c for 1 hour. 100 µl aliquots of this culture were 
spread on selective media (containing 20 µg tetracycline/ml 
or 50 µg ampicillin/ml) and the plates incubated overnight 
at 37°c. 
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For JM103 transfections, subsequent to the heat shock, 
dilutions of the transfection mix were added to 200 µl of 
mid-log phase JM103 cells, 20 µl of O.lM isopropyl-S-D-
thiogalactopyranoside (IPTG), 10 µl of 5-bromo-4-chloro-3-
indolyl-S-D-galactopyranoside (X-gal) (100 µg/ml in 
dimethyl formamide), and 2.5 ml of molten soft agar (0.7% 
agar in L-broth). This mixture was rapidly mixed and 
poured onto an L-plate and incubated overnight at 37°C. 
Recombinant phage were initially detected as those forming 
white or colourless plaques. Wild-type Ml3 form a blue 
plaque as they retain the ability to cleave the galactosyl 
residue from the synthetic galactosidase substrate X-gal. 
2.4.2 Plasmid miniscreen 
The presence of the plasmid pBR322 confers resistance 
to ampicillin and tetracycline (Apr,Tcr) (Bolivar et al., 
1977). The insertion of a piece of DNA into restriction 
sites within these antibiotic resistance genes (e.g.: 
HindIII and BarnHI in Tcr and PstI in Apr) leads to a loss 
of this phenotype. Cells harbouring recombinant plasmids 
were identified initially by their ApsTcr or AprTcs 
phenotypes. Colonies of the required phenotype were 
screened for the presence of a recombinant plasmid by the 
following procedure. 
A portion of the colony was picked and incubated on 
ice for 30 minutes in the presence of lysozyme (1 µl, 
5 µg/ml) EDTA (1 µl, 0.25 rnM) ribonuclease A(l µl, 1 µg/ml) 
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and TE ( 20 µ 1) . 6 µl of sample dye (25% glycerol; 5% SDS; 
0.2% bromophenol blue; 0.2% xylene cyanol FF) were added 
and the reaction mixture incubated at 65°C for 5-10 
minutes. After vigorous vortexing for 1 minute the sample 
was electrophoresed on a 1% agarose gel (2.5.1). 
Supercoiled vector DNA was used as a size control. 
2.4.3 Colony and plaque hybridisation (Grunstein and 
Wallis, 1979; Benton and Davis, 1977) 
Plasmid gene banks, bacteriophage A libraries and Ml3 
plaques were screened for recombinants by hybridisation. 
After overnight growth, plate replicas were made on pre-cut 
0.45 µm nitrocellulose filters (Schleicher and Schlill, 
BA85). Cells or phage present on the replica filters were 
lysed and the DNA denatured by placing the filter on 
Whatman 3 MM paper saturated with 0.5 M NaOH, 0.5 M NaCl, 
for 1-2 minutes. Filters were neutralized on 0.5 M Tris-
HCl, pH7.2, 2 M NaCl, rinsed in 2 x SSC (0.3 M NaCl; 0.3 M 
trisodium citrate) and allowed to air dry before being 
baked at 80°C in vacuo for 2 hours. The filters were 
hybridised with the appropriate DNA probe as described in 
2.6.1. After autoradiography, the nitrocellulose filters 
were aligned with both the X-ray film and the original 
plates to enable positively-hybridising colonies or plaques 
to be selected. Two to three successive rounds of 
purification and hybridisation were .necessary to ensure 
plaque or colony homogeneity. 
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2.5 Gel electrophoresis of nucleic acids 
2.5.1 Agarose gel electrophoresis 
All agarose gels were electrophoresed in Tris-Acetate-
EDTA (TAE) buffer (40 mM Tris; 5 mM NaOAc; 1 mM EDTA, 
pH7.8). 1-1.5% agarose gels were run in a vertical 
apparatus (165 mm x 165 mm x 1.5 mm) for the resolution of 
0.7-23 kilobase (kb) DNA fragments. A fifth volume of SDS 
dye (20% sucrose; 5 mM EDTA; 1% SDS; 0.2% bromophenol blue) 
was added to the sample and electrophoresis was conducted 
at 150 V, 50 rnA for 1-2 hours. The gel was stained with 
ethidium bromide, destained in water and the DNA visualized 
on an ultra-violet (UV) trans-illuminator (245 nm for 
analytical gels, 302 nm for preparative gels). Gels were 
photographed using Polaroid Type-107 film. This system was 
used for routine analytical purposes and for the 
preparation of DNA samples for chemical degradation 
sequencing (2.7.1). 
For increased resolution of DNA fragments, 
particularly genomic DNA, a horizontal agarose gel system 
was employed. These gels (190 mm x 140 mm x 5 mm, or 
190 mm xl40 mm x 12 mm) were electrophoresed in TAE buffer 
at 40 V, 40 rnA for 12-16 hours. Low-melting point agarose 
gels were used for preparative separation of DNA fragments 
required for cloning experiments or for use as 
hybridisation probes. 
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2.5.2 Acrylamide gel electrophoresis (Peacock and 
Dingham, 1967) 
DNA in the size range of 700 base pairs (bp) to 20 bp 
was fractionated on 5-10% polyacrylamide gels. Vertical 
polyacrylamide gels were cast in a 165 mm x 165 mm x 1.5 mm 
frame and electrophoresed in Tris-borate-EDTA (TBE) buffer 
(50 mM Tris; 40 mM boric acid; 1 IDL~ EDTA, pH8.3) at 200 V, 
30 mA for 1-2 hours. Gels were prepared by diluting an 
appropriate amount of filtered 30% acrylamide/N,N'-
methylene bisacrylamide (20:1) with TBE. Polymerisation 
was achieved by the addition of 0.5 ml of 10% (w/v) 
ammonium persulphate and 20 µl of N,N,N',N'-
tetramethylethylenediamine (TEMED) to the 50 ml mixture. 
Gels were stained and photographed as set out in 
2.6.1. 
2.5.3 Electro-elution of DNA 
DNA was isolated from polyacrylamide or agarose gel 
slices by electro-elution. Gel slices were placed in 
dialysis tubing containing 0.25 x TBE (12.5 mM Tris; 10 mM 
boric acid; 0.25 mM EDTA, pH8.3) and placed in an electro-
elution chamber containing 0.25 x TBE. The DNA was 
electrophoresed out of the gel slice into the buffer by 
applying a current of 10-15 mA for 1-2 hours. The DNA was 
then precipitated by the addition of 0.3 M NaOAc, pH6.0 and 
2.5 volumes of ethanol. 
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2.5.4 DNA sequencing gel electrophoresis 
The products of DNA sequencing reactions were resolved 
in thin denaturing (7.0 M urea) polyacrylamide gels. For 
20% acrylamide gels, a 50 ml mixture containing 2.5 ml of 
20 x TBE, 10 g of acrylamide, 0.5 g of N,N 1 -methylene 
bisacrylamide (Bis), 21 g of urea was filtered and 
degassed, 0.5 ml of 10% (w/v) ammonium persulphate, 20 µl 
TEMED added and poured into a 380 x 170 x 0.3 mM gel mould, 
and allowed to polymerize for several hours before use. 
The 20% gel was pre-run (15 W, 1500 V, 10 mA) in 1 x TBE 
(no urea) for 30 minutes before samples were loaded. After 
the sample had run the required length of time, the gel 
frame was removed and the sequencing gel transferred to a 
section of previously-used X-ray film. The gel was exposed 
to a sheet of X-ray film (Kodak X-omat RP-5 or AR film) at 
70°C for 12-16 hours with intensifying screens. 
10% (380 mm x 300 mm) and 5% (980 mm x 170 mm, 980 mm 
x 300 mm) gels with correspondingly-reduced amounts of 
acrylamide and Bis were run in 2 x TBE buffer. These gels 
were electrophoresed at between 1500-2000 volts, for 
varying lengths of time. The combination of running a 
sample on a 20% (2 hrs), 10% (3 hrs) and twice on a 5% gel 
(16 hrs and 36 hrs) allowed resolution of up to 500 
nucleotides from the point of initiation of the DNA 
sequence. 
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2.6 Transfer of nucleic acids to nitrocellulose filters 
2.6.1 Southern transfer (Southern, 1975) 
DNA fractionated on agarose gels (2.5.1) was 
depurinated in 0.25M HCl (5-10 minutes), rinsed in water, 
and denatured in 0.5 M NaOH, 0.5 M NaCl (30-60 minutes). 
The gel was neutralised by washing in 0.5 M Tris-HCl pH7.2, 
2 M NaCl (30-60 minutes). The time periods of these 
washes was varied according to the thickness of the agarose 
gel. The denatured DNA was transferred to a 0.45 µm 
nitrocellulose filter (Schleicher and Schilll, BASS) by 
blotting the gel in 20 x SSC (3M NaCl, 3M trisodium 
citrate) for 12-16 hours. The filter was washed in 2 x 
SSC, air-dried and baked at 80°C in vacuo for 2-3 hours. 
Nitrocellulose filters were prehybridised in a 
solution of 3 x SSC, 0.1% SDS, denatured herring sperm DNA 
(10 µg/ml), E.coli tRNA (20µg/ml), 0.2% Ficoll, 0.2% bovine 
serum albumin Fraction V, 0.2% Polyvinylpyrrolidone and 
0.05 M Hepes pH7.0 for at least 2 hours at 65°C. 
Hybridisation to a denatured DNA probe (2.3.3) was carried 
out in a minimal volume of hybridisation mix at 65°C for 16 
hours. The filter was then washed in varying 
concentrations of SSC (O.l-2X) and at different 
temperatures (20-65°C) depending on the stringency of 
hybridisation required. Filters were then air-dried and 
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exposed for autoradiography at -70°C with intensifying 
screens for 1-7 days. 
2.6.2 Northern transfer (Thomas, 1980) 
One microgram of poly(A)+ mRNA was denatured at 50°C 
for 1 hour in a 20 µl reaction mixture containing 2 µl of 
100 rnM Na phosphate buffer pH7.0, 10 µl deionised dimethyl 
sulphoxide and 4 µl of freshly-deionised 40% glyoxal. 
After incubation bromophenol blue and xylene cyanol FF were 
added to 0.05% and the sample was electrophoresed in a 
vertical 1.5% agarose gel run in 10 rnM Na-phosphate buffer 
pH7.0. During electrophoresis the buffer was constantly 
recirculated to maintain a constant pH. After the sample 
had run the required distance, the gel was soaked in 6 x 
SSC and transferred to a 0.1 µm nitrocellulose filter by 
blotting overnight in 20 x SSC. The filter was baked in 
vacuo at 80°C for 2 hours and prehybridised for 16 hours at 
42°C in 50% deionised formamide, 3 x SSC, 0.1% SDS, 
denatured herring sperm DNA (10 µg/ml), E.coli tRNA (20 
µg/ml), 0.2% Ficoll, 0.2% bovine serum albumin Fraction V, 
0.2% polyvinylpyrrolidone and 0.05 M Hepes, pH7.0. The 
filter was hybridised to a radioactive DNA probe at 42°C 
for 24-48 hours, washed and exposed to X-ray film as 
described in 2.6.1. 
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DNA sequencing reactions 
Chemical degradation method (Maxam and Gilbert, 
DNA fragments, labelled at one end, were prepared and 
purified as described in 2.3.4 and 2.5.3. The end-labelled 
DNA was subjected to chemical reactions specific for 
guanine (G), purine (P), pyrimidine (Y) or cytosine (C) 
bases. 
The labelled DNA, dissolved in 30 µl, water was 
divided into four aliquots: G (5 µl), P (10 µl), Y (10 µl) 
and C ( 5 µ 1). 
G reaction: 200µ1 of cacodylate buffer (50 mM Na 
cacodylate; 0.1 mM EDTA, pH8.l) and 1 µl of dimethyl 
sulphate were added to G and incubated at 21°c for 2.5 
minutes. The reaction was terminated by the addition of 
50 µl of G-stop mix (3M NaOAc, pH6.0; 2.5 M 
S-mercaptoethanol; 1 mM EDTA; 0.1mg E.coli tRNA/ml), 750 µl 
of ice-cold ethanol and the DNA was precipitated at -70°C 
for 1 hour. 
P reaction: 25 µl of formic acid was added to P and 
incubated at 21°C for 5 minutes, stopped by the addition of 
200 µl of P-stop mix (0.3 M NaOAc, pH6.0; 0.1 mM EDTA; 25 
µg E.coli tRNA /ml), 750 µl of ethanol and the DNA 
precipitated at -70°C for 1 hour. 
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Y and C reaction: 10 µl of H2o was added to Y and 
15 µl of 5 M NaCl to C, followed by the addition of 30 µl 
of hydrazine. After 5 minutes at 21°c, the reactions were 
stopped by the addition of respective stopmixes (Y-0.3 M 
NaCl; 0.1 mM EDTA, pH8.0; 25 µg E.coli tRNA/ml, C-0.1 mM 
EDTA, pH8.0; 25 µg E.coli tRNA/ml) and the DNA precipitated 
. 
in ethanol at -70°C for 1 hour. 
All four samples were precipitated, dissolved in 0.3 M 
NaOAc, pH6.0, reprecipitated, washed in ethanol and 
redissolved in 25 µl of 1 M piperidine. The strand-
scission reaction was carried out at 90°C for 15 minutes. 
Piperidine was removed by evaporation in vacuo. The DNA 
was resuspended in 25 µl of water, dried in vacuo and 
dissolved in formamide loading dye (90% deionised 
formamide; 0.05% (w/v) bromophenol blue; 0.05% (w/v) xylene 
cyanol FF; 10 mM Tris-HCl, pH8.0; 0.1 mM EDTA). Samples 
were heated to 90°C for 1.5 minutes before loading onto 
denaturing polyacrylamide sequencing gels (2.5.4). 
2.7.2 Chain termination method using bacteriophage Ml3 
(Sanger et al., 1977; Schreier and Cortese, 1979) 
Restriction fragments were cloned into appropriate Ml3 
vectors (Figure 2.2) and single-stranded Ml3 template DNA 
was prepared as described in 2.2.6. The primer was a 
chemically-synthesised 17-mer (5' GTAAAACGACGGCCAGT-3') 
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complementary to codons 7 to 11 of the E. coli lac Z 
gene. 1 µl of 10 x RT buffer (50 mM Tris-HCl, pHB.3; 20 mM 
KCl; 7 mM MgC1 2 ; 10 mM S-mercaptoethanol) were mixed, 
heated to 65°c for 90 seconds and for a further 10 minutes 
at 37°C. Subsequently the DNA was diluted to 21 µl by the 
addition of 16 µl of 1 x RT buffer and 1 µl (1 unit) of 
E.coli DNA polymerase I (Klenow). 5 µl aliquots of this 
mix were distributed to four separate tubes containing 0.3 
µCi a 32P-dATP (~3000 Ci/ mmol) and 1 µl of the appropriate 
(G, A, Tor C) reaction mix. The mixes contained the 
following ratios of dideoxy/deoxy nucleotide triphosphates. 
dGTP ddGTP dATP 
G mix 5 250 5 
A mix 50 5 
T mix 50 5 
C mix 50 5 
(µM) 
ddATP 
250 
50 
50 
5 
50 
ddTTP 
250 
dCTP ddCTP 
50 
50 
50 
5 250 
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After 10 minutes incubation at 21°C 1 µl of chase mix 
(1 mM dNTP's) was added to each tube and the reaction was 
allowed to proceed for a further 10 minutes at 20°C. The 
reaction was stopped by the addition of 8 µl of formamide 
loading dye (90% formamide; 0.05% (w/v) bromophenol blue; 
0.05% (w/v) xylene cyanol FF; 10 mM Tris-HCl, pH8.0; 0.1 mM 
EDTA) and the DNA denatured by boiling for 2 minutes prior 
to loading on a DNA sequencing gel (2.5.4). 
2.8 Mapping of RNA transcripts 
2.8.1 Mung bean nuclease mapping (Sharp et al., 1980) 
This technique was used to map exon-intron 
boundaries. Fragments (~song), labelled at the S'termini 
or 3'termini of the strand complementary to mRNA 
(S'labelled Sau3A-PstI 400 bp fragment from pK-1-HSm.8; 
3'labelled Sau3A-EcoRI 224 bp fragment pK-1-HSm.8; 
S'labelled TaqI-EcoRI 900 bp fragment from pK-l-B2.6) were 
used as template in an annealing reaction with male mouse 
submaxillary gland poly(A)+ mRNA (~s µg). The annealing 
reaction was performed at 66°C for 5 minutes and 
subsequently at 60°C for 12 hours, in a reaction volume of 
10 -µl containing 80% formamide, 0.4 M NaCl, 0.05 M PIPES, 
pH6.5, 1 mM EDTA. After incubation, the reaction mixture 
was diluted with 190 µl of ice-cold mung bean nuclease 
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buffer (0.29 M NaCl; 0.03 M NaOAc, pH4.6; 1 mM Znso4 ). 
Mung bean nuclease (50 units) was added and the sample 
incubated at 37°C for 90 minutes. The protected DNA was 
phenol-chloroform (1:1) extracted, ethanol precipitated and 
resuspended in formamide loading dye (2.7.1). The size of 
the protected fragment was determined by electrophoresis on 
a 10% denaturing sequence gel (2.6.4). Maxam and Gilbert 
(2.7.1) sequencing reactions of a 900 bp TaqI-EcoRI 
fragment of known sequence were used as size markers. 
2.s.2 Primer extension 
The primer extension analysis was performed 
essentially as described by Hagenbuchle et al., (1980). A 
58 bp TaqI-RsaI fragment was isolated from pK-l-B2.6 by 
polyacrylamide gel electrophoresis. Following electro-
elution, the primer was dephosphorylated (2.3.7) and 
5'labelled (2.3.5) using y- 32 P-ATP and T4 polynucleotide 
kinase. Five picomoles (~150 ng) of labelled primer were 
hybridised with 30 µg of male mouse submaxillary gland 
poly{A)+ mRNA in 50 µl of 80% formamide, 0.4M NaCl, 40 mM 
PIPES, pH6.5, 1 mM EDTA, for 1 hour at 50°C. The reaction 
was terminated by ethanol precipitation and dissolved up in 
40 µl of RT buffer (2.3.4) containing 1 mM each of the four 
deoxynucleotide triphosphates. After the addition of 30 
units of AMV reverse transcriptase the reaction mix was 
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incubated at 42°C for 1 hour. The resulting products were 
ethanol precipitated and treated with 0.1 M NaOH, before 
sizing on a 10% sequencing gel (2.6.4). Denatured 3' end-
labelled HpaII fragments of pBR322 were used as size 
markers. 
CHAPTER THREE 
ISOLATION AND CHARACTERISATION OF A MOUSE GLANDULAR 
KALLIKREIN cDNA CLONE 
I, 
: 
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3.1 Introduction 
1 
The molecular cloning of complementary DNA (cDNA) 
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synthesised from a mRNA population is a well-established 
method for obtaining purified gene fragments for sequence 
analysis and use as hybridisation probes. During the 
isolation of cDNA clones which encode bioactive peptides 
synthesised in the male mouse submaxillary gland, cDNA 
sequences homologous to pig pancreatic kallikrein were 
identified (Richards et al., 1982). The submaxillary gland 
of the male mouse was chosen as a source of mRNA for these 
studies since it contains many different growth factors and 
other bioactive peptides as well as kallikrein 
activities. The latter comprise approximately 5% of the 
total soluble protein found in this tissue (Bothwell 
et al., 1979; Wilson and Shooter, 1979). Given the high 
level of kallikrein found in the male mouse submaxillary 
gland it is reasonable to assume that kallikrein mRNA is 
fairly abundant and probably comprises a similar 5% of the 
total mRNA. Based on this assumption, the technique of 
judging the predominance of a particular cDNA clone within 
the total cloned population by its extent of hybridisation 
to heterogeneous single-stranded cDNA was used in an 
attempt to isolate specific cDNA clones, including those 
encoding both NGF and EGF as well as kallikrein activites. 
This chapter describes the isolation and 
characterisation of a cDNA clone coding for a member of the 
glandular kallikrein gene family. Although extremely 
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homologous in sequence with the three known mouse 
submaxillary gland kallikreins, Y-NGF, ( Thomas et al . , 
1981) EGF-BP (Silverman, 1977) and y-renin (Poe et al., 
1983) it represents an uncharacterised member of this 
family. 
The isolation of a kallikrein cDNA clone should enable 
the levels and type of kallikrein gene expression in 
different tissues to be determined, as well as providing a 
means of investigating the genomic organisation of the 
glandular kallikrein gene family. 
3.2 Results 
The work described in this thesis was carried out 
after the isolation of the cDNA clone pMK-1. 
Acknowledgement is made in the text to those involved in 
the stage preceding the characterisation of pMK-1. 
3. 2. 1 cDNA library construction 
Submaxillary glands were surgically removed by D. 
Catanzarro from adult male Quackenbush mice and the RNA 
extracted using guanidine thiocyanate and centrifugation 
through CsCl (2.2.2). Poly(A)-containing RNA was purified 
by two cycles of hybridisation to oligo(dT)-cellulose 
(2.2.3). 
Double-stranded cDNA was constructed by R.I. Richards 
using sequential reverse transcriptase reactions with 
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submaxillary gland poly(A)+ mRNA as template. The ends of 
the ds cDNA were blunt-ended by s1 nuclease and repaired by 
E.coli DNA polymerase I (Klenow fragment) (2.3.6). 
Synthetic "linker" DNA encoding the HindIII recognition 
sequence (5'-CCAAGCTTGG-3') was ligated to the ds cDNA 
(2.3.8). After cleavage with the restriction endonuclease 
HindIII, the ds cDNA was fractionated on a 6% 
polyacrylamide gel. cDNA of 400 base pairs (bp) or greater 
was excised and electro-eluted from the gel (2.5.3). The 
ds cDNA was ligated into the HindIII site of the plasmid 
pBR322 and the resultant chimeric DNA was used to transform 
E.coli RRl cells (2.3.8~ 2.4.1). Five hundred 
recombinants were selected on the basis of their 
ampicillin-resistant, tetracycline-sensitive phenotype. 
3.2.2 Selection of recombinants 
The predominance of a particular cDNA clone within the 
total cloned population can be estimated by the extent of 
its hybridisation to singte-stranded cDNA synthesised from 
total mRNA. If a cDNA clone contains a sequence 
corresponding to a mRNA species present at a level of 5% it 
will hybridise more strongly with the total heterogeneous 
ss cDNA than a clone representing an mRNA species present 
at less than 1% of the population. This approach was used 
to isolate cDNA clones representing mRNA species of 
approximately 1-5% abundance. 500 recombinants were 
screened by R.I. Richards for their ability to hybridise to 
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total 32P-labelled male submaxillary gland ss cDNA by 
colony hybridisation (2.4.3). Weakly hybridising colonies 
adjudged to contain cDNA inserts corresponding to mRNA of 
1-5% abundance were picked for further analysis. Both 
those which hybridised very strongly (presumably including 
the highly abundant amylase sequence) and those which did 
not hybridise significantly were discarded. 
Plasmid DNA was prepared from these colonies (2.2.4) 
and examined for the presence and size of cloned DNA 
inserts by both agarose and polyacrylamide gel 
electrophoresis after cleavage with the restriction 
endonucleases HindIII and/or HaeIII. Plasmids containing 
inserts exceeding 400 bp in length were subjected to 
preliminary sequence analysis by R.I. Richards. For this 
purpose, HindIII-cleaved plasmid DNA was radioactively 
labelled with a- 32 P-dATP using reverse transcriptase (2.3.4 
a). The DNA was then cleaved with HaeIII and the labelled 
fragments subjected to sequence analysis by the chemical 
degradation method (2.7.1). 
Possible reading frames derived from the 5' end of the 
mRNA sequences were compared by a computer program (SEQ) 
against all the peptide sequences of the Dayhoff atlas 
(Dayhoff, 1978). 
3. 2. 3 Identification and sequence analysis of pMK-1 
The deduced amino acid sequence encoded from the 5' 
end of one recombinant plasmid (pMK-1) possessed 65% 
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homology with amino acids 95-124 of pig pancreatic 
kallikrein. This recombinant plasmid contained a 500 bp 
insert and was found to possess a poly(A) tract of 8 
residues 19 bp downstream from the 5'-AATAAA-3' poly(A) 
addition signal sequence (Proudfoot and Brownlee, 1976). 
As this clone was assumed to code for a mouse kallikrein it 
was designated pMK-1. This initial identification was 
accomplished by R.I.-Richards. 
In order to confirm that pMK-1 contained a kallikrein-
like sequence, the pMK-1 insert was completely sequenced. 
The clone was mapped for the presence of restriction sites 
suitable for further sequence analysis. Fig 3.1 shows the 
restriction map of pMK-1 deduced by a series of digests 
with the restriction enzymes AluI, BamHI, HaeIII, HindIII, 
HinfI, Sau3A, Sau96 and RsaI. The sequencing strategy used 
was based on the position of these restriction sites as 
outlined in Figure 3.1 and involved the cleavage of plasmid 
DNA with one of the enzymes, 3' end labelling of the 
resultant fragments with the appropriate a-3 2P-dNTP and 
reverse transcriptase, followed by cleavage of the 
end-labelled fragments with another of the enzymes 
(2.3.4). Fragments labelled at only one end, and therefore 
suitable for sequence analysis, were purified by 
polyacrylamide gel electrophoresis and electro-elution 
(2.5.2, 2.5.3). The purified fragments were subjected to 
chemical degradation sequence reactions (2.7.1) and 
electrophoresed on 20% and 10% denaturing sequence gels 
Figure 3. 1 Restriction map of pMK-1 insert and sequencing 
strategy. 
the insert 
Restriction 
The position of restriction sites within 
are indicated by 
sites: H-HindIII, 
vertical 
B-BamHI, 
lines. 
A-Alu I, 
S-Sau3A, N-HinfI, Ha-HaeIII, Sa-Sau96, R-RsaI. The 
arrows below the line indicate the length and 
direction of sequence obtained by the chemical 
degradation method (Maxam and Gilbert, 1980). 
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(2.5.4). Where possible the sequence was determined in 
both directions (Figure 3.1). To ensure that two or more 
restriction sites did not exist very close together, 
thereby resulting in possible errors in the ordering of 
sequencing data, all the cleavage sites used for sequence 
analysis were confirmed by sequence determination across 
the restriction sites. 
The clone pMK-1 was found to contain an open reading 
frame coding for 149 amino acids terminating at the stop 
codon TGA, followed by a relatively short 3 1 untranslated 
region of 51 nucleotides. The complete nucleotide sequence 
of pMK-1 and its corresponding encoded amino acid sequence 
are presented in Figure 3.2. 
3.2.4 Amino acid sequence comparisons 
The predicted amino acid sequence encoded by pMK-1 was 
aligned with the known amino acid sequences of other 
kallikreins (Figure 3.3). These included mouse Y-NGF, 
mouse EGF-BP, mouse Y-renin, pig pancreatic kallikrein and 
also the sequence of pig pancreatic trypsin. The predicted 
peptide sequence encoded by pMK-1 is 57% homologous to that 
of pig pancreatic kallikrein, 76% homologous with the amino 
acid sequence of mouse Y-NGF, and 67% homologous to the 
partial amino acid sequences of mouse EGF-BP and Y-renin. 
The pMK-1 clone clearly contains only a portion of the 
coding potential (the COOH-terminal . 149 amino acids) of a 
kallikrein-like peptide. By analogy to Y-NGF, one would 
Figure 3. 2 Nucleotide sequence of the 498 bp cDNA cl9ned 
in pMK-1. The predicted amino acid sequence encoded 
by the mRNA . lS shown 
sequence. Nucleotides 
above 
derived 
the 
from 
nucleotide 
oligonucleotide linkers are underlined. 
synthetic 
The poly 
(A) addition signal sequence 5'-AATAAA-3' in the 
3'untranslated . . region is over lined ( Proudfoot and 
Brownlee, 1976). 
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Figure 3.3 Comparison of amino acid sequences of the 
serine prote~ses. Aligned, to maximise homology 
with the peptide encoded by pmK-1, are the partial 
amino acid sequences of Y-renin ( Poe et al., 1983) 
and EGF-BP (Silverman, 1977) rrom mouse submaxillary 
gland, and the complete sequences of porcine 
pancreatic kallikrein (Tschesche et al., 19 79) , 
mouse submaxillary gland Y-NGF (Thomas et al., 
1981), and porcine pancreatic trypsin (Hermodson et 
al., 1973). Residues common to the pMK-1 amino acid 
sequence are boxed. Residues common to all 
characterised serine proteases are indicated by a 
star (Young et al., 1978). Numbers refer to 
residues . in the porcine pancreatic kallikrein 
sequence (Tschesche et al., 1979). 
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expect the pMK-1-encoded protein to be a total of 
approximately 233 amino acids in length (Thomas et al., 
1981). The pMK-1-encoded protease fragment possesses many 
of the amino acids found to be common to all characterised 
serine proteases (Young et al., 1978), including the active 
site residues aspartic acid (residue 102) and serine 
(residue 197) (See Figure 3.3). The cysteine residue at 
position 157 is common to both trypsin and kallikrein-like 
activities and is also found in pMK-1 but not in any of the 
other serine proteases (Young et al., 1978; Tschesche et 
al., 1979). 
Y-NGF, EGF-BP and y-renin are members of a highly 
homologous group of enzymes which have been isolated from 
the mouse submaxillary gland and possess substantial 
kallikrein arginyl esteropeptidase activity (Bothwell 
et al . , 19 7 9) . The extensive overall homology and 
conservation of functionally-important amino acids that the 
pMK-1 encoded protein shares with these proteases 
demonstrates that it belongs to the same enzyme family. 
3.3 Discussion 
In an attempt to characterise genes encoding the 
glandular kallikreins and several other bioactive peptides 
expressed in the male mouse submaxillary gland, a cDNA 
library was constructed using mRNA isolated from this 
tissue. Analysis of the cDNA library by hybridisation and 
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·nucleic acid sequence analysis led to the identification of 
the recombinant plasmid pMK-1. This plasmid contains cDNA 
coding for a peptide sequence homologous with pig 
pancreatic kallikrein and three known mouse submaxillary 
gland kallikreins, y-NGF, EGF-BP and y-renin. Thus, the 
mRNA from which pMK-1 was derived appears to encode a 
previously uncharacterised member of the glandular 
kallikrein subgroup of the serine protease family. One 
possibility is that pMK-1 encodes a portion of S-NGF 
endopeptidase, a poorly cha.racterised kallikrein in the 
salivary gland (Wilson and Shooter, 1979). However, a 
comparison of the amino acid composition of S-NGF 
endopeptidase (Wilson and Shooter, 1979; Table 1.1) with 
the sequence encoded by pMK-1 suggests that they are not 
identical. For example, S-NGF endopeptidase contains four 
Met and twelve Thr residues, whereas the pMK-1 sequence, 
which does not contain the complete coding sequence for the 
active peptide, already encodes one more of each of these 
residues. The protein encoded by pMK-1 is probably not the 
major form of mouse glandular kallikrein activity since 
Bothwell et al., (1979) have shown that S-NGF endopeptidase 
and most of the submaxillary gland kallikrein activity co-
purify, suggesting that the same peptide is responsible for 
both activities. 
The protein encoded by pMK-1 thus appears to be 
kallikrein-like but different from any of the presently 
known members of this enzyme group found in the 
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submaxillary gland. This suggests that there are at least 
five members (pMK-1, Y-NGF, EGF-BP, Y-renin, and S-NGF 
endopeptidase) of this enzyme family expressed in this 
tissue. This is in agreement with the data of Wilson and 
Shooter (1979) who found at least four enzyme activities 
addition to EGF-BP, y-NGF and S-NGF endopeptidase in the 
submaxillary gland. Given the known role of y-NGF and 
EGF-BP (Frey et al., 1979), one may speculate that the 
pMK-1 encoded protein proteolytically modifies the 
precursor of a yet uncharacterised hormone or growth 
factor. 
Trypsin-like esteropeptidases and kallikrein 
. 
in 
activities, as well as NGF and EGF, have been localised to 
the tubular duct cells of the mouse submaxillary gland 
(Ekfors and Hopsu-Havu, 1971: Simson et al., 1978: Schwab 
et al., 1976, and Gresik and Barka, 1977) by 
immunocytochemical and related techniques. Similar studies 
in the kidney have localised kallikrein activity to the 
distal convuluted tubules (Orstavik, et al., 1979). 
Hybridisation histochemistry experiments on mouse 
submaxillary gland and kidney tissue - two known sites of 
kallikrein synthesis, were performed by Jenny Penschow, 
Peter Hudson and John Coghlan at the Howard Florey 
Institute. Hybridisation experiments were conducted on 6 
µm sections of tissue as described by Hudson et al., 
(1981b). Using 32P-labelled pMK~l insert (2.3.3), 
sequences homologous to pMK-1 were detected in the tubular 
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duct cells of the submaxillary gland (Fig 3.4) and the 
distal convoluted tubules of the kidney (Fig 3.5). These 
results have localised cross-reacting mRNA species to the 
same cells where kallikrein proteins are stored in both the 
submaxillary gland and kidney. These data reinforce the 
hypothesis that pMK-1 encodes a protein belonging to the 
glandular kallikrein group of enzymes, and shows that these 
cells are the site of kallikrein synthesis as well as 
protein storage. 
The isolation of a kallikrein cDNA clone provides a 
means of examining the level of synthesis of a variety of 
kallikreins in different tissues. The success of such 
experiments depends on the ability of pMK-1 to cross-react 
with other kallikrein mRNAs. The results presented in the 
following chapters demonstrate this cross-reactivity. 
Figure 3. 4 Hybridisation histochemistry used to detect 
the site of kallikrein synthesis at the mRNA level 
in mouse submaxillary gland. Tissue sections (6 µm) 
were cut on a cryostat, fixed and hybridised with 
a 
32 P-labelled pMK-1 cDNA probe according to the 
method of Hudson (1981b). 
(a) Tissue section of submaxillary gland stained 
with eosin and haematoxylin. Alongside . is - an 
autoradiograph of the next section hybridised with 
the pMK-1 probe (Magnification X 15). 
(b) A thin section of submaxillary gland stained 
with haematoxylin and subsequently hybridised with 
the pMK-1 probe. 
stripping film 
autoradiography. 
The slide was coated with X-ray 
(AR-10, Kodak) and exposed for 
Silver grains are localised to the 
tubular duct cells of the submaxillary gland 
(Magnification X 140). 
I 
, ... , 
a 
b 
Figure 3.5 Hybridisation histochemistry used to detect the 
site of kallikrein synthesis at the mRNA level in 
mouse kidney. Tissue sections (6 µm) were 
hybridised with a 32P-labelled pMK-1 cDNA probe 
according to the method of Hudson (1981b). 
(a) Tissue section of kidney stained with eosin and 
haematoxylin. Alongside is an autoradiograph of the 
next section hybridised with the pMK-1 probe 
(Magnification X 15). 
(b) A thin section of kidney stained with 
haematoxylin and subsequently hybridised with the 
pMK-1 probe. Sections were coated with X-ray 
stripping film and exposed for autoradiography. 
Shown is the autoradiograph viewed under dark-field 
microscopy (left) and light microscopy. The silver 
grains are localised to the distal convoluted 
tubules of the kidney. (Magnification X 160) 
a 
b 
u 
• 
II 
It 
I 
I 
11 
I 
I 
1"1 
)! 
I 
I 
11 
CHAPTER FOUR 
GENOMIC ORGANISATION OF THE GLANDULAR KALLIKREIN 
GENE FAMILY 
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4.1 Introduction 
The analysis of the complexity and organisation of the 
glandular kallikrein genes, as described in this chapter, 
was based on the ability of pMK-1 to cross-react with other 
members of this multi-gene family. The technique of 
genomic Southern blot hybridisation analysis can be used to 
gauge whether a particular sequence is unique, or whether 
it is homologous to other sequences in the genome. This 
approach was used to estimate the number of genes that 
would cross-react with pMK-1 at the DNA level. Since 
variation in the levels and type of kallikrein _gene 
expression in the submaxillary gland has been reported in 
several mouse strains (Hiramatsu et al., 1981) the gene 
structure and copy number in different strains of mice was 
also compared by this technique. 
A convenient method of mapping sequences to particular 
chromosomal locations is to make use of hybrid cell 
lines. The DNA from these cell lines, which contain an 
assortment of different chromosomes, can be analysed for 
the presence of a sequence by Southern blot analysis. The 
assignment of chromosomal location for any particular gene 
can then be made by correlation of the pre?ence of a 
particular chromosome in the hybrid cell line and 
hybridisation to cloned sequences. The distribution of 
kallikrein genes within the mouse genome was investigated 
by using pMK-1 as a hybridisation probe on DNA isolated 
from Chinese hamster - mouse hybrid cell lines. 
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The results presented in this chapter demonstrate that 
in the mouse there is a family of highly homologous 
glandular kallikrein genes, all of which are located on 
chromosome seven. The hybridisation of pMK-1 to rat 
genomic DNA was used as a means of investigating the gene 
copy number and similarity of the kallikrein genes in 
another mammalian . species. 
4.2 Results 
4.2.1 Southern blot analysis of mouse and rat genomic DNA 
High molecular weight genomic DNA was prepared as 
described in 2.2.1 and digested to completion with the 
restriction endonuclease EcoRI. The DNA (20 µg) was 
electrophoresed on a horizontal 1% agarose gel (2.5.1) and 
transferred by the method of Southern (2.6.1) to a 
nitrocellulose filter. The denatured DNA immobilized on 
the filter was hybridised with the random primed, 32 P 
-labelled 500 bp insert from pMK-1 under stringent 
conditions (see Legend Figure 4.1). Figure 4.1 shows the 
hybridisation pattern obtained when pMK-1 is used as a 
probe on EcoRI-cleaved Quackenbush mouse DNA (lane 1) and 
Sprague-Dawley rat DNA (lane 2). In both species multiple 
EcoRI fragments hybridise to pMK-1. 
In mouse DNA there are at least 12 different sized 
restriction fragments which hybridise with pMK-1. The 
Figure 4.1 Autoradiograph of a Southern blot of total 
genomic Quackenbush mouse DNA (Lane 1) and Sprague-
Dawley rat DNA (Lane 2) digested with EcoRI and 
hybridised with the 32P-labelled pMK-1 insert probe 
at 65 °C in 3 x SSC buffer for 24 hours. After 
hybridisation, the nitrocellulose filter was washed 
in two changes of 2 x SSC at 65°C for 1 hour before 
autoradiography for 7 days at - 70°C in the presence 
of an intensifying screen. Numbers alongside the 
autoradiograph represent the size in kilobases of 
markers derived from a HindIII digest of 
bacteriophage lambda cl857 DNA. 
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sizes of these restriction fragments were estimated, by 
comparison with those of a HindIII digest of bacteriophage 
A DNA, to be 23.5, 8.8, 8.2, 7.4, 6.7, 6.4, 4.2, 3.4, 3.1, 
2.4, 2.2 and 1.8 kb. Further studies on bacteriophage 
lambda genomic kallikrein clones (Chapter 6 and B. Evans, 
pers. comm.) have led to the identification of at least 
three distinct genes containing a 2.4 kb EcoRI fragment and 
, 
another three genes with 6.7 kb EcoRI fragments. Therefore 
the differences in the intensity of hybridisation of 
certain restriction fragments (e.g: 2.4 and 6.7 kb) are due 
to the conservation of particular restriction sites around 
several different genes. The analysis of bacteriophage 
lambda genomic clones together with this data from Southern 
blot analysis suggests there are 25-30 distinct kallikrein 
genes (see Chapter 6). 
The gene copy number in the rat appears to be similar 
to that of the mouse, with about ten EcoRI fragment sizes 
observed (Figure 4.1, Lane 2). It should be noted that the 
extent of hybridisation to the rat genome is significantly 
less than to the mouse genome, suggesting that the mouse 
kallikrein genes are more similar to each other than to 
their counterparts in the rat genome. 
4.2.2 Comparison of different mouse strains 
As variation in both the levels and type of kallikrein 
gene expression in the submaxillary gland have been 
reported in several mouse strains (Hiramatsu et al., 1981), 
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it was important to determine whether variation occurred at 
the DNA level in the kallikrein locus of different mice. 
The pMK-1 hybridisation patterns of genomic DNA 
prepared from the Quackenbush, Balb/c and C57BL/6 strains 
of mice was compared after Southern blotting. DNA from 
these mice were cleaved with the restriction endonucleases 
EcoRI, SacI, BamHI and HindIII and hybridised to pMK-1 as 
described in 4.2.1. The hybridisation patterns observed 
with EcoRI- (data not shown) SacI- and HindIII-cleaved DNA 
(Figure 4.2) were indistinguishable from each other. 
However, there were slight differences in the hybridisation 
patterns observed with BamHI-cleaved DNA. The patterns 
observed for Balb/c DNA (lane 6, Figure 4.2) and 
Quackenbush DNA (lane 5, Figure 4.2) differ in a single 
uniquely hybridising band - 3.4 kb for Balb/c and 2.0 kb 
for Quackenbush. In each case this difference is probably 
due to a single restriction site polymorphism since the 
hybridisation pattern _observed with C57BL/6 DNA (lane 7, 
Figure 4.2) includes both of these fragments. 
The strong conservation of restriction sites in the 
kallikrein genes of these mice indicate both a similar 
structural organisation and kallikrein gene copy number in 
each of the three strains. 
4.2.3 Chromosomal location of kallikrein sequences 
The distribution of kallikrein genes within the mouse 
genome was investigated by using pMK-1 as a hybridisation 
Figure 4. 2 Southern blot analysis of Quackenbush, Balb/c 
and C57BL/ 6 mouse genomic DNA (ca. 7. 5µ g per lane) 
digested with HindIII (lanes 2-4 respectively); 
BamHI (lanes 5-7 respectively); SacI (lanes 8-10 
respectively) and Eco RI ( lane 1 - Quackenbush DNA) 
and hybridised with the 32P-labelled pMK-1 probe. 
Hybridisation and washing conditions were as 
described in the legend to Figure 4.1. Numbers 
indicate the position of HindIII size markers. 
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probe on DNA isolated from a variety of Chinese hamster-
mouse hybrid cell lines. These cell lines (supplied by 
D. Cox, UCSF) were constructed by fusing V-79 Chinese 
hamster cells with cells derived from two feral strains of 
mouse, Abruzzi and Cremona. Both of these mouse strains 
are homozygous for nine metacentric chromosomes derived by 
centric fusion of eighteen acrocentric autosomes. The 
Abruzzi mice have metacentric chromosomes in acrocentric 
combinations 1/7, 2/18, 3/8, 4/15, 5/17, 6/13, 9/16, 19/11, 
and 12/ 14 which differ from_ the acrocentric combinations of 
Cremona mice: 1/6, 2/8, 3/4, 5/15, 7/18, 9/14, 10/12, 
11/13, and 16/17 (Cox et al., 1982). Somatic cell hybrids 
constructed from these mice strains and Chinese hamster 
cells contain differing numbers and combinations of mouse 
chromosomes and are thus ideal for mapping sequences to 
particular chromosomes. 
All hybrid cell lines used to prepare DNA were 
karyotyped and/or analyzed by D. Cox for various 
characteristic enzymes in order to definitively assign the 
particular mouse chromosomes present in each hybrid line. 
DNA was prepared from each cell line as outlined in 2.2.1. 
Figure 4.3 shows the hybridisation pattern observed 
with EcoRI-cleaved DNA from Quackenbush mice (lane 2), S-49 
cells (mouse cell line, lane 3), Chinese hamster cells 
(lane 5) and III-16 cells (lane 4). III-16 is a Chinese 
hamster-mouse hybrid cell line containing mouse chromosomes 
in the following combination: 7, broken 1, 2/18, 3/8, 5/17, 
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6/13, 9/16, 12/14, 19 and x. It can be seen that the 
complete set of EcoRI fragments observed for Quackenbush 
mouse DNA is also present in the DNA prepared from the III-
16 cell line. The pattern observed with the hybrid DNA 
differs in only one position from that of Quackenbush DNA 
(III-16 shows an additional 2.6 kb band). This is probably 
due to a single restriction site polymorphism - as 
previously observed between Balb/c, Quackenbush and C57BL/6 
mice (4.2.2). These bands are not due to Chinese hamster 
sequences since under the hybridisation conditions used 
pMK-1 only weakly cross-reacts with Chinese hamster 
sequences (lane 5, Figure 4.3). 
DNA was prepared from 12 different hybrid cell lines 
(Figure 4.6) as outlined in 2.2.1. These particular cell 
lines were selected as they possessed different 
combinations of the mouse chromosomes present in III-16 
cells. The hybrid DNAs were cleaved with EcoRI and 
subjected to Southern blot hybridisation analysis (Figures 
4.4, 4.5). It can be seen that when hybridisation to pMK-1 
does occur, the complete set of EcoRI fragments is always 
present. Chromosome 7 is the only chromosome common to the 
DNAs which hybridised (Table 4.1) and therefore all the 
kallikrein genes that are detectable by hybridisation to 
pMK-1 are located on this chromosome. 
Figure 4. 3 Autoradiograph of a Southern blot of EcoRI-
digested Quackenbush mouse DNA (lane 2), S-49 mouse 
cell line DNA (lane 3), III-16 Chinese hamster-mouse 
cell hybrid DNA ( lane 4), and Chinese-hamster DNA 
(lane 5) hybridised with the pMK-1 probe. 
Conditions were as 
4. 1) . The markers 
previously described (Figure 
(lanes 1 and 6) are 32P-labelled 
Acl857 DNA digested with Hind III and are 23.5, 9.5, 
6.7, 4.4, 2.3, 2.0 and 0.55 kb in size. 
1 2 3 4 5 6 
Figure 4 . 4 Southern blot analysis of DNA isolated from 
Chinese hamster-mouse cell hybrids. Approximately 
7.5 µg of genomic DNA, prepared from cell lines: I-5 
(lane 1), I-7B-4 (lane 2), I-3A-3 (lane 3), I-8-5 
(lane 4), I-3A-2 (lane 6), III-23 (lane 7) and 
Chinese Hamster (lane 8), were digested to 
completion with EcoRI and fractionated on a 1% 
agarose gel, transferred to a nitrocellulose filter 
and hybridised with the pMK-1 probe (2.5.1, 
2 . 6.1). The autoradiograph shown was obtained after 
exposure at -70 ° C for 7 days. The size of markers 
( lane 4) are 23. 5, 9. 5, 6. 7, 4. 4, 2. 3 and 2. 0 kb. 
The mouse chromosomes present in the hybrid cell 
lines are as outlined in Table 4.1. 
1 2 3 4 5 6 7 8 
Figure 4.5 Autoradiograph of the Southern blot of DNA from 
hybrid cell lines III-12 (lane 2), I-8-2 (lane 3), 
III-13 (lane 4), CIV-12 (lane 5), III-14 (lane 6), 
III-16-1 ( lane 7), which was hybridised with 32p_ 
labelled pMK-1 insert. Conditions were as described 
previously (Figure 4.1, 4.4). Lane . lS 8 a 
Quackenbush mouse DNA control and lane 1 shows the 
HindIII A markers described in Figures 4.1, 4.4 . 
1 2 3 4 5 6 7 8 
Table 4.1 Segregation of mouse chromosomes in Chinese 
hamster-mouse cell hybrids used for Southern blot 
analysis (Figures 4.4, 4.s)·. Hybrid cell lines 
which contained kallikrein sequences are designated 
with a star ( *) and shown in the column marked 
'hyb I• Only chromosome 7 is common to all these 
hybrid lines. (t) This clone contained a rearranged 
2/18 metacentric chromosome, involving a 
translocation of chromosomal material of unknown 
origin to chromosome 2 at band 2D, with deletion of 
the normal chromosome material distal to band 2D 
( Cox et al., 1982). 
l 
!11 
M o u s e  C h r o m o s o m e  
C l o n e  
1  
2  
3  
4  
5  
6  7  
8  
9  1 0  1 1  1 2  1 3  1 4  1 5  1 6  1 7  1 8  1 9  X  
H y b .  
I - 5 *  
+  
+  
+  
+  
+  
+  +  
+  
+  
+  
+  
I  
+  
I - 7 B - 4  
+  
+  
+  
+  
}  
+  
+  
I - 3 A - 3  
+  
+  
+  
+  
+  
+  
+  
+  
I - 8 - 5 *  
+  
+  
+  +  
+  
+  
+  
+  
+  
I - 3 A - 2 *  
+  
+  
+  
+  
+  
+  
+  
+  
+  
+  
+  
I I I - 2 3  
+ t  
+  
+  
+  
+  
+  
+  
I - 8 - 2 *  
+  
+  
+  
+  
+  +  
+  
+  
+  
+  
+  
+  
+  
+  
I I I - 1 3 *  
+  
+  
+  
+  
+  
+  
I I I - 1 4 *  
+  
+  
+  
+  
+  
+  
+  
+  
I I I - 1 2  
+  +  
+  +  
+  
+  
+  
C I V - 1 2  
+  
+  
+  
+  
+  
+  
+  
I I I - 1 6 - 1 *  
+  
+  
+  
+  
+  
+  
+  
+  
+  
+  +  
+  
I  
+  
64 
4.3 Discussion 
The cross-reaction of pMK-1 sequences with a large 
number of differently sized restriction fragments in the 
mouse genome suggests that pMK-1 is a member of a highly 
homologous multi-gene family. This supports the hypothesis 
of Bothwell et al., (1979) that y-NGF and EGF-BP are 
members of a large group of enzymes sharing similar 
structural and physico-chemical properties. When compared 
with the data on kallikrein genomic clones presented in 
Chapter 6 these results show that there are some 25-30 
members of this multi-gene family. Although b~sed on only 
preliminary data, the hybridisation of pMK-1 to rat genomic 
DNA suggests that there are a similar number of kallikrein 
gene sequences in the rat. The extent of hybridisation to 
the rat genome is significantly less, suggesting that the 
mouse genes are more homologous to each other than to their 
rat counterparts. This is consistent with the results of 
immunological experiments which have shown that mousey-
NGF, EGF-BP and S-NGF endopeptidase are more similar to 
each other than to rat submaxillary gland kallikrein(s) 
(Bothwell et al., 1979). 
There is a high degree of nucleotide _sequence homology 
in the kallikrein gene loci of different strains of mice, 
as evidenced by the conservation of restriction sites and 
the extent of cross-hybridisation between Balb/c, 
Quackenbush and C57BL/6 mice. This data shows that the 
gene copy number and structural organisation of the 
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kallikrein gene locus is highly conserved in different mice 
strains. Therefore the variation in both the levels and 
type of kallikrein gene expression in different strains of 
mice (Hiramatsu et al., 1981) is probably due to 
differences in gene expression rather than polymorphism in 
gene number and/or type. 
Many different loci encoding esterase activities . in 
the mouse have been described (Womack, 1980). The only 
esterase activity that has previously been mapped to 
chromosome 7 by other techniques is the TAMase (tosyl-
arginine-methylester) group of enzymes which, like the 
kallikrein genes, are arginyl esteropeptidases and are 
expressed in the mouse submaxillary gland. However, Skow 
(1978) has shown that the TAMases are both immunologically 
and electrophoretically distinct from Y-NGF, one of the 
members of the kallikrein gene family. Further chromosome 
mapping studies using cell lines containing deletions in 
portions of chromosome _7 are required to establish the 
relationship of the TAMase locus to that of the kallikrein 
genes. 
The identification of a large number of DNA 
restriction fragments which cross-react with pMK-1 and the 
demonstration of their presence only in Chinese hamster-
mouse hybrid cell lines containing the mouse chromosome 7, 
indicates that the members of the glandular kallikrein gene 
family are both highly homologous in primary structure and 
linked on this chromosome. 
CHAPTER FIVE 
ISOLATION AND SEQUENCE ANALYSIS OF A 
KALLIKREIN GENOMIC CLONE 
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5.1 Introduction 
Elucidation of the structure and organisation of many 
eukaryotic genes has led to the discovery that a large 
number of protein-coding genes are interrupted by 
intervening sequences (intrans). These studies have been 
made possible by the use of bacteriophage lambda gene 
libraries from which genomic clones containing regions 
homologous to cDNA sequences have been isolated (Maniatis 
et al., 1978). An examination of the molecular anatomy of 
eukaryotic genes has made it possible to develop theories 
on their evolution, possible mechanisms of RNA splicing and 
the nature of sequences involved in gene expression 
(Breathnach and Chambon, 1981). 
To determine in more detail the organisation of 
kallikrein genes and to elucidate the molecular anatomy of 
a member of this multi-gene family, genomic clones 
homologous to the cDNA clone pMK-1 were isolated from a 
library of cloned mouse DNA sequences in bacteriophage 
lambda. This has allowed the exon-intron arrangement of a 
kallikrein gene to be determined and may provide some 
insights into the evolution of the multi-gene family as 
well as providing information on the complete structure of 
a preprokallikrein protease. The demonstration that all 
the kallikrein gene sequences are present on chromosome 7 
suggests that these genes may be closely linked, as 
previously described for most mammalian multi-gene 
families, for example the growth hormone family (Kidd and 
Ii 
' 
I 
II 
11 
i 
I i' 
1i 
i 
I 
I i 
I 
I I 
I i 
i 
I ' 
II 
Ii 
I 
I 
1, 
Ii 
i 
67 
Saunders, 1982) and the a. and S globins (Lauer et al., 
1980; Efstratiadis et al., 1980). The work discussed in 
this chapter deals with the isolation and sequence analysis 
of a genomic clone (AMSP-1) which was found to contain two 
linked kallikrein genes, mGK-1 and mGK-2. In addition, the 
gene mGK-1 was shown to be transcriptionally active in the 
male mouse submaxillary gland. 
5.2 Results 
s.2.1 Isolation of genomic clones 
A bacteriophage lambda genomic library of Quackenbush 
mouse DNA was constructed by ligating a partial MboI digest 
of high molecular weight DNA (10-20 kb) into BamHI-cleaved 
Charon 28 DNA (Liu et al., 1980). The recombinant DNA was 
packaged in vitro by R.I. Richards according to the method 
of Hohn (1979) and 30,000 clones isolated. 
Bacteriophage from the cloned mouse DNA library were 
plated out at high density and screened with the pMK-1 
hybridisation probe (2.4.3). Two independent lambda 
clones, AMSP-1 and AMSP-2, were isolated in pure form after 
three rounds of plaque purification (Benton and Davis, 
1979). One of these clones, AMSP-1, was chosen for 
detailed analysis. Studies on the other clone, AMSP-2 will 
be discussed in Chapter 6. 
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5.2.2 Restriction analysis of AMSP-1 
AMSP-1 phage DNA was purified as described in 2.2.7 
and cleaved in either single or double digestions with the 
restriction endonucleases BamHI, EcoRI, SacI, HindIII, 
SmaI, and BglII. The digests were then fractionated on a 
1% agarose gel and the DNA transferred to a nitrocellulose 
filter. The filter was hybridised to a 32P-labelled pMK-1 
probe and exposed for autoradiography as described 2.6.1. 
The autoradiograph of one of these gels is shown in Figure 
5. 1. 
The data from these restriction digestions, 
subsequently confirmed by sequence analysis, enabled the 
construction of a physical map of the genomic clone AMSP-1 
as shown in Figure 5.2. This clone comprises 13.5 kb of 
genomic DNA and contains two closely linked kallikrein 
genes which are transcribed in the same direction. The 
first gene (mGK-1) is complete in this clone (see below) 
and consists of five exons and four intrans, . spanning 
4.5 kb. The 3' end of another gene (mGK-2) is located 3.7 
kb upstream from the 5' end of mGK-1. In AMSP-1 no other 
kallikrein gene sequences could be detected downstream from 
mGK-1. 
The sequences present in the cDNA clone pMK-1 were 
found to hybridise with corresponding sequences in mGK-1 
and mGK-2, although they were interrupted by the presence 
of two intervening sequences (Figure 5.1, 5.2). As pMK-1 
is only a partial cDNA clone and contains the coding 
....... 
Figure 5.1 Restriction and Southern blot analysis of 
>..MSP-1. 
(a) Ethidium bromide stained 1% agarose gel after 
electrophoresis of >..MSP-1 DNA digested with HindIII 
( lane 2) , Eco RI ( lane 3) , BamHI ( lane 4), Hind II I 
plus Eco RI ( lane 5), Hind I II plus BamHI ( lane 6), 
EcoRI plus BamHI (lane 7). The marker DNA (lane 1) 
is >..cl857 DNA cut with HindIII. Sizes are 23.5, 
9.5, 6.7, 4.4, 2.3 and 2.0 kb. 
(b) Autoradiograph of the Southern blot of the above 
gel hybridised with the 32P-labelled pMK-1 cDNA 
probe at 65 °C in 3 x SSC. Restriction digests are 
as above. Hybridising bands in lane 6 show up upon 
longer exposure. 
a  
b  
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Figure 5. 2 Restriction map of the bacteriophage lambda 
genomic clone, AMSP-1, which contains the kallikrein 
genes mGK-1 and mGK-2. Boxes denote exons of the 
respective genes mGK-1 and inGK-2. Both genes are 
transcribed in the direction indicated by - the 
arrows. The position of restriction sites within 
the 13.5 kb insert are indicated by vertical 
lines. Abbreviations used are as follows: B-BamHI, 
R-EcoRI, S-SacI, H-HindIII , Sm-SmaI, Bg-BglII. ~he 
wavy lines represent the left and right arms of the 
lambda vector, Charon 28. The 5'BamHI site within 
the mGK-2 gene is the end point of the clone and 
therefore may only represent an MboI site in the 
genome. 
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information for only approximately half of a kallikrein 
mRNA, the exons comprising each of the two genes were also 
mapped by northern blotting and confirmed by DNA sequence 
analysis as described in the following sections. 
5.2.3 Subcloning of genomic sequences 
Restriction fragments from AMSP-1 were subcloned into 
the plasmid ' pBR322. Generally, the desired restriction 
fragment was isolated from a low-melting point agarose gel 
(2.5.1), ligated to appropriately cleaved and 
dephosphorylated pBR322 DNA (2.3.7, 2.3.8) and transformed 
into the bacterial host RRl (2.4.1). Recombinants were 
detected by hybridisation with 32 P-labelled AMSP-1 DNA 
fragments and by a plasmid miniscreen method (2.4.2). 
Plasmid DNA was prepared from amplified cultures (2.2.4). 
In this manner the 13.5 kb insert of AMSP-1 was 
subcloned to give a series of overlapping clones, 
including:-
nK-2-B.3 . 300 bp BamHI fragment J.: . 
pK-2-Bl.l . 1.1 kb BamHI fragment . 
pK-1-ES.O . s.o kb EcoRI fragment . 
pK-1-HSm.8 . 800 bp HindIII-SmaI fragment . 
pK-l-B2.6 . 2.6 kb BamHI fragment . 
pK-l-E8.0 . 8.0 kb EcoRI fragment . 
pK-1-BH.8 . 800 bp BamHI-HindIII . 
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The locations of the cloned DNA fragments in these 
recombinant plasmids is illustrated in Figure 5.5. 
5.2.4 Exon mapping by northern blot analysis 
As mentioned in 5.2.2, pMK-1 only cross-hybridises 
with exons 3, 4 and 5 of the gene mGK-1 and exons 4 and 5 
of mGK-2. This is to be expected since pMK-1 only contains 
approximately half of the coding region for a kallikrein 
protease. The approach used to locate the remaining coding 
sequences of mGK-1 was to hybridise 32P-labelled 
restriction fragments, from the gene region separating 
exons 3, 4 and 5 of mGK-1 and exons 4 and 5 of mGK-2 to 
northern blots of submaxillary gland mRNA. 
Multiple samples of poly(A)+ mRNA (1 µg) were 
fractionated on a 1% agarose gel and the RNA transferred to 
a nitrocellulose filter as described 2.6.2. The filter was 
cut into individual lanes and each was separately 
hybridised to the rest~iction fragments I-VIII as outlined 
in Figure 5.3. The restriction fragments which contained 
exon sequences hybridised to a common mRNA size class of 
approximately 950 nucleotides (Figure 5.4). This result 
demonstrates homogeneity in the mRNA size of the many 
different kallikrein genes expressed in this tissue. By 
this technique the 5' exon of mGK-1 was located to a 800 bp 
HindIII-SmaI fragment. All the exon-intron boundaries were 
precisely mapped by detailed sequence analysis as described 
below. 
-.... 
Figure 5. 3 (a) Location of 
the mGK-1, mGK-2 gene 
probe submaxillary RNA 
restriction fragments within 
region, which were used to 
(see Figure 5.4). The DNA 
fragments designated I-VIII were prepared as 
hybridisation probes from the following plasmids: 
I pK-2-B.3 
II - pK-2-Bl.l 
III - 2.6 kb BamHI-HindIII fragment isolated from 
pK-1-ES.O 
IV 
V 
VI 
0.8 kb HindIII - Smar fragment isolated from 
pK-1-ES.O 
1.25 kb SmaI-BamHI fragment isolated from 
pK-1-ES.O 
0.7 kb EcoRI-BglII fragment isolated from 
pK-l-B2.6 
VII - 0.8 kb BglII doublet isolated from pK-l-B2.6 
VIII - pK-1-BH.8. 
(b) Physical map of 9.5 kb portion of AMSP-1 
containing mGK-1 and mGK-2. Exons are denoted as 
boxes, and the direction of transcription of the 
genes . lS indicated by the heavy arrows. 
Abbreviations used are: B-BamHI, Bg-BglII, ~-EcoRI, 
P-PstI, S-SacI, H-HindIII, Sm-SmaI, T-TaqI, 
Hp-HpaII. 
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Figure 5.4 Northern blot analysis of poly(A)+ mRNA 
isolated from male mouse submaxillary gland. Eight 
samples of poly(A)+ mRNA (1 µg) were fractionated on 
a 1% agarose gel and transferred to a nitrocellulose 
filter as described . in 2.6.2. Tracks I-VIII were 
individually , hybridised at 42 °C in 3 x SSC, 50% 
formamide for 36 hours with 32P-labelled 
hybridisation probes prepared from the restriction 
fragments I-VIII, respectively (as illustrated . in 
Figure 5.3). Filters were washed in 2 x SSC at 21°C 
and exposed for autoradiography at -70°C for 12 
hours in the presence of an intensifying screen. 
The numbers alongside the autoradiograph represent 
the position of the eight RNA . species from an 
influenza type A laboratory recombinant H3N2 strain 
(Sleigh et al., 1979) which were run as . size 
markers. Restriction fragments I, II, IV, VII and 
VIII hybridised to a common mRNA size of 
approximately 950 bases. The lower intensity of 
hybridisation observed with fragments I and II were 
due to the lower specific activity of these two 
hybridisation probes. 
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5.2.5 Sequence analysis of AMSP-1 
The overlapping pBR322 subclones of AMSP-1 described 
in 5.2.3 and outlined in Figure 5.5 were used as a source 
of DNA for sequence analysis. Almost 9,500 contiguous base 
pairs of the mGK-1, mGK-2 gene region were determined by 
the strategy shown in Figure 5.5. The majority of the 
sequence was derived from both strands of DNA. 
Sequen'ces were determined by a combination of the 
chemical degradation method (2.7.1) and dideoxy sequencing 
methods using the single-stranded Ml3 phage vectors mp8 and 
mp9 ( 2 . 7 . 2 ) . 
Sequencing by the chemical degradation method was 
based on the availability of the restriction sites shown in 
Figure 5.5. Plasmid DNA was cleaved by one enzyme and 
3'end labelled with the appropriate a- 32P-dNTP using 
reverse transcriptase (2.3.4a). PstI and SacI restriction 
sites were 3'end labelled using terminal transferase with 
a- 32P-cordycepin (2.3.4b). In each case the labelled 
fragments were then cleaved with another restriction 
enzyme(s) in order to produce fragments labelled at only 
one end and easily resolved by polyacrylamide or agarose 
gel electrophoresis. Purified labelled fragments were 
chemically modified and prepared for DNA sequencing gel 
electrophoresis as described in 2.7.1. The cleavage 
products of the DNA sequencing reactions were separated on 
thin 20%, 10% and 5% polyacrylamide denaturing (7.0 M urea) 
gels (2.5.4). Routinely up to 500 bases of sequence could 
Figure 5.5 Sequencing strategy for the 9.5 kb mGK-1, mGK-2 
gene region. The pBR322 subclones used for sequence 
determination are shown as solid lines below the 
restriction map of the 9. 5 kb portion of )... MSP-1. 
Sites on the restriction map are abbreviated as 
follows: B-BamHI, Bg-BglII, E-EcoRI, P-PstI, S-
SacI, H-HindIII, Sm-SmaI, T-TaqI, Hp-HpaII. Only 
the TaqI and BpaII sites used for sequence analysis 
are shown. The arrows above and below the solid 
the direction and length of sequence lines give 
obtained. Sequences indicated by arrows above the 
were obtained by the chemical degradation 
The arrows below the subclones indicate 
subclones 
method. 
dideoxy 
HaeIII, 
sequencing of a 
RsaI or BglII) 
defined (AluI, Sau3A, 
restriction fragment 
subcloned into Ml3 mp8 or mp9. The arrows above the 
subclone pK-2-Bl .l in the area of overlap with pK-l-
E5.0 indicate chemical degradation sequencing as do 
the arrows above pK-l-B2. 6 in the area of overlap 
with pK-1-ES.O. Wavy lines below the subclones 
indicate sequence data obtained by cloning a series 
of Bal 31 exonuclease-generated deletions into mp8. 
For more details on this method see 5.2.5. 
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be resolved using this gel system. 
Portions of the sequence were determined by cloning 
specific restriction fragments into the Ml3 vectors mp8 and 
mp 9 ( 2 . 7 . 2 ) • For example the two 800 bp BglII fragments 
from pK-l-B2.6 and the 600 bp PstI fragment from pK-l-E5.0 
were partially sequenced by this technique as were other 
fragments outlined in Figure 5.5. 
The DNA sequencing method termed "shotgunning" 
(Messing et al., 1981) was used to partially sequence the 
1,050 bp SacI-HindIII fragment from pK-l-E5.0. Aliquots (2 
µg) of this fragment were cleaved with the restriction 
enzymes AluI, HaeIII and RsaI. The blunt-ended cleavage 
products of these separate digests were ligated into HincII 
cleaved Ml3 mp8 DNA (2.3.8) and transformed into the host 
JM 10 3 ( 2 . 4. 1 ) . The resultant 36 clones selected by 
hybridisation to the SacI-HindIII fragment were subjected 
to sequence analysis (2.7.2). As illustrated in Figure 
5.5, the overlapping sequence obtained from 11 of these 
clones was sufficient to sequence the majority of this 
region on both strands. 
Several regions were difficult to sequence due to the 
lack of suitable restriction sites for chemical degradation 
and dideoxy sequence analysis. To overcome this problem, a 
rapid method of 'non-random' sequencing based on the 
generation of a series of deletions with the exonuclease 
Ba131 was developed. For example the plasmid pK-l-B2.6, 
containing the 2.6 kb BamHI fragment from mGK-1, was 
73 
linearised within the pBR322 sequences by the endonuclease 
Clal, digested with Bal31 and aliquots taken at 1 minute 
time intervals over a 4 minute period (2.3.2). By this 
procedure, it was possible to generate a range of defined 
deletions from the Clal site towards the EcoRl site within 
the 2.6 kb BamHl insert. Under the conditions used the 
exonuclease removed 400 bp from each end of the linearised 
plasmid per minute, as monitored by agarose gel 
electrophoresis. These deleted plasmids were then cleaved 
with EcoRl in order to release fragments having one blunt-
end due to Bal31 digestion and one cohesive end due to 
EcoRl cleavage. The fragments were then subcloned into 
EcoR1-Hinc111-cleaved Ml3 mp8 DNA. Recombinant phage were 
detected by hybridisation to AMSP-1 DNA and sequenced using 
a synthetic DNA primer (2.7.2). As illustrated in Figure 
5.5, the majority of the sequence of pK-l-B2.6 was 
determined by this technique. 
The DNA cloned in the plasmids pK-2-Bl.l, pK-1-EB.O 
and pK-l-E5.0 were also partially sequenced by this 
method. The plasmid pK-2-Bl.l was linearised within the 
pBR322 sequences by the restriction enzyme Sall (the pBR322 
Sall site is 170 bp distant from the BamHl site containing 
the 1.1 kb insert), and digested with Bal31 for 2, 3 and 4 
minutes. Approximately 400 bp/minute was removed from each 
end of the plasmid, thus resulting in the loss of one of 
the BamHl sites. These shortened DNA fragments were then 
cloned into BamHl-Hincll-cleaved mp8 DNA. Only one 
74 
recombinant deletion clone was obtained as shown in Figure 
5.5. This poor cloning efficiency could be explained by 
the incomplete digestion of the Ml3 vector with BamHI and 
HincII which was probably due to the closeness of these 
sites within mp8 (see Figure 2.2). 
The DNA from the plasmid pK-1-ES.O was linearised 
within the insert by the restriction enzyme Smar. After 
, 
Bal31 digestion for 1-6 minutes, the plasmids were cleaved 
with EcoRI. As this plasmid would still contain both EcoRI 
sites, a range of deletions _ extending towards both sites 
would be expected to result. The Ml3 recombinants obtained 
(see Figure 5.5) after ligation of these products into 
EcoRI-HincII-cleaved mp8 DNA, were screened by 
hybridisation with probes specific for the 5' and 3' ends 
of the pK-l-E5.0 insert (900 bp EcoRI - BamHI fragment from 
pK-2-Bl.l and the 100 bp BamHI-EcoRI fragment from pK-1-
B2.6 respectively). In this way it was possible to 
determine the orientation of the Ml3 recombinants. Two 
deletion clones from the plasmid pK-1-EB.O were constructed 
by initially cleaving the plasmid with BamHI, digesting 
with Bal31 for 2 and 3 minutes and releasing the required 
fragments by EcoRI digestion before ligating into EcoRI-
HincII-cleaved mp8 DNA (Figure 5.5). 
The complete 9,436 bp sequence of this region is 
presented in Figure 5.6 a and b. 
Figure 5. 6 (a) ( b) Sequence of the mouse mGK-1 and mGK-2 
gene region. Only the sense strand is shown. The 
coding sequences which make up the five exons of the 
complete mGK-1 gene and 3' two exons of mGK-2 have 
been translated. The arrows in exon 2 of mGK-1 
define the proposed boundaries between the signal 
peptide, zymogen peptide and the active protease. 
The GT-AG sequences at the intron-exon boundaries 
are boxed. The 'CAT' box (Benoist et al., 1980) and 
the variant 5'-TTTAAA-3' 'Goldberg-Rogness' box 
(Corden et al., 1980) preceeding mGK-1 are 
over lined. The two putative initiation sites of RNA 
transcription for mGK-1 are marked by triangles. 
The polyadenylation site sequences 5'-AATAAA-3' 
(Proudfoot and Brownlee, 1976) found . in the 
3'untranslated . regions of mGK-1 and mGK-2 are 
boxed. Circles indicate the transcription 
termination sites. The TC-rich repeat. in the 
intergenic space is underlined. 
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GlnAsnAlaLysAspLeuGlnCysValAsnLeuLysLeuLeuProAsnGluAsnCysAspLysAsnH1sAsnLysLysValThrAspValMetValCysValGlyGlu 
GGATCCA~CCAAAATGCAAAAGATCTCCAGTGTGTGAACCTCAAGCTCCTGCCTAATGAGAATTGTGACAAAAACCACAATAAGAAGGTGACAGATGTCATGGTGTGTGTAGGAGAG 
.50 .100 
MetAspGlyGlyLysAspThrCysVal 
ATGGATGGAGGCAAAGACACTTGTGT~AGACAGCCACTTTCTGCTGTGAGGTGAAGGGCTGAAAGCTGGAACTGAGGTTCTTGGTTCC.:CACTTCAACACCCTGACTAGGCAGGCTCT 
.150 .200 
TTTTATCCTTCCCTATGGAAGGGATGTGCACTGGGAGGGGAGGATCCTGTAGCTGGCATGATTTCTCACCTTAGACTTGTCTTAGGGGACAGTCTTGTGAGCCCCTCACC.:ACAAACCAAT 
.250 .300 .350 
GTTCTCATACGATCTGAGGTCCCAAGAGCTAGATTCCCTCACCTACTGACTAGAGCTGCCTCTTAAGAGTCCCTGTGTTCCTCCCTGGGGTCAGTTCCAGGTTGTCAAGTAGGACTCCAA 
.400 .450 
GlyAspSerGlyGlyProLeuileCysAspGlyValLeuGlnGlylleThrSecTrpGlySerlleProCysSerLysP 
AGTCAGGTCCTCCATTACTGCTGTCCCTT1CCTTCTTT~GAGACTCAGGAGGCCCACTGATATGTGATGGTGTTCTACAAGGTATCACATCATGGGGCTCTATCCCATGCAGTAAAC 
.51!0 .550 600. 
roAsnAlaProGlylleTyrThrLysLeulleLysPheAsnSerTrplleLysAspThrMetThrLysAsnAlaTer 
CCAATGCGCCGGGCATCTACACCAAACTTATTAAGTTTAACTCC1GGATAAAAGACACTATGACGAAAAATGCCTAAGTGTCACATTATCCTCTGTTCT~TCCACTATGCAAC 
e .650 .700 
AAATGAGTCAAGGTCTGACAGTCTCTATCCTACTGGAATACAGTACACAACCAAGGTCCCAACTAAGGTGAGGGCTTCCAAAGTAGATCAGCAAGGGACAGGTGTACATGTACTGTTGGT 
.750 .800 
TAAGGACATGGGGTTGAGACAAATGCAGACAAAAGGCTCAGACCAACTCAAGGATTCCACTTGAGTCTCCTCTGGCAAAGAAAATGTTCATATCACAGAGGAAAAGTCTAAAGAGATCAG 
.850 .900 .950 
AA TGGGAGAC TCCAGC TAGGCCTGA TC CTA TACTGGAAGC CGAAGGGA TGA T AAACAGTC AGACGC TC CGAA TTC AGAC TGC CTAC C TGAGTTTC 1'TAGG TTGGGC TGGGGTGTTTTGTT 
.1000 .1050 
AATACAGCCTTGGCTCGCTGGAGAAGAATTTGTGCACAGAAGGGCAGGGACTGCCAAAGGCTAGGTAGGCTGCAGTGTCTCTGCTCCCAGTGGCCACTGGAGGGGGTTTCTTTGGTAGGG 
.1100 .1150 1200. 
CTGGATCAAAGGATGAAGAGTGACTTAGAACCATGTCCTGTGGGCAGAGTAATACCCATCTTAGGAAAAGGGCCACACTGCTGCTGCACAGGACCACAAACC.:ACTGTCTGTTTTAGAGGG 
.1250 .1300 
GACATAACCACAGCTAAGAGTATCAGAGATCCGAAGAAGGGCCAGAGAAGGTCAGAAAGATAGACAGAACTGGAAATCTACCAACAACTCTGGGTAGGAGGAGGCACTGGGGTTAAATGG 
.1350 .1400 
AGGATCCCCAGACACCCTTGTCCTTGCCAACACATATTGATTCCAATGCTAAGGAAACTGAAGATGAAGTCTATCTTCTTCAGGCAGCAGCAGACTGGTCGAAAGGAGAAGAACATGGTG 
.1450 .1500 .1550 
GGCAGGAGGATGAAGCATAGTTCCAGGGCCAGAATTATGAAGCCCTTGCTCATGTGAATGTGAACTGGGGAGGAAAGTTGGAAAGATAACTACAGTCATTAGTCATTCAAACCTCTCTCT 
.1600 .1650 
CTCTCTCTCTTTCTCTCTCTCTCTCTCTCTCTCTC.:TCTCTCTCTCTCTCTCTCTCTCTCTCTC.:1'CCCCCCCTCTCTCTCTCCCTCCCCTCCCCCAGTCTAGCTTCCTCTCTCCTTCCTCT 
.1700 .1750 1800. 
CACACCATTGGAGCACAACCTAAGTACTCCAGCACGCTGGAAGGGAGTGGGGGAATGTCTTTTCATGTTCTGACTGTGAAGTTAGAGACACATTGATCTTTTCTTGTTCTAAATACAAGG 
.1850 .1900 
TAAAAGCAGTCGAGGGTCTTGATGTATCTTTTTTTGGCAGAATATTTGCATACGTTGAGCAGCCTGCATTTCATTCTCAACACTGTGCTGAGCTGAGTCTGCAGCACATGCCTGTGATCC 
.1950 .2000 
CTGCAACTGGGAGGAGGATCAGA/\AATCATGGTTGTCCACAGATACACATTGAGTTGGAGGTCAGCCTGGGCTAAACAGACATGTTACAAAGAGTGCAGAAGAAGGGAATGTAGCTGTCT 
.2050 .2100 .2150 
AGAATCCATCCCACAATGAGGGTCAGGAAATGGTTCTGAGTACAGCAAGTC.:CTAGAGTCTCAATAGGTGGAGTTCTTTGGGGGTGTGGGCTTCAAGTAGATAGAGACCCTGTGGAGTGTT 
.2200 .2250 
TGTGTGGCGACTGGGTGCTGACTTCAGAAATTCCCATAAAAGAGGTATAAGAAAAACACCACCCTCCACTTCACATTAACAAAATCATTCCCTAGAAATTCTAAAGTAACTCTACTGCAA 
.2300 .2350 2400. 
CTCATTGAATGACCTACCATCGATGATGTCCCCACTGTGAGCCCAAACCTAGACCCCCAGAAAGAGT~CTGGGAGAGTGGGAGTATACCACCCACACAGCCACCTCTAGAATACAATGGA 
.2450 .2500 
ATGAACCCCCAGTCTATATATTCACTGACCAGAGATTTGTCCCACGTTGTCATATTTATGCCCCCTGCAGCCAATCCAGAGGCTATGAATCCAGTGTATGTTCGGTGCGCATAGGTATTC 
.2550 .2600 
ACACATCCATTATACTGAACACCAACAAGGTTACCGAGAGGATGAACATGAGGGACCAGTTTCGTAGGACAAGATTTCAGTCCTCCTCCCCAGGAATAGAGCAGGACAGCAGGGGAGGGA 
.2650 .2700 .2750 
AAAAATTCTGGGACCTGGATCTTTTCTCCCCTCTCTCTCAATGCATACAAACCTCCATCTTCTTCCTCATTTACATATTCCCCCTCATCTACAACC1GTTCCCTGTGGATGCTGTTTGGA 
.2800 .2850 
GCTCGTCTCCAGCACCACTTCATCTCTTTCTATTCTCATGCACTGGACTCTTCCGGTGCAGTACACCTATCTCAAACTCCAGCATGATTATGTGTGCTTGAAGACATACAAAAAGATCAA 
.2900 .2950 3000. 
GTGCATGGATGTACTCACAAGTGGATGAATGCAGGCTTCCTCTCTTGTCCTTTAGAGCAAAGAACAGTGCAATTTTCAGAAAAACTTCAGCACAGAGGCCTAGGGCCAGAGGAGAACTTG 
.3050 .3100 
GTGGCCAGTTGATCACCAAGTCCTCACTTACCCTAGATTAGGGTTAGCCTAGCCTTCTTGGAGCTTACAGGGCACACAGGAATACACCCAAGTCAAATGTGCTAACTGTCATGAGAGCTG 
.3150 .3200 
AAATAGTCTAGATGCTCAACAAGAGGGGATGGGTCTGAAACCTGCAACAGTAAGTAGGTGTCAAAGGCTGGGTATTTCCCCTTCTCTGTACCAGAACCCATGCTGACTTCTTGATGTTTT 
.3250 .3300 .3350 
AACGTTTGAGACAAAGTCGTCTCCTGTGTAGTTTCACTGGCCTAAATACACTATGTGCACAGTCTAACCTGGACCTCAC.:CAAGATCCACCAGCCCCTGACTCCTAAGTTCTGGGATCAAG 
.3400 .3450 , 
GTGTGC ACCAAAA TA TGC AGC TGC CAAGC TGAAC CC TTAA TGAGG C TC TTGGAGGGAAGTGACA TTTTC TGG T TGC TG TTTC TTGAGAAAGGG TCTC ACA'I GAAC CTTGGC TTGG CTAAC 
.35ilil .3550 3600. 
CTCAAAATGTAGCTCCTGATCTAGGAGATGAGGAAGGGAAAAGTCATAGTGACCCCAACATTGTTCAGGACAGGTGACACTCCCCTGGAATAACCTGAATT1TCATACTTTTGAATAAAA 
.3650 .3700 
GACTGATCAGGCCATGGTAATGTGCACCATAACTTTTATTCATTTTATTTTATAGGTTTGTTTTGAGACAGCTCTATATATAACCTTGGCTGTCTTGAAAGTCACTATGTAGACTAGGTT 
.3750 .3800 
GGTCTACATCACAGAATAC1AGAGCCTAGAATCACACAGATCCACCTGGCTTCAAAG'l'ACTGGTATTAGAGGAGTGCACTGCTATACACTGCTCCCAAGCTTCTCTTAGAAACAATAAAA 
.3850 .3900 .3950 
TCAGTGATCCAGAGTTCCAAGTCCAAAAAGGAAGCATTTTGGCATTCTCCAAGAAAGGATTTGTATCTGCAGGGAGCTTGCAGCCCTCTAGGCTATCACTTGTGAAAGACTCTGTTCTAA 
.4000 .4050 
CTGCAACTTTCTGGGATAATCTTGGACTTGAGGTACAGGACCTTCCTTAAAGTTGTGGGTTAGGCAGCACTTGCTCCACTACCCACCATTCATACCAAGTCACCATTTCCACGACCTTGC 
.4 100 .4150 4200. 
CATCTGGCTCCCAGTACCCGGAACACTAACAGTTCCAGAAACAGCAGGAATTGCCCTCCCAATCTCATTCTTGGGAATGTATCCAGGGTGACCTAGAGCCTTCTGGACAGTGGGTGCAAC 
.4250 .4300 
GAGGTCATCCCTTACCACAGCCAGGATGGTGCAAGTAGAGAATCCTAACCCTGTCAGCAAGGGCAGGGCTTTGTCAGCATCTGGGTGGCAACAGGACAGAGGAGGGGCTGTGGGGAGAAT 
.4350 , .4400 
, , M~tTr~PheLeulleLeuPheLeuAlaLeuPheLeuGlyGlylle 
GGGGGATTTAAAGTCTCCCCAGGGAGCCTCAATAGCTCCAAGCTCACTGCCTGCTGC1CCTGAACACCTGTTACCATGTGGTTCCTGATCCTGTTCCTAGCC.:CTGTCCCTAGGAGGGATT 
.4450 .4500 .4 550 
A 
(@AGATGAGGGAATGGGAGGGGACACAGCCC.:TCACTCCCCTGCTTACTTAGGCCC.:TGGCTGTCCCTTTCCCCTTGCCCCTCTCCCCAGCTACATCATGAGCACCACCTGCTCC1CCTT 
.4600 .4650 
TTCTGGCCCTGTACACTGCCAGGTCCCTCACATTCCTTGCTCCCGGGACAGGCCCCTGTTCCCTCCCACTTTCCAGTAATTTCTCC1CTTCCTTGGACACATAACCATCTCTGGTCTTCT 
.4700 .47 50 480~. 
CCAGTCTTTCTAAGGAACCCAACCTCTTACCAAACTTAGGACCTCAGATTTCCCTACAGTTCATTATTTTTCCTAGAGCCTCATAACACAAAC1CTAAGTCAGAGGCCTGCTTAAATCCT 
.4850 .4900 
CTAACTGCCACGCTTCAACTGTGTTTGCCACATCCTGACAACTGGTGCTACTCTTCTTAAATTGCCCAGTTTCTACCAAAACTTTCACTTCTCAAATTGGCTTGTGATATAAGATGGGTT 
.4950 . 5000 
ACTCCCCTTTGTGCTGTGGGAAAAATGTGCATATACCTATCCAATGACTTTTTGGTTTCGTCTGGTTTTTTAGAGAAGGGATCAGGTTGGAGACACCAGACATGGACATCATGTATCTTC 
.5050 .5100 .5150 
ATCAATCACTCGCCACCTGAGACTGGGTCTCTCACTGTATGGAGAGTTCCTGTTAGGCTAAGATGACTGTGCAGCAAGCCTCGGGGGAATCTTCCTG'fT'fCCACCTCCCCTAGATCTGGG 
.5200 .5250 
GTTACAGGTGCACAGCATCACACCTGACTTTTTGCCTTGGGGTCTGGAAGGTTTAGCTCCAGTCTTAAGGTTTACATGAGCAATCTTGTAGCAACCAAGCCATCTCCAGTCCAGCATTTT 
.5300 .5350 5401!. 
GGAATAAGATCTGAGTTAGTGTCTCATGATGTAGCCCAGGCTTCTCTTCCGTCCATGGCAATTCTTTTGCCTCAGCCTGCTGTTTACTGGGGTTACAGAGAAGTGCGGCTTATGCATGGC 
.5450 .5500 
TTGCCAAGATTTCCTGTTTCCAAATGCTGTGGCTTGGCCTGCTCTTCCCTCTCATGCCTTACTGCCTGAGAGTAAGGCTGCCATCCCATCTCCCTAGAGCTCCACTGCACAGTTCTAGCT 
.5550 .5600 
CCCACTCTGTGCAGGACACCACAAAGACCCCAATGCTTAACCCTAGTACCTCACATCAGCTTGGCTTGCCTCTCTACCTCAGAGTGGCCTGACTTGCTGTAACTATGTTTCCAGTCTTGT 
.5650 .5700 .5750 
CCTGAGGCTGCCTCAAAAAGAACTCTGAGCCTCTCCAATACTCATATTACTTGTTCCACATCCACAAGAAGCAGATCCTGTCTGTCACAGACTTTCCAGATTTTCCACCTCTAACTGCTC 
.5800 .5850 
GCACCATATCAAACTCCTTTCTTAGGGAGATCCACACCTCTTAGATGCCATCTCCACCACAGACACAAACAGGAGCCCACGCACCTTTTATCGGATCCCCTCACTCTCTCCAT'fCCAGCT 
.5900 .5950 6000. 
GCCACTTCACACCCAACCAAAGAAACCAAAAATCAACCCCAGCTCCCTTTCCTGGATTCATTTATTCATTGAGATCCAGTTTCCTGCGACCTCACCCTTTCCAGAATTCCCAAAACCCAG 
.6050 .6100 
CCAAGGCAGTGGTCTTTTCTCAAGCCTTGGAGACTCTAAATTCCAAATCAGAGGATTCTCATTGGAATAAAAATGAACAGGAAGTCTCTCTCTGTCTCTCTCTGTCAGTGTCTTTGTCTC 
.6150 .6200 
ATGCTCTCTCTGTCTCTTTTTCTCACTGTCTCTCTCTCTCTCTGTCTCTCTCTCTGTCCCTCTCTCTTTCTCTCTTTCTCATTGCCCATCTGTCCTTTAGTCAAAAACTATAAAGTGATT 
.6250 .6300 .6350 
TCCACAGTGGTTGTACAAGCTTGCAATCCCACCAACAATGGAGGAGTGTTCCTCTTTCTCCATATCCTCGCCAGCATCTGCTGTCACCTGAATTTTTGATCTTAGCCATTCTGATTGGTG 
.6400 .6450 
TGAGGTGGAGTCTCAGGGTTGTTTTGATTTGCAATTCCCTGATGATTAAGGATGCTGAACATTTTATCAGGTGCTTCTCAGCCATTCGGTATTCCTCAGGTGGAAAGAGAGGCCCATAGG 
.65011 .6550 _ 6600. 
TCTTGCAAACTTTATATGCCTCAGTACAGGGGAACACCAGGGCCAAGAAGTGTGAGTGGGTGGGTAGGGGAATGTGGGGGGAGGGTATGGGGGACTTTTGGGATAGCATTGGAAATTTAA 
.6650 .6700 
ATGAAGAAAATACC'fAATAAAAAATAATAATAATTAAAAAAAACTATAAAGTGGCCTGATACTATACCCAATTCTTGATTCTAGAGTTATTTCTGTACCCACAGCATAGATCTCCCTATC 
.6750 .6800 
CAAGACCAGCCATATACGGGTCCTTTGCCCAGATCACCTGACAATGTCCCCTGAACCCTGTCCTGCTTAACTTTGTCCCCCAAAAGTGCACCTCCCTACATGTGCCAACTCTCCCCTCCC 
.6850 • • .6900 .6950 
spAlaAlaProProValGlnSerArglleValGlyGlyPheLysCysGluLysAsnSerGlnProTrpHisValAlaValTyrArgTyrLysGluTyrileCy 
CCATTGCCACTTTG~TGCTGCACCTCCTGTCCAGTCTCGAATAGTTGGAGGATTTAAATGTGAGAAGAACTCCCAGCCCTGGCATGTGGCTGTGTACCGCTACAAGGAATATATATG 
.7000 .7050 
sGlyGlyValLeuLeuAspAlaAsnTrpValLeuThrAlaAlaHisCysTyrTyrGl 
CGGGGGAGTCCTGTTGGATGCCAACTGGGTTCTCACAGCTGCCCACTGCTATTATG~AGTAAGGGTGGAGACAGAAAAGCAGGGTGGCAGCCATAGATCATGACGACGGGACAAGCT 
• 7100 . 7150 7200. 
GGGTACTGTAGGGCAGGTGGTTAGGACTGGATGAAAGTCTATCCATGATATCCTGGGTCTCTCTTTGCTCCTCCAATCCAGCCTTGGGTTCAGAGTACTGTTTCTTTCTTTTCTGTCTTA 
.7250 .7300 
TTTTTTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTACTGTCTGTATCACATCAGAGTGTCTTCCTGGCCATCTCTACTGTGTGTCTCTTCCTTGGAACTCTGACA 
.7350 .7400 
ACATCTGTCTGGGTCTGGGTCTCATGTGTTCTCTTGTATCACTACTGCCCATAGTGGGGACAAATCCTAACCAGCCCTTGATGATAGAAAGTGCTGTCCATGAAGGTAGGCTGTGAGAGA 
.7450 .7500 .7550 
AGTCCTTACTCTCCTTAGACCAGATCTGCATTTAGGACCTACTGTCACTCTGAGGACACACAGAGAAGGGCTGGTCGTAACTGGAGCTGGGTGAGGTAACTGAGTTCAGTGAGAGACCTG 
.7600 .7650 
GATGCTAGGAAGGTAAGAGAGAGCTCAGACCTTGGGCTGCAGGTCAGGCCTTACCTGCTGGGGAAGTACAGACCCGTCCTAGCTGCACCTGAGCAGCTCTCAGGTCTGCCACTCCTCCTT 
.7700 .7750 7800. 
ACTACCTCTTCCAAGTGTGTGTGTGTCCGTCCGTTCTTGTGTTTTTCTCTCTCTGAGTCTTTCTCTTCCTGCTTCCCTCTTTCCCCTCTTCTCCTATACTTTTTAACTCTCCTTGGTTGC 
.7850 .7900 
uLysAsnAsnValTrpLeuGlyLysAsnAsnLeuTyrGlnAspGluProSerAlaGlnHisArgLeuValSerLysSerPhe 
CTCTTCTCAATCTCTCCATGTCAT'fTCATGCCC'fC~AAGAACAACGTTTGGCTGGGCAAAAACAACCTATACCAAGATGAACCCTCTGCTCAGCACCGATTAGTCAGCAAAAGCTTC 
.7950 .8000 
LeuH1sProCysTyrAsnMetSerLeuHisArgAsnArglleGlnAsnProGlnAspAspTyrSerTyrAspLeuMetLeuLeuArgLeuS~rLysProAlaAsplleThrAspValVal 
CTTCACCCTTGCTACAACATGAGCCTCCATCGGAACCGCATCCAAAATCCTCAGGACGACTACAGCTATGACCTGATGCTGCTCCGACTCAGCAAGCCTGCTGACATCACAGATGTTGTG 
.8050 .8100 .8150 
L)'S Pro 11 eAl ale uProTnrGl uGl uPro Lys Le uGl ySe r The Cys Le uAl a Se rGl yTr pGl yse r 11 e Ile Pro Va 1 Lys P 
AAGCCCATCGCCCTGCCCACTGAGGAGCCCAAGCTGGGGAGCACATGCCTTGCCTCAGGCTGGGGCAGCATTATACCTGTCAAG~AGTCTGGTCCAAGCAACACAGCTGGGTGTGGA 
.8200 . .8250 
heGlnTyrAlaLysAspLeuGlnCysValAsnLeuLysLeuLeuProAsnGluAspCys 
GGAGGGGCAGAAAGGACTTAGCTGGCACCTGCTCACCACCCTCTTGCCTCCTGATCCA@rCCAATATGCAAAAGATCTCCAGTGTGTGAACCTCAAGCTCCTGCCTAATGAGGAC'fGT 
.8300 .8350 8400. 
AspLysAlaTyrValGlnLysValThrAspValMetLeuCysAlaGlyValLysGlyGlyGlyLysAspThrCysLys 
GACAAAGCCTATGTACAGAAAGTCACAGATGTCATGCTGTGTGCAGGAGTGAAGGGTGGAGGCAAAGACACTTGTAA~AGACAGACCCTCCCTGCAGTGAGGTGAAGGCCTGTAAGA 
.8450 .8500 
GGGAACTGAGGTTCTTGGTTCCCACTTCAACACCCTGACTAAGCAGGCTCTTTGCATCCTTCCCTATGGACGGGATGTGCACTGGGAGGGGAGGATCCTGTAGCTGGTACTATTTCTCCT 
.8550 .8600 
CTGTGACATCGCTTAGGGGACTGTCTAGTCAACCCCTCACCCCCGCTCCATGTCTCTGGAAGAGATGGCCTTCTAAGATCTGTGTTCTTACCTATTGAACAGAGCTGCCTCTTAGAGTCC 
.8650 .8700 .8750 
Gl yAspSe r Gl yGl y Pro Leu 11 e CysAs p 
CTGTGTTTATCCCCTGGGAGTCAGTTCCAGCTTGTTGAGTAGAATCCAACTGCCAGGCCCTGCTTACTCCTGTCCCTGTCCTTCTTT~GAGACTCAGGAGGCCCACTGATCTGTGAT 
.8800 .8850 
GlyValLeuGlnGlyLeuTnrSerTrpGl~TyrAsnProCysGlyGluProLysLysProGlyValTyrThrLysLeulleLysPheThrSerTrplleLysAspThrTrpAlaGlnAsn 
GGTGTTCTCCAAGGTCTCACATCATGGGGCTATAACCC~TGTGGTGAACCCAAAAAGCCGGGCGTCTACACCAAACTTATTAAGTTCACCTCCTGGATCAAAGACACTTTGGCCCAAAAC 
.8900 .8950 9000. 
Pro Tee e 
CCCTGAGTGACACACTGTCTGTTCT~TCCACCATGCAACAAATGAGTTCAAGGTCTGACATTCTCTGTCCTACTAGAGTGTGACACCCAATCATGATTTCCCTCAGCTAAGAT 
.9050 .9100 
CAGGATTTCCAAAGTAGATCAGCAAGGGACAGGTGTACATGTACTGTTGGCTAAAGGAACAGGGTTGAAACAAATGTAGACAAAAGGCTCAGGCAAACTCACGGATGCCACTTGAGTCTC 
.9150 .9200 
CTCTGGCAAGGAAAATTCTCAGATCACAGAGCAAAAAGTTAGAGACATCAGAAAGTTCAACTGTAGCTATGCTCATCCACACTGGAAAGCAGAAGAGATGATAAACAGTCAGACACAGAG 
.9250 .9300 .9350 
AATTTAGACAGCAAACCAAGTTGTACTGTGTTGGGGAAGCCAGGAAGGAGGCAGGGGTGTTACGTTAATTAAGCTT 
.9400 
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5.2.6. Exon-intron assignment 
When the previously-sequenced kallikrein cDNA clone 
pMK-1 was aligned with the coding sequences from mGK-1 or 
mGK-2, it was obvious that neither mGK-1 nor mGK-2 
represent the genomic pMK-1 sequence. However, both are 
very closely related to pMK-1 and show 82-84% nucleotide 
sequence homology. 
As previously mentioned, the sequences contained in 
pMK-1 cross-hybridise with exons 3, 4 and 5 of the genes 
mGK-1 and mGK-2. Comparison of these sequences facilitated 
the mapping of exon-intron boundaries. The exact location 
of exon 2 was assigned by a comparison of the amino acid 
sequence of y-NGF with the predicted coding potential of 
mGK-1 in this region (see Figure 5.12 for comparison). All 
the intron sequences assigned (Figure 5.6 a and b) obey the 
5'-GT-AG-3' consensus sequence (Lerner et al., 1980). The 
sequence of y-NGF is only for the active protease and no 
sequence data is available for the prepropeptides of 
kallikreins. The 5' exon of mGK-1, which contains a 
portion of the prepeptide, was located on an 800 bp 
HindIII-SmaI fragment, 2.4 kb 5' to exon 2 of mGK-1 by 
means of northern blot analysis (5.2.4). The boundaries of 
this exon and the 5' boundary of exon 2 were determined as 
outlined below. 
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5.2.7 Expression of mGK-1 
In an attempt to both demonstrate the expression of 
mGK-1 and to map the 5'end of exon 2 and the 3' end of exon 
1, a cDNA library was constructed from submaxillary gland 
poly(A)+ mRNA. The cDNA library was constructed in a 
specific limited fashion in order to select for a mGK-1 
cDNA clone spanning exons 1 and 4. The rationale behind 
, 
this approach is illustrated in Figure 5.7. 
Sites for the restriction enzyme MboI are present in 
exon I (nucleotide 4527) and exon 4 (nucleotide 8356) of 
mGK-1 (Figure 5.6 a and b). Double-stranded cDNA was 
synthesised as described in 2.3.6, cleaved with MboI and 
cloned into the BamHI site of pBR322. A library of 2,500 
clones was constructed and subsequently screened by filter 
hybridisation (2.4.3) with an exon 1 (pK-1-HSm.8 insert) 
-specific probe from mGK-1. One of the positive clones, 
pMK-4, was s~lected for sequence analysis. The sequence of 
this clone was determined on both strands by chemical 
degradation and dideoxy methods (data not shown). The 
complete 500 bp sequence of pMK-4 agrees exactly with the 
exon sequences of mGK-1 between the two MboI sites 
(nucleotide 4527-8356). This result confirms the exon-
intron assignments (Figure 5.6 a and b) for exons 1-4 and 
demonstrates that the mGK-1 gene is transcriptionally 
active in the submaxillary gland. At present it is not 
known whether the gene mGK-2 is also expressed. 
Figure 5. 7 Schematic representation of the strategy used 
for obtaining the cDNA clone pMK-4. Double-stranded 
cDNA was constructed 
transcriptase reactions 
. 
using 
with 
sequential 
submaxillary 
reverse 
gland 
poly(A)+ mRNA as template (2.3.6). To select for an 
mGK-1 cDNA clone, the ds cDNA was cleaved with the 
restriction endonuclease MboI. As MboI sites are 
present in exon 1 (nucleotide 4527) and exon 4 
( nucleotide 83 56) of mGK-1 ( see Figure 5. 6), this 
cleavage should result in the production of a 590 bp 
ds cDNA fragment corresponding to mGK-1. The MboI-
cleaved ds cDNA (~ 20ng) was ligated with lOOng of 
alkaline phosphatase-treated BamHI-cleaved pBR322 
DNA (2.3.7, 2.3.8). The ligation mix was 
transformed into the E. coli host RRl, and the 
resultant 2500 clones screened by filter 
(2.4.3) with an mGK-1 (exon 1)-hybridisation 
specific probe. The sequence of one positive clone, 
pMK-4 corresponded exactly to the coding sequences 
of mGK-1 between the two MboI sites. 
mGK-1 
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5.2.8 Transcription initiation site of mGK-1 
Mung bean nuclease mapping experiments were carried 
out in an attempt to map the site of transcription 
initiation of mGK-1. To map the boundaries of exon 1, two 
fragments were labelled on the strand complementary to the 
mRNA. These were as follows: The PstI-Sau3A 499 bp 
fragment (nucleotides 4027-4527) from pK-1-HSm.8, 5' end 
, 
labelled at the Sau3A site; a 224 bp ·fragment from pK-1-
HSm.8 (Sau3A(nucleotide 4027) - EcoRI site in pBR322), 3' 
end labelled at the Sau3A site; a 5' end labelled EcoRI-
TaqI 877 bp fragment (nucleotides 6104-7001) containing a 
portion of exon 2, isolated from pK-l-B2.6 (see Figure 5.6a 
and b). These templates were annealed to submaxillary 
gland poly(A)+ mRNA and digested with mung bean nuclease as 
described in 2.8.1. The size of the protected fragments 
was determined by electrophoresis on a 10% denaturing 
sequence gel. A portion of the labelled EcoRI-TaqI 
fragment was sequenced by the chemical degradation method 
and the resultant cleavage products run as size markers. 
The results of this analysis are shown in Figure 5.8. It 
can be seen that there are no obvious protected fragments 
but rather a whole range of different size fragments in 
each lane. These data could be due to poor digestion by 
the mung bean nuclease of unprotected fragments, as well as 
a reflection of sequence heterogenity in both the coding 
regions and 5'untranslated region of different kallikrein 
mRNAs present in the submaxillary gland. Indeed, if each 
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of the 25-30 kallikrein genes (see Chapter 6) is expressed 
in the submaxillary gland, such a result would be expected 
since the mung bean nuclease would cleave the template at 
any single base mis-matches. 
To overcome this problem a primer extension experiment 
(2.8.2) using a short primer isolated from exon 2 of mGK-1 
was performed. A 58 bp TaqI-RsaI fragment (nucleotides 
7001-7059) was isolated from pK-l-B2.6, 5'end labeiled and 
annealed with submaxillary gland poly(A)+ mRNA as set out 
in 2.8.2. The primer was extended with reverse 
transcriptase and cold dNTP's and its size estimated by 
electrophoresis on a denaturing 10% polyacrylamide gel 
(2.8.2; Figure 5.9). When the length of the primer was 
aligned with the exon sequence of mGK-1, two putative 
capping sites 36 and 42 bp upstream from the initatior ATG 
were found (Figure 5.6 a). Given that there . is a 
heterogeneous population of different kallikrein mRNA 
species in the submaxillary gland, each capable of 
annealing to the primer, it is impossible to determine if 
both mRNA sizes represent mGK-1 transcripts. The only 
conclusion that can be drawn is that there are two 
potential cap sites present in mGK-1. Interestingly, the 
sequence 5'-AGCTC-3' is present at both putative cap sites. 
-II 
~ 
Figure 5.8 Mung bean nuclease mapping of the exon 1 and 2 
boundaries of mGK-1. 877 bp EcoRI-TaqI fragment 
containing sequences from exon 2; a 499 bp PstI-
Sau3A fragment containing sequences from exon 1; a 
224 bp Sau3A-EcoRI fragment containing sequences 
from exon 1 were labelled on the strand 
complementary to the mRNA (2.8.1). These were 
annealed to submaxillary poly(A)+ mRNA and digested 
with rnung bean nuclease (2.8.1). Shown . lS an 
autoradiograph of a 10% sequencing gel used to size 
the products of digestion (Lane 1: EcoRI-TaqI 
fragment; Lane 3: PstI-Sau3A fragment; Lane 4: 
Sau3A-EcoRI fragment). A portion of the labelled 
EcoRI-TaqI fragment was sequenced by the chemical 
degrada tion method (2.7.1) and electrophoresed as 
size markers ( lanes 2: left to right G, P, Y and C 
cleavage products). 
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Figure 5.9 Primer extension analysis. Autoradiograph of a 
10% sequencing gel used to size extension 
products. The experiment was performed as outlined 
in 2 . 8. 2 and 5. 2. 8. Lane b shows the position of 
the two extension products obtained and lane a shows 
the position of end-labelled HpaII fragments of 
pBR322. The size ( in bases) of these fragments . is 
indicated by the numbers alongside the 
autoradiograph. 
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5.2.9 Structure of a kallikrein gene 
The mGK-1 gene spans 4,572 bp from the point of 
initiation of transcription (if 36 bp upstream from ATG) to 
the poly{A) addition site. There are four intervening 
sequences interrupting the coding region of the mGK-1 
gene. All four intrans begin with a GT dinucleotide and 
end with an AG, sequences thought to be necessary for 
correct RNA splicing (Lerner et al., 1980). The four 
intrans are 2418, 821, 96, and 372 bp long, respectively, 
and the corresponding five exons code for 15, 54, 95, 46, 
and 51 amino acids. The mGK-2 gene exhibits a virtually 
identical 3'end structure to that of mGK-1. Intron D 
occurs in exactly the same position and separates exons 4 
and 5 by a similar 374 bp. While these exons from the 
respective genes are 82% conserved in nucleotide sequence, 
the intron D sequences of both genes are 79% homologous 
when aligned for maximum homology. 
The 3'untranslated regions of mGK-1 and mGK-2 (as 
predicted by analogy with the 3' untranslated region of 
pMK-1) are 45 and 48 bp respectively (Figure 5.6 a and 
b). The high degree of nucleotide sequence homology in 
exons 4 and 5 is retained in the 3'untranslated region. 
Allowing for a single 3 bp insertion in the mGK-2 
untranslated region, the respective sequences can be 
aligned to give 91% sequence homology. Both genes possess 
the putative poly(A) addition signal sequence 5'-AATAAA-3' 
(Proudfoot and Brownlee, 1976) located 19 bp from the 3 1 
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end of the mRNA (with respect to the pMK-1 mRNA 
sequence). The predicted size of the spliced transcript 
from mGK-1 is 873 nucleotides (if the cap site is 36 bp 
upstream from ATG). Northern blotting techniques show that 
kallikrein mRNA present in submaxillary gland is 
approximately 950 nucleotides in length (see Figure 5.4). 
The difference in size (873 compared with 950) can be 
accounted for by the presence of a poly(A) tail of between 
50-100 bases, as observed for most eukaryotic mRNAs (Adams, 
1977; Darnell, 1982). 
5.2.10 Control sequences in the intergenic spacer region 
The complete nucleotide sequence of the 3,754 bp 
spacer region between mGK-1 and mGK-2 has been determined 
(Figure 5. 6 a) . This sequence should contain many of the 
sequences necessary for the expression of the mGK-1 gene. 
The two putative capping sites are preceded by a "Goldberg-
Hogness" box (Carden et al., 1980) located 22 and 28 bp 
upstream. This sequence 5 1 -TTTAAA-3 1 , also seen in the 
carboxypeptidase A gene (Quinto et al., 1982), is a variant 
of the consensus sequence 5'-TATAAA-3 1 , which is thought to 
be important in determining the specificity of the 
initation of RNA synthesis by RNA polymerase II (Grosschedl 
and Birnstiel, 1980). In addition a 'CAT' box is located 
roughly 80 bp upstream from the cap sites ( Benoist et al., 
1980) . This sequence is believed to be necessary for 
efficient RNA transcription (Grosveld et al., 1982). 
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The most striking feature of the spacer region is the 
presence of a TC-rich region 2,700 bp upstream from mGK-1 
(Figure 5.6 a). A sequencing gel covering this region is 
shown in Figure 5.10. The simple T+C repeat is 
interspersed by occasional runs of C residues. This 
sequence is possibly repetitive DNA since the 580 bp BamHI-
PstI fragment containing this sequence hybridises strongly 
when total mouse genomic DNA is used as a probe (data not 
shown). 
5.2.11 Primary structure of the mGK-1 encoded kallikrein 
The complete 261 amino acid sequence of the 
preprokallikrein encoded by mGK-1 is presented in Figure 
5.11. The NH 2-terminal sequence of the primary translation 
product consists of a proposed hydrophobic signal peptide 
18 amino acids in length. The assignment of the signal 
peptide was based on the observations that most signal 
peptides are between 17 and 30 amino acids in length and 
that the last residue · before the cleavage point is often a 
small side chain amino acid (e.g: Ala, or Gly) (Chretien 
and Seidah, 1981). Analogous to trypsin, the active 
kallikrein of 237 amino acids is preceded by a short 6 
amino acid zymogen peptide (MacDonald et al., 1982). 
Kallikreins are known to be glycosylated; the typical 
glycosylation site of y-NGF (Asn-Met-Ser) (Thomas et al., 
1981) is also found in the same position (residue 102-104, 
Figure 5.11) in the mGK-1-encoded protease. 
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Figure 5 .10 
E5.0. 
DNA sequence analysis of a portion of pK-1-
0ne of the Bal31 deletion Ml3 subclones 
derived from pK-l-E5.0 (see Fig. 5.5) was subjected 
to chain-termination analysis. - The 
products 
denaturing 
of this 
sequence 
reaction were analysed by 
electrophoresis on a 10% sequencing 
gel. The sequence shown . J.S of the complementary 
strand of nucleotides 1820~ 1 700 (Fig. 5. 6a) . The 
TC repeat referred to in 5.2.10 is thus represented 
on this gel as AGn. 
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The coding potential of mGK-1 (Figure 5.11) predicts 
an active serine protease with a histidine (residue 41 ) , 
serine (residue 189) and aspartic acid (residue 170) in the 
correct spatial configuration necessary for the formation 
of a serine protease catalytic site (Young et al., 1978; 
Krieger et al., 1974). The presence of aspartic acid at 
position t83 (Figure 5.11) also confers the specificity 
needed for cleavage at basic residues (Krieger et al., 
1974). 
s.2.12 Comparison of mouse glandular kallikrein amino 
sequences 
A comparison of the predicted amino acid sequences of 
mGK-1, mGK-2 and pMK-1 with the known amino acid sequence 
of Y-NGF and the partial sequences of EGF-BP and y-renin is 
shown in Figure 5.12. As all of these proteases share 
extensive amino acid sequence homology of approximately 
75%, it is clear that Y-NGF, EGF-BP and Y-renin are encoded 
by members of the same kallikrein multi-gene family as the 
clones isolated here. All these proteases are structurally 
very similar (for example, in the location of disulphide 
bridges) as previously noted for EGF-BP and Y-NGF (Server 
and Shooter, 1976). Even though EGF-BP and Y-NGF are 
highly homologous, they differ in their substrate 
specificities (Frey et al., 1979), a function attributed to 
alterations in the residues which make up the substrate 
binding pocket of serine proteases (Tschesche et al., 1979; 
., 
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Figure 5.11 Exon sequences from the gene mGK-1. The 
coding region has been translated. The two putative 
initiation sites of RNA transcription for mGK-1 are 
at positions 1 and 7. The arrows indicate the 
proposed boundaries between the signal peptide, 
zymogen peptide and the active protease. 
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MET TRP PHE LEU ILE LEU 
AGC TCC AAG CTC ACT GCC TGC TGC TCC TGA ACA CCT GTT ACC ATG TGG TTC CTG ATC CTG 
-24 
' ' 
PHE LEU ALA LEU SER LEU GLY GLY ILE ASP ALA ALA PRO PRO VAL GLN SER ARG ILE VAL 
TTC CTA GCC CTG TCC CTA GGA GGG ATT GAT GCT GCA CCT CCT GTC CAG TCT CGA ATA GTT 
-1 +l 
GLY GLY PHE LYS CYS GLU LYS ASN SER GLN PRO TRP HIS VAL ALA VAL TYR ARG TYR LYS 
GGA GGA TTT AAA TGT GAG AAG AAC TCC CAG CCC TGG CAT GTG GCT GTG TAC CGC TAC AAG 
20 
GLU TYR ILE CYS GLY GLY VAL LEU LEU ASP ALA ASN TRP VAL LEU THR ALA ALA HIS CYS 
GAA TAT ATA TGC GGG GGA GTC CTG TTG GAT GCC AAC TGG GTT CTC ACA GCT GCC CAC TGC 
40 
TYR TYR GLU LYS ASN ASN VAL TRP LEU GLY LYS ASN ASN LEU TYR GLN ASP GLU PRO SER 
TAT TAT GAA AAG AAC AAC GTT TGG CTG GGC AAA AAC AAC CTA TAC CAA GAT GAA CCC TCT 
60 
ALA GLN HIS ARG LEU VAL SER LYS SER PHE LEU HIS PRO CYS TYR ASN MET SER LEU HIS 
GCT CAG CAC CGA TTA G'fC AGC AAA AGC TTC CTT CAC CCT TGC TAC AAC ATG AGC CTC CAT 
80 
ARG ASN ARG I LE GLN ASN PRO GLN ASP ASP TYR SER TYR ASP LEU MET LEU LEU ARG LEU CGG AAC CGC ATC CAA AAT CCT CAG GAC GAC TAC AGC TAT GAC CTG ATG CTG CTC CGA CTC 
100 
SER LYS PRO ALA ASP ILE THR ASP VAL VAL LYS PRO ILE ALA LEU PRO THR GLU GLU PRO 
AGC AAG CCT GCT GAC ATC ACA GAT GTT GTG AAG CCC ATC GCC CTG CCC ACT GAG GAG CCC 
120 
LYS LEU GLY SER THR CYS LEU ALA SER GLY TRP GLY SER ILE ILE PRO VAL LYS PHE GLN AAG CTG GGG AGC ACA TGC CTT GCC TCA GGC TGG GGC AGC ATT ATA CCT GTC AAG TTC CAA 
140 
TYR ALA LYS ASP LEU GLN CYS VAL ASN LEU LYS LEU LEU PRO ASN GLU ASP CYS ASP LYS 
TAT GCA AAA GAT CTC CAG TGT GTG AAC CTC AAG CTC CTG CCT AAT GAG GAC TGT GAC AAA 
160 
ALA TYR VAL GLN LYS VAL THR ASP VAL MET LEU CYS ALA GLY VAL LYS GLY GLY GLY LYS 
GCC TAT GTA CAG AAA GTC ACA GAT GTC ATG CTG TGT GCA GGA GTG AAG GGT GGA GGC AAA 
180 
ASP THR CYS LYS GLY ASP SER GLY GLY PRO LEU I LE CYS ASP GLY VAL LEU GLN GLY LEU 
GAC ACT TGT AAG GGA GAC TCA GGA GGC CCA CTG ATC TGT GAT GGT GTT CTC CAA GGT CTC 
200 
THR SER TRP GLY TYR ASN PRO CYS GLY GLU PRO LYS LYS PRO GLY VAL TYR THR LYS LEU 
ACA TCA TGG GGC TAT AAC CCA TGT GGT GAA CCC AAA AAG CCG GGC GTC TAC ACC AAA CTT 
220 
ILE LYS PHE THR SER TRP ILE LYS ASP THR LEU ALA GLN ASN PRO 
*** ATT AAG TTC ACC TCC TGG ATC AAA GAC ACT TTG GCC CAA AAC CCC TGA GTG ACA CAC TGT 
237 
CTG TTC TCA ATA AAA TCC ACC ATG CAA CAA ATG 
., 
I 
I 
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Figure 5.12 Comparison of the coding potential of mGK-1 
and mGK-2 with other mouse kallikrein amino acid 
sequences. 
-The predicted amino acid sequence of 
mGK-1 and mGK-2 is aligned with the amino acid 
sequence of y-NGF 
partial sequences 
y-renin (Poe et 
(Thomas et 
of EGF-BP 
al., 1983) 
al., 1981) and the 
(Silverman, 1977), 
and the predicted 
sequence from the cDNA clone pMK-1 (Chapter 3). The 
boxed areas denote regions of the sequences which 
have identical residues. From the alignment of the 
sequences it seems that four amino acids have been 
removed from y-NGF during maturation (see Discussion 
5. 3) . The residues believed to 
binding pocket are heavily boxed 
line the substrate 
(Tschesche et al., 
Stroud et al., 1975; Hartley and Shotton 1979; 
1971). Residues are numbered from the beginning of 
the active protease. 
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Stroud et al., 1975; Hartley and Shotton, 1971). By 
analogy with the overall structure of trypsin and elastase, 
the residues that line the substrate binding pocket can be 
predicted (Tschesche et al., 1979; Stroud et al., 1975; 
Hartley and Shotton, 1971). The kallikreins Y-NGF, EGF-BP 
and y-renin, as well as those encoded by mGK-1, mGK-2 and 
pMK-1, show a significant variation in these particular 
residues compared to the rest of the sequence (Figure 
5.12). It is therefore tempting to speculate that each of 
these kallikreins exhibits a different substrate 
specificity. 
5.3 Discussion 
This chapter describes the isolation and 
characterisation of two closely linked kallikrein genes 
(mGK-1 and mGK-2). The complete sequence of the region 
containing mGK-1 and the 3' half of mGK-2 has been 
determined. The gene mGK-1 spans 4.5 kb and is split into 
five exons totalling 873 bp in length, and is therefore 
typical of most eukaryotic genes, in possessing a mosaic 
exon-intron arrangement. The region 5' to the cap site of 
mGK-1 exhibits some of the signals ('TATAA' and 1 CAT 1 box) 
known to be necessary for eukaryotic gene expression 
(Grosschedl and Birnstiel, 1980; Benoist et al., 1980). 
Although no known protein homologous to the mGK-1-encoded 
protease has yet been isolated, the finding of a cDNA clone 
identical to the coding sequence of mGK-1 indicates that 
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this gene is expressed in the male mouse submaxillary 
gland. The very similar chemical and physical properties 
of the mouse submaxillary gland kallikreins has made their 
characterisation at the protein level difficult and 
probably explains why no protease completely homologous to 
mGK-1 has as yet been characterised. The use of 
recombinant DNA technology has thus allowed many of the 
usual problems encountered in analysis of highly homologous 
related peptides to be circumvented. 
The 3' end of another kallikrein gene (mGK-2) is found 
3.7 kb upstream from mGK-1. This demonstrates that at 
least some of the kallikrein genes are tightly linked . ln 
the genome. The close linkage of kallikrein genes . lS 
further demonstrated by the finding of other genomic clones 
containing more than one kallikrein gene (Chapter 6). The 
3' end of mGK-2 exhibits an identical exon-intron 
arrangement to that of mGK-1. Exons 4 and 5 are 82% 
homologous to their respective counterparts in mGK-1. The 
intron separating them is also highly conserved in sequence 
(79%). All the kallikrein genes which have so far been 
examined in detail (Chapter 6) appear to exhibit an 
identical exon-intron arrangement. 
The mGK-1-encoded protease is initially synthesised as 
a preprokallikrein of 261 amino acids. The presence of a 
signal peptide has not been previously demonstrated for the 
kallikreins but is expected on the basis of their 
localisation in secretory granules (Pasquini et al., 1974). 
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Analogous to other serine proteases (Neurath and Walsh, 
1976), kallikreins possess a short 6 amino acid zymogen or 
activation peptide. This prediction is consistent with the 
isolation of an inactive kallikrein which can be 
proteolytically activated without significant change in 
molecular weight (Schachter, 1980). y-NGF isolated from 
mouse submaxillary gland is either a two chain or three 
chain species (Burton and Shooter, 1981) whilst EGF-BP is 
exclusively a three chain protein (Server and Shooter, 
1976). Chain breakage is believed to be an auto-catalytic 
event with the subsequent removal of some resi9ues by a 
carboxypeptidase B-like enzyme (Burton and Shooter, 
1981). The alignment of the sequences of mGK-1 and y-NGF 
shows an additional 4 amino acid residues (83-86, Figure 
5.12) in the kallikrein autolysis loop where chain breakage 
in Y-NGF is known to occur (Thomas et al., 1981). This 
result suggests that there are four amino acid residues 
removed from the y-NGF molecule during chain breakage. 
Kallikrein-like enzymes possess an extended autolysis loop 
of 11 additional amino acids (82-92, Figure 5.12) relative 
to trypsin. This kallikrein autolysis loop . is on the 
surface of the enzyme and would be expect~d to extend far 
into solution, readily explaining the observed sensitivity 
of Y-NGF and EGF-BP to proteolytic cleavage (Bode et al., 
1983). 
Recently, Swift et al., (1982) described the isolation 
and sequence analysis a cDNA clone encoding a rat 
1 
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pancreatic kallikrein. The nucleotide sequence of the 
mGK-1 gene is 77% homologous with the corresponding 
sequence of the rat cDNA. The only difference in the 
overall structure of these coding sequences is at their 
5' ends, where the rat cDNA contains an additional AUG. As 
illustrated in Figure 5.13, the rat mRNA appears to code 
for an additional four amino acids at the NH 2-terminus, 
owing to a postulated translation initiation at the first 
AUG. Consequently, Swift et al. (1982) have assigned the 
cleavage point between the signal peptide and zymogen 
peptide to a different position from that predicted for the 
mGK-1 protease. Owing to the overall homology between both 
these sequences, it is highly unlikely that the rat 
kallikrein would be so markedly different from the mouse 
kallikrein gene in this position; translation is therefore 
likely to initiate at the second AUG in the rat mRNA. 
Analysis of the amino-terminal end of rat preprokallikrein 
would resolve this question. 
Each of the mouse kallikrein-type sequences (Figure 
5.12) so far examined differs at amino acid residues 
implicated in the substrate specificity of serine 
proteases. This may reflect functional differences between 
most, if not all, of the 25-30 members of the kallikrein 
gene family (Chapter 6). 
Figure 5.13 Comparison the 5 1 end structure of mGK-1 and a 
rat pancreatic kallikrein cDNA clone (Swift et al., 
1982). The mouse sequence (top line) and rat 
sequence have been translated. As shown, Swift 
et al. ( 1982) assigned the translation initiation 
point at the first ATG in the rat cDNA sequence. 
The proposed boundaries between the signal peptide, 
zymogen peptide and active protease for the mGK-1-
encoded protease and rat pancreatic kallikrein are 
indicated by arrows. 
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CHAPTER SIX 
THE GLANDULAR KALLIKREIN GENE LOCUS 
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6.1 Introduction 
. The demonstration that all of the kallikrein genes 
the mouse are located on chromosome seven and that two 
in 
members of this gene family are present in a single lambda 
clone spanning only 13.5 kb suggest that all the individual 
members of the kallikrein gene family may be tightly linked 
in one locus on chromosome seven. In an attempt to 
determine if other members of the family were also as 
closely linked as mGK-1 and mGK-2, further bacteriophage 
lambda genomic isolates were analysed in detail. 
Furthermore, detailed analysis of the structure of the mGK-
1 gene (Chapter 5) facilitates the selection of 
exon-specific hybridisation probes which could be used to 
ascertain whether other kallikrein genes possess the same 
exon-intron arrangement as that of mGK-1. The results 
presented in this chapter show that close linkage is a 
common feature of members of this gene family. In 
addition, members so far examined all appear to possess 
similar exon-intron arrangements. 
Since hybridisation analysis of restriction digests of 
genomic DNA (Figure 4.1) has demonstrated that many, if not 
all, members of this family are highly homologous at the 
DNA level, it is impossible to distinguish between 
individual kallikrein genes by using extensive hybridi-
sation probes such as pMK-1. For this reason the use of a 
chemically synthesised oligonucleotide probe homologous to 
only a portion of mGK-1 was investigated. This study 
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demonstrates the usefulness of synthetic oligonucleotides 
in the investigation of the expression of individual 
members of the kallikrein gene family. 
6.2 Results 
6.2.1 Characterisation of AMSP-2 
Another kallikrein genomic clone (AMSP-2) was isolated 
from a genomic library derived from Quackenbush mouse as 
described in 2.2.7 and cleaved with different combinations 
of the restriction endonucleases BamHI, EcoRI, HindIII, 
SacI and Smar. Following agarose gel electrophoresis the 
DNA was transferred to a nitrocellulose filter and 
hybridised either to a 32P-labelled pMK-1 probe (specific 
for exons 3, 4 and 5) or to a probe prepared from the 
subclone pK-1-HSm.8 (specific for exon 1). An 
autoradiograph obtained after hybridisation with a pMK-1 
probe is shown in Figure 6.1. The exon 1-specific probe 
did not hybridise with AMSP-2 DNA. 
The restriction map of AMSP-2 (Figure 6.2a) shows the 
presence of a kallikrein gene (mGK-6) organised in a 
fashion analogous to that of mGK-1. The structure of mGK-6 
was determined by hybridisation analysis with exon-specific 
probes (see above) and confirmed by sequence analysis as 
detailed in the following section. The clone only contains 
exons 2-5 of a kallikrein gene. The failure of the exon 
• 
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Figure 6.1 Restriction and Southern blot analysis of 
AMSP-2. 
(a) Ethidium bromide stained 1% agarose gel after 
electrophoresis of AMSP-2 DNA digested with HindIII 
( lane 2), Eco RI ( lane 3) , BamHI ( lane 4), Hind I I I 
plus Eco RI ( lane 5), Hind I II plus BamHI ( lane 6), 
EcoRI plus BamHI (lane 7). The marker DNA (lane 1) 
is AC1857 DNA cut with HindIII. 
9.5, 6.7, 4.4 2.3 and 2.0 kb. 
Sizes are 23. 5, 
(b) Autoradiograph of the Southern blot of the above 
gel hybridised with the 32 P-labelled pMK-1 cDNA 
probe at 65°c in 3 x SSC. 
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1-specific probe to hybridise with AMSP-2 DNA could be due 
to a lack of homology between the 5' exons of the genes 
mGK-1 and mGK-6. This seems unlikely since the exon 
1-specific probe cross-hybridises strongly with kallikrein 
mRNA (Figure 5.4), and with all other kallikrein genes so 
far analysed (see later). If exon 1 of mGK-6 was . in a 
similar position to that observed for mGK-1 (i.e. 2400 bp 
5' to exon 2) one would not expect AMSP-2 to contain the 5 1 
end of mGK-6. As shown in Figure 6.2a exon 2 is located 
only 2 kb from the 5 1 end of AMSP-2. The isolation of 
another A clone containing mGK-6 has shown exon 1 of this 
gene to be 2.4 kb distal to exon 2 (6.2.4). 
6.2.2 Sequence analysis of mGK-6 
To obtain limited DNA sequence of mGK-6, especially 
around the exon-intron junctions, the 3.7 kb EcoRI-HindIII 
fragment (Figure 6.2), containing exons 2-5 of mGK-6, was 
subcloned into pBR322. DNA prepared from this plasmid, 
pK-6-EH3.7, was used for DNA sequence analysis. 
Sequencing data was obtained by the chemical 
degradation method and also by using the Bal31 exonuclease 
procedure (Figure 6.2b). The plasmid pK-3-EH3.7 was 
linearised by the endonuclease HindIII, digested with Bal31 
and aliquots taken at 1 minute time intervals over a 6 
minute period (2.3.2). The deleted plasmids were then 
cleaved with EcoRI and the required fragments subcloned 
into EcoRI-HincII-cleaved Ml3 mp8 DNA. Clones selected on 
.. 
I 
.... -
Figure 6.2 
(a) Restriction map of >..MSP-2. The 12 kb insert 
was mapped for the presence of kallikrein sequences 
as described 6.2.1. The boxes denote exons 2-5 of 
the kallikrein gene mGK-6 present on >.. MSP-2. The 
arrow indicates the direction of transcription. 
Wavy lines indicate the left and right arms of >.. 
vector Charon 28. 
(b) The 3.7 kb EcoRI-HindIII fragment containing the 
coding 
pBR322. 
EH3.7 is 
region from mGK-6 was subcloned into 
The restriction map of this subclone pK-6-
shown. Restriction sites are: 
s-sacI, B-BamHI, H-HindIII, P-PstI. 
E-EcoRI, 
The arrows 
below the subclone indicate the direction and length 
of sequence obtained by the chemical degradation 
method. Circled arrows indicate sequence obtained 
by cloning a series of Bal 31 exonuclease-generated 
deletions into mp8. 
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the basis of specific hybridisation to AMSP-2 DNA were 
analysed by dideoxy sequencing (2.7.2). 
The sequence obtained from the analysis of eight Bal31 
deletion clones and from several chemical degradation 
sequencing experiments is presented in Figure 6.3. 
6.2.3 Structure of the mGK-6 gene 
The partial sequence of the subclone pK-3-EH3.7 
presented in Figure 6.3 includes that of exons 2,3 and 4 
and intrans B and D of the _mGK-6 gene. Comparison of this 
sequence with the previously described sequences of mGK-1, 
mGK-2, pMK-1 and the amino acid sequence of Y-NGF suggest 
that mGK-6 may represent the gene for the cDNA clone 
pMK-1. The nucleotide sequences corresponding to amino 
acid residues 150-158 and 206-210 of mGK-6, pMK-1 and mGK-1 
are compared in Figure 6.4. Although the sequences of mGK-
6 and pMK-1 are identical and differ at three positions 
from the sequence of mGK-1, more nucleotide sequence data 
from mGK-6 is required before this gene can be definitively 
assigned as the genomic equivalent of the sequences present 
. in pMK-1. 
The sequence data from mGK-6 shows t~at the position 
of the intrans is exactly conserved between mGK-6, mGK-1, 
and mGK-2. In mGK-6, an intervening sequence (intron B) of 
approximately 1150 bp splits the codon for amino acid 69, 
as does the 841 bp intron B of mGK-1. Although the precise 
boundaries of intron C have not been located by sequence 
r."" 
Figure 
..._ 
6.3 Partial DNA sequence of mGK-6 . The . regions 
that have been translated are from exon 2 (residues 
34-69), exon 3 (residues 70-85 and 150-158) and exon 
4 (residues 206-210). Numbers refer to the position 
in a 261 amino acid preprokallikrein. 
boundaries are boxed. 
Exon-intron 
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Asn Ser Gl n Pro Tr pGl n Val Al a Val Ty r Ar g Ph e Th r Ly s Ty r Gl nCy sGl yG l y Ile Leu 
GAATTCCCAGCCCTGGCAAGTGGCTGTGTACCGCTTCACCAAATATCAATGTGGGGGTATCCTG 
60 
LeuAsnValAsnTrpValLeuThrAlaAlaHisCysHisAsnAs 
CTGAACGTCAACTGGGTTCTCACAGCTGCCCACTGCCATAATG~AGTAAGGGTGGAAACAG 
GAAA GC AGGGTGGCAGCCAGAGAACATGACTCCAAGACAGGCTGGGGTACTGAAGGGCAGAGTG 
GGGGACTGGCTGAAAGTCTATCAATGGCCTCCTGGTTCTCTATTTGCTCCTCCATCCAGGTTTA 
TG 'f ACAGAGTCC1'GTTACTTTCTTTTCTGTATTAT'fGTCTGTGTATCTCCTG'fCTGTATTCACA 
TTTGAGTGTCTCTGTGGTCATCTGTCACTGTGTGTCTCTGCCTTGGGACACTGGGCACACCTTT 
CTGGT 'fCTGGGTCTCATGTGTTTTTTTATCACTACTGCCCTAGTGGGGACCAGGACTTTAGGGC 
ccc-----350bp----CTGCAGGCCAGGCCTTACCTGCTGGGGAAGTTCAGCCCTGTCCTAGCT 
GCACCTGAGCAGCTCTCAGGCCTGCCCCTCCTCCCTGCCCCCTTTTACTTTGTCTTCTGTTCCT 
GTCTCTGTCTCTTTCAGCCTCTCCGACTCTATATGTATTTGTGTCTGTCTGTCTGTCTGTCTTT 
CCGTGTTTCTGTCTCTGAGTCTCTCTTCTACCTCCCTCCCTTCCCCGACTCTTCCCCTTACTCT 
70 
pLysTyr 
GCCCAATCTCCCTGGTTGCCTCCTCTCACTCCCTTCATCTCCTTCCCTGACCCCC~AAGTAC 
80 150 
GlnValTrpLeuGlyLysAsnAsnPheLeuGluAspGluPro SerThrCys 
CAGGTGTGGCTGGGCAAAAACAACTTTTTGGAGGATGAACCC----195bp----AGCACATGC 
210 
LeuAlaSerGlyTrµGly LysAspThrCysAla 
CTAGCCTCAGGCTGGGGCA----240bp----AAAGACACTTGTGCG~AGACAAACCCCCTC 
TGCAATGAGGTGAAGGGCTGAGAGAACTGAGGTTCTTGGTTCCCAGTTGAACACCCTGGCTAGG 
CAGGCTCTTTGCACCTTCCCTATGGAAGGGA----17bµ-----GGATCCTGTACCTGGTACTA 
TTTCTCGCTCTGTGACTTCGCTTAGGGGAATGTCGACCGATCCACCACTCACCCCAACCCCATG 
ACCCTGGAAAAGATGGCCTCCCAAGAGC 
• 
I 
I 
I 
I Figure 6.4 Comparison of the coding region of mGK-6, pMK-1 
and mGK-1. The nucleotide sequence encoding amino 
acid residues 150-158 and 206-210 from these three 
genes are compared. The three nucleotides of mGK-1 
that differ from those of mGK-6 and pMK-1 are 
indicated by stars. The genes mGK-6 and pMK-1 share 
complete homology over this region. 
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analysis, restriction mapping suggests that intron ·c of 
mGK-6 is approximately 100 bp long and occurs in the same 
position as its counterpart from mGK-1. The 5' boundary of 
intron D separates the sequence coding for amino acids 210 
and 211 as demonstrated for mGK-1. Exon 5 from mGK-6 and 
mGK-2 are both located on 1.1 kb BamHI fragments. 
Sequences from this intron are approximately 70% homologous 
with the corresponding regions from mGK-1 and mGK-2. This 
suggests that the structure of this last exon is conserved 
between these genes, and thus exon 5 of mGK-6 is probably 
separated from exon 4 by an intron of 370-380 bp as seen in 
mGK-1 and mGK-2. 
These results demonstrate that the three genes mGK-1, 
mGK-2 and mGK-6 possess an identical arrangement of intrans 
and exons, although variation is observed in intron size. 
For example, intron Bis approximately 330 bp longer in 
mGK-6 than in mGK-1. 
6.2.4 Organisation of the kallikrein gene locus 
To study the molecular organisation of additional 
kallikrein genes, a Charon 28 Balb/c mouse embryonic 
library (supplied by P. Leder) was screened for kallikrein 
sequences utilising pMK-1 as a hybridisation probe. 
Approximately 4 X 10 5 phage were screened as described . in 
2.4.3. Of the 65 clones initially picked, 30 were purified 
to homogeneity and analysed in detail using the following 
exon-specific probes. 
Exon 1 
Exon 2 
Exon 3, 4, and 5 
Exon 4 
Exon 5 
. 
. 
. 
. 
. 
• 
. 
. 
. 
. 
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pK-1-HSm.8 - containing exon 1 of 
mGK-1 
118 bp TaqI-PvuII fragment from 
pK-l-B2.6 - containing part of 
exon 2 from mGK-1 
pMK-1 
pK-2-B.3 - containing exon 4 of 
mGK-2. 
pK-1-BH.8 - containing exon 5 of 
mGK-1 
The restriction maps and the location of the 
kallikrein genes within AMSP-1-2 are illustrated in Figure 
6.5 and compared to the other kallikrein gene-containing 
lambda clones subsequently analysed by B. Evans. The use 
of exon-specific probes enabled the position of each exon 
to be determined and the direction of transcription of each 
gene to be established. It should be noted that the 
lengths of certain regions of DNA, particularly those of 
the first intervening sequence, are only approximate. More 
precise restriction mapping and limited DNA sequence 
analysis is needed to clarify the exact location of some 
exons. 
• 
Figure 6.5 Restriction maps of cloned DNA fragments 
containing mouse glandular kallikrein genes. The 
clones AMSP-1-8 were isolated from mouse . genomic 
libraries using pMK-1 as a hybridisation probe. The 
characterisation of AMSP-1 and AMSP-2 are described 
in Chapters 5 and 6, respectively. The positions of 
exons ( denoted by boxes) within the other clones 
(AMSP-3-8) were mapped by using exon-specific 
hybridisation probes (see 6.2.4). 
transcription of the genes . is 
The direction of 
indicated by the 
arrows. Nucleotide sequence data indicates that the 
gene mGK-6 on AMSP-2 is identical to the mGK-6 gene 
on AMSP-8. Clones AMSP-6 and AMSP-8 overlap. Wavy 
lines indicate the two arms of the A Charon 28 
vector. Restriction sites: B-BamHI, E-EcoRI, H-
HindIII, S-SacI, Sm-SmaI. 
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Several of these additional clones (AMSP-3, 6, 7 
and 8) contain part or all of two kallikrein genes. These 
linked genes are transcribed off the same strand and are 
separated by a spacer region of between 3.5 and 5.0 kb. 
Sequence analysis of one of the genes present on AMSP-
8 (B. Evans, pers. comm.) indicates that it is identical 
with the mGK-6 kallikrein gene contained on AMSP-2. This 
assignment was also based on the similarity of the 
restriction maps of the two clones in this region - the 
only difference being the presence of an additional EcoRI 
site in intron A of the mGK-6 gene contained on AMSP-8. 
Since AMSP-2 was obtained from a Quackenbush mouse genomic 
library, this difference probably reflects the restriction 
site polymorphisms such as that described in 4.2.2. 
6.2.5 Gene-specific hybridisation probes 
All the kallikrein gene sequences (mGK-1, mGK-2, 
pMK-1) so far analysed possess sequence homology of greater 
than 80%. Hybridisation data (4.2) indicate that all the 
mouse kallikrein genes share such extensive sequence 
homology. If the expression of individual kallikrein genes 
is to be studied, a means of distinguishing between 
different members of this highly homologous gene family is 
essential. The use of specific oligonucleotides 
representing the more variable regions of the coding 
sequence as specific hybridisation probes was therefore 
investigated. 
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A 19 bp region from the 3' end of the coding region 
was selected as the most divergent in nucleotide sequence 
among the three gene sequences available (mGK-1, mGK-2, 
pMK-1). The sequences from this region of the three genes 
is compared in Figure 6.6a. Within this 19 bases, both 
mGK-2 and pMK-1 have a total of 7 base mis-matches with the 
coresponding sequence from mGK-1. A synthetic oligo-
nucleotide of sequence 5'-CAGGGGTTTTGGGCCAAAG-3', which is 
complementary to this region of mGK-1, was chemically 
synthesised by the phosphoramidite method (Beaucage and 
Caruthers, 1981). Approximately 10 ng of the 19-mer (a 
gift from J. Coghlan, Howard Florey Institute, Melbourne) 
was labelled at the 5' terminus to high specific activity 
with y- 32P-ATP and T4 polynucleotide kinase (2.3.5). This 
probe was hybridised to a nitrocellulose filter on which 
EcoRI-cleaved DNA, containing 14 distinct kallikrein genes 
(see Discussion), had been immobilised (Figure 6.6 b,c). 
As shown in Figure 6.6c, only the 8.0 kb EcoRI fragment 
from AMSP-1 hybridised with the labelled oligonucleotide. 
This restriction fragment contains the appropriate region 
of mGK-1 which is homologous to the 19-mer. Under the 
hybridisation conditions used (Legend Figure 6.6) the 
oligonucleotide is able to specifically detect mGK-1 
kallikrein sequences. As previously demonstrated (5.2.5), 
the mGK-1 gene is expressed in the male submaxillary 
gland. The 19-mer was shown by northern blot analysis to 
hybridise to mGK-1 mRNA present in this tissue (data not 
shown). 
Figure 6.6 mGK-1 specific hybridisation probe. 
(a) Comparison of the nucleotide sequence of mGK-2, 
mGK-1 and pMK-1 across the 19 bp region used to 
design a mGK-1 specific oligonucleotide. This 
region includes the last two nucleotides of the 
codon for amino acid residue 256, through to the 
first two nucleotides of the termination codon. 
Stars indicate the positions at which the sequence 
of mGK-2 or pMK-1 differ from that of mGK-1. The 
sequence of the synthetic 19-mer which . is 
complementary to this region of mGK-1 is shown. 
(b) Ethidium bromide stained 1% agarose gel after 
electrophoresis of EcoRI-cleaved DNA from the A 
clones: AMSP-1 (lane 2), AMSP-22 (lane 3), AMSP-8 
(lane 4), AMSP-25 (lane 5), AMSP-7 (lane 6), AMSP-5 
(lane 7), AMSP-11 (lane 8), AMSP-20 (lane 9), and 
AMSP-4 (lane 10). These clones contain 14 kallikrein 
genes (see Figure 6.5 and B. Evans, pers. corrun.). 
The marker DNA is Acl857 DNA cut with HindIII. 
(c) Autoradiograph of the Southern blot of the above 
gel hybridised with the 5'end labelled mGK-1 
primer. The nitrocellulose filter was hybridised 
with the labelled . primer for 16 hours . in 50% 
formamide, 3 x SSC at 4 ° C. The filter was washed 
twice at 21 ° C in two changes of 2 x SSC. The only 
fragment which hybridised was the 8.0 kb EcoRI 
fragment from AMSP-1. 
a 
b 
mGK-2 
mGK-1 
pMK-1 
Primer 
5'-CTATGACGAAAAATGCCTA-3' 
* * ** ** * 5'-CTTTGGCCCAAAACCCCTG-3' 
* **** ** 
5'-CTATGATGAAAAATGCCTG-3' 
5'-CAGGGGTTTTGGGCCAAAG-3' 
C 
1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 10 
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These experiments demonstrate that by using synthetic 
oligonucleotides homologous to short stretches of a 
particular kallikrein gene, the tissue-specific expression 
of that gene can be studied. Clearly, the isolation of the 
remaining kallikrein gene sequences is necessary before the 
uniqueness of such probes can be conclusively established. 
6.3 Discussion 
The assignment of the mouse kallikrein genes to 
chromosome seven and their frequent close linkage is 
consistent with the clustering of these genes into a single 
locus. Out of the 30 lambda clones analysed to date (this 
work and B. Evans, pers. comm.) a total of 14 distinct 
kallikrein genes have been identified. Many of the 
kallikrein genes are tightly clustered in a head to tail 
arrangement each separated by an intergenic space of 
between 3.5 and 5.0 kb. More recently, B. Evans (pers. 
comm.) has been able to map a series of overlapping lambda 
clones and demonstrate that at least 4 kallikrein genes 
(mGK-3, 4, 5 and 6) are tightly linked in the genome. 
These four genes are encoded on the same strand of DNA and 
are roughly 4-5 kb apart. However examination of other 
clusters of kallikrein genes show that some intergenic 
spaces are considerably larger than observed for this group 
of four genes. 
The strong conservation of restriction sites observed 
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between different genes and their high degree of cross-
hybridisation suggest that sequences in the coding and non-
coding regions are highly conserved. The location of 
EcoRI restriction sites around and within different 
kallikrein genes is strongly conserved. The different 
EcoRI fragments from the 14 genes so fa~ analysed, are all 
represented among the EcoRI fragments detected by genomic 
blot analysis using pMK-1 as a hybridisation probe (Figure 
4. 1) . Three of these genes contain sequences homologous to 
pMK-1 on 6.7 kb EcoRI fragments and another three contain 
hybridising sequences on 2.4 kb EcoRI fragments (B. Evans, 
pers. comm.). Therefore, the relatively more intense 
hybridisation of certain EcoRI fragments (e.g: 2.4 and 6.7 
kb) observed by genomic blot analysis can be explained by 
the conservation of EcoRI restriction sites around several 
distinct genes. By a comparison of the intensity of 
hybridisation of differently-sized EcoRI restriction 
fragments (see Figure 4.1) with the prevalence of the same-
sized EcoRI fragments among different kallikrein gene 
isolates, it is possible to estimate that there are between 
25 and 30 distinct kallikrein genes in the mouse. 
The high degree of sequence homology observed in 
coding and non-coding regions of different kallikrein genes 
suggests that these 25-30 genes have recently diverged from 
a common ancestor. Similar to other multi-gene families, 
for example a and s· globin (Lauer et al., 1980; 
Efstratiadis et al., 1980); and growth hormone 
(Seeburg, 1982), the precise boundaries of exon-intron 
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junctions are conserved between members, although variation 
is observed in intron size. These data indicate that the 
intrans were present prior to any event of gene 
amplification and subsequent divergence. 
As observed in Chapter 5, functional differences exist 
between the kallikreins so far analysed. One might 
postulate that such differences exist between all the 
kallikreins and that each individual member is involved in 
the processing of a specific peptide precursor. At 
present, it is not known whether all the 25-30 kallikrein 
genes are transcriptionally active. In the submaxillary 
gland at least 6 members are known to be expressed (Y-NGF, 
EGF-BP, Y-renin, S-NGF endopeptidase, pMK-1 and mGK-1). 
The use of synthetic oligonucleotides as gene-specific 
probes offers a method by which the levels and type of 
kallikrein gene expression in different tissues can be 
examined. At present it is known that kallikreins are 
expressed in the submaxillary gland, kidney, mammary 
glands, pancreas, stomach, intestine, lung and brain cells 
(Orstavik et al., 1975; Simson et al., 1978; Orstavik and 
Glenner, 1978; Orstavik et al., 1979; Peeters et al. , 
1976; Uchida et al., 1980; Moriwaki et al., 1980 and 
Werle, 1982). Due to the immunological cross-reactivity of 
many members of this family it is impossible to ascertain 
which particular kallikrein protease is being detected. 
The use of gene-specific probes should resolve this 
problem. 
CHAPTER SEVEN 
GENERAL DISCUSSION 
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The use of the kallikrein cDNA clone pMK-1 as a 
hybridisation probe to study the kallikrein family of 
enzymes at the genomic level has led to the discovery of a 
very large group of homologous kallikrein genes. 
Each of the sequences so far examined, although 
displaying an overall homology of approximately 75%, differ 
at amino acids implicated in the substrate specificity of 
serine proteases. It is possible that such differences may 
exist between most, if not all, of the kallikrein gene 
family members. Given the known role of three of these 
enzymes, namely glandular kallikrein, EGF-BP and Y-NGF, it 
seems likely that the members of this family fulfill a 
general role in the specific processing of bioactive 
peptides. This work supports the previously-suggested 
hypothesis that kallikrein is only one member of a highly 
homologous group of enzymes. This suggestion was based on 
the finding of at least four other kallikrein-like 
activities in addition to Y-NGF, EGF-BP and glandular 
kallikrein in the mouse submaxillary gland (Wilson and 
Shooter, 1979; Bothwell et al., 1979). The work presented 
in this thesis clearly shows that many of the problems 
encountered in working with this group of enzymes at the 
protein level, which have made it difficult even to 
ascertain how many different kallikrein activities exist, 
can be obviated by the application of recombinant DNA 
technology. 
Detailed structural analysis of the two kallikrein 
genes in the genomic clone AMSP-1 demonstrated that these 
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genes (mGK-1 and mGK-2) are closely linked in the genome. 
Furthermore, they are greater than 80% homologous . in 
nucleotide sequence in the coding regions and exhibit an 
identical exon-intron structure. Subsequent studies have 
shown this to be true for other members of this gene family 
(B.Evans, pers. comm.). The kallikrein genes each consist 
of five exons spanning approximately 4.5 kb. The intrans 
separate the coding regions of a preprokallikrein as shown 
in Figure 7.1. As illustrated, the histidine, serine and 
aspartic acid residues, which are essential for the 
formation of a serine protease active site (Young et al., 
1978; 
exons. 
Krieger et al., 1974), are located on separate 
Furthermore, the aspartic acid residue (pos.183) 
which is required for cleavage at basic amino acids 
(Krieger et al., 1974), a characteristic of these enzymes, 
is also located on a separate exon. The residues lining 
the substrate binding pocket which tend to be the more 
variable regions of the protein are widely distributed 
throughout the exons (see Figure 5.12). The genomic 
structure of the related rat trypsin genes is identical to 
that reported here for kallikrein genes (C. Craik, pers. 
comm.). These data are consistent with the evolution of a 
serine protease by the formation of an active site through 
the joining of different exons - each encoding an amino 
acid sequence crucial to the final tertiary structure of 
the catalytic pocket. 
Figure 7.1 Position of exon-intron boundaries in the mGK-1 
gene. The position of intrans A-D are shown in 
relation to the structure of the preprokallikrein 
encoded by mGK-1. The three circled residues (His, 
Asp and Ser) are crucial to the formation of a 
serine protease catalytic site (Young et al., 1978; 
Krieger et al., 1974). The aspartic acid residue 
represented as a triangle confers on a serine 
protease the ability to cleave at lysine or arginine 
basic residues (Krieger et al., 1974). 
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Elucidation of the complete structure of the mGK-1 
gene was necessary to form a firm basis on which other 
members of this family could be studied. The high degree 
of cross-hybridization, as observed by Southern blot 
analysis, suggests that they are roughly 80-85% homologous 
at the nucleotide level (as are the genes mGK-1, mGK-2 and 
pMK-1). By a comparison of the information gained from 
genomic blot analysis with the subsequent data obtained 
from the analysis of genomic clones (B. Evans, pers. coTILm.) 
it is estimated that there are between 25-30 kallikrein 
genes in the mouse. The fact that all the kallikrein genes 
are located on chromosome 7 and their frequent close 
linkage suggests that they may form a tandem array of 25-30 
genes. This arrangement is consistent with the 
organisation of other mammalian multi-gene families e.g. a 
and S globin (Lauer et al., 1980; Efstratiadis et al., 
1980) the light and heavy chain immunoglobulin families 
(Tonegawa, 1983), and the growth hormone family (Kidd and 
Saunders, 1982) where highly homologous genes are found in 
tandem. 
In several multi-gene families, e.g. hu~an S-globin 
genes (Slightam et al., 1981) and the mouse 
Y-immunoglobulin-constant region genes (Schreier et al., 
1981; Ollo and Rougeon, 1983), gene conversion has been 
suggested as the mechanism by which the set of genes 
maintains its sequence homogeneity. Gene conversion 
involves an interaction between gene A and gene B such that 
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the nucleotide sequence of part or all of gene A becomes 
identical to that of gene B. By this mechanism, as 
distinct from unequal crossing-over, gene A and gene B 
retain their physical locations, although a non-reciprocal 
alteration of one gene sequence occurs. In the case of the 
immunoglobulin y-constant region genes (y 2a, Y2b) it was 
shown that the two non-allelic genes of Balb/c mice share 
homologous sequences not present in their allelic 
counterparts in the C57BL/6 mouse strain (Ollo and Rougeon, 
1983). If such gene conversion events were operating in 
the kallikrein gene locus, one would expect to find 
extensive nucleotide sequence allelic heterogeneity between 
different strains of mice. Restriction analysis of the 
kallikrein gene loci of the mice strains Balb/c, C57BL/6 
and Quackenbush indicates very little heterogeneity in 
their respective kallikrein loci. Obviously, the 
nucleotide sequences of a variety of kallikrein gene 
alleles needs to be determined before any gene conversion 
mechanisms could be implicated. If one assumes, as 
suggested by the results presented in this thesis, that 
each of the kallikrein genes has a specific functional role 
in protein processing, a mechanism of gene conversion would 
seem detrimental. Gene conversion would only serve to 
duplicate one gene function whilst destroying another. 
Indeed, before these questions can be examined, the exact 
number of functional kallikrein genes needs to be 
ascertained. One would expect the presence of some 
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'pseudogenes' as found in most other eukaryotic multi-gene 
families (Proudfoot, 1980; Sharp, 1983). The use of gene-
specific synthetic oligonucleotides, as hybridisation 
probes on mRNA isolated from a wide range of of tissues, 
offers the most practical way of determining whether each 
of the different 25-30 kallikrein genes is expressed. 
As described in Chapter 4, the hybridisation obtained 
with pMK-1 on rat genomic DNA was considerably less intense 
than that observed for mouse genomic DNA. This result 
suggests that all the mouse genes are more homologous to 
each other than to their respective counterparts in the 
rat. Recently, the complete nucleotide sequence of a cDNA 
clone encoding rat pancreatic kallikrein was published 
(Swift et al., 1982). 
----
The nucleotide sequence of the rat 
gene shows 77-80% homology with that of the mouse genes 
mGK-1, mGK-2 and pMK~l (which themselves are >80% 
homologous). The lower extent of hybridisation observed 
between rat and mouse genes can be explained by the finding 
that, although these genes share extensive homology, the 
rat gene lacks the long stretches of homology (up to 50 bp) 
retained among the mouse genes. Preliminary nucleotide 
sequence analysis of different rat kallikrein genes has 
demonstrated that such long stretches of nucleotide 
sequence homology also exist between distinct rat genes 
(B. Evans, pers. comm.). Therefore it appears that the 
mouse genes have maintained more extensive homology with 
each other than their rat counterparts - this is supported 
. I 
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by the low immunological cross-reactivity observed between 
rat and mouse kallikrein proteases (Bothwell et al., 1979). 
-Following the identification of the existence of a 
multi-gene family, whose members could fulfill a general 
role in bioactive peptide processing, there are several 
aspects of the molecular biology of the kallikrein gene 
family which remain to be investigated in detail. One of 
the most intriguing problems to be elucidated is the 
pattern of tissue-specific expression. As outlined in 1.8, 
kallikrein or kallikrein-like activities have been found in 
a wide variety of tissues. The isolation and 
characterisation of all the 25-30 kallikrein genes would 
aid such an analysis and enable the design of gene-specific 
oligonucleotides. These could be used as hybridisation 
probes to detect specific-kallikrein mRNA in different 
tissues. The construction of cDNA libraries from the mRNA 
of tissues found to contain kallikrein sequences should 
facilitate the complete analysis of the different 
kallikrein genes expressed in such tissues. Once a pattern 
of tissue-specific expression has been established, the 
basis for this phenomenon could be investigated at the 
molecular level. 
Since EGF-BP and Y-NGF are members of the same family 
one can speculate that the other kallikreins may also 
process a specific bioactive peptide. The most challenging 
aspect of this work is to determine the specific roles 
played by each kallikrein gene in the activation and 
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processing of a variety of physiologically important 
polypeptides. The results gained from the tissue studies 
should give clues as to which polypeptide each member is 
processing, since it is probable that the processed 
polypeptide would be co-ordinately expressed with its 
respective processing enzyme. The use of eukaryotic gene 
expression systems as a means of obtaining highly purified 
kallikreins should be investigated. If successful, the 
purified proteases could be tested in vitro for the ability 
to process a wide variety of prohormones and growth 
factors. 
In addition, experiments could be conducted to 
investigate the molecular basis of co-ordinate gene 
. 
expression. Since in vivo, the S-NGF and Y-NGF proteins 
are found in stoichiometric amounts (Server and Shooter, 
1976), their expression is presumably co-ordinately 
regulated. Gene transfer experiments involving the 
introduction of the genes coding for S-NGF and Y-NGF into 
eukaryotic cells coupled with in vitro mutagenesis of 
'control' regions may provide insights into the molecular 
basis for co-ordinate gene expression. 
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